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Abstract 
Abstract 
Amoebic gill disease (AGD) is a condition of some marine-cultured fish worldwide and 
is the result of Neoparamoeba spp. infection. If AGD-affected fish are left untreated, 
major mortalities can occur. In Tasmania, Australia, fresh water bathing remains the only 
treatment for AGD, a practice that represents approximately 10-20% of production costs. 
Therefore, development of a preventative measure such as vaccination is a priority for 
Tasmanian salmon growers. In this project, resistance of Atlantic salmon to AGD and the 
development of a serum antibody response to Neoparamoeba spp. were assessed. Sera 
from AGD-affected Atlantic salmon were screened to identify potential candidate 
antigens for an AGD vaccine. Atlantic salmon exposed to Neoparamoeba spp. and 
subsequently challenged with AGD demonstrated resistance in terms of increased 
survival compared to AGD-narve fish. In addition, antibodies that bound cell-surface 
carbohydrate epitope(s) of Neoparamoeba spp. were detected in the sera of some fish 
after secondary exposure to Neoparamoeba spp .. In light of this, further screening of sera 
from Atlantic salmon exposed to Neoparamoeba spp. in the laboratory or during sea-cage 
culture was conducted. Antibodies present in the sera of some AGD-affected Atlantic 
salmon predominately bound carbohydrate residues expressed on the cell-surface of 
Neoparamoeba spp .. 
Ideally an AGD vaccine would contain peptide antigen(s) that can easily be produced by 
recombinant DNA technology. Therefore, an alternative approach to identify candidate 
vaccine antigens for an AGD vaccine was needed. Some pathogenic amoebae colonise 
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host tissues via lectin-mediated attachment and lectins have shown promise as candidate 
vaccine antigens. The in vivo effect of mucus and saccharides on the ability of 
Neoparamoeba spp. to cause AGD was investigated. The number of AGD lesions was 
significantly reduced when amoebae were incubated in mucus or any of the range of 
saccharides assessed. These data suggest that colonisation of Neoparamoeba spp. on gill 
tissues of Atlantic salmon may be lectin-mediated and the ensuing infection can enhance 
resistance to Neoparamoeba spp .. However, very few AGD-affected Atlantic salmon 
develop a serum antibody response to Neoparamoeba spp. suggesting that the 
development of antibody-mediated protection of Atlantic salmon during Neoparamoeba 
spp. infection is unlikely. 
Note to the reader 
Each research chapter presented in this thesis was prepared as a stand-alone piece of 
work in view of submitting each chapter for publication. As a result, there is a level of 
unavoidable repetition in the Introduction and Materials and Methods sections of the 
research chapters. The referencing style of this thesis follows the style of the Journal of 
Fish Diseases. 
AGD is caused by Neoparamoeba perurans. However it has been shown that a range of 
amoebae can be isolated from gills of AGD-affected Atlantic salmon. As my work 
utilises gill-isolated amoebae, it is likely that the preparations contain N. perurans and 
other Neoparamoeba species. Therefore, throughout this thesis I refer to gill-isolated 
amoebae as Neoparamoeba spp .. 
2 
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Amoebic gill disease of Atlantic salmon 
Amoebic gill disease (AGD) predominately affects sea-caged Atlantic salmon, Salmo 
salar L., and was first described by Munday (1986) shortly after Atlantic salmon culture 
began in Tasmania. In southern Tasmania, AGD is most prevalent during summer months 
in association with water temperatures in excess of 15°C and salinity of 35 %0 (Kent, 
Sawyer & Hedrick, 1988; Clark & Nowak, 1999; Adams & Nowak, 2003). AGD of 
salmonids has also been reported in Ireland (Rodger & McArdle, 1996; Palmer, Carson, 
Ruttledge, Drinan & Wagner, 1997), the USA (Kent, et al., 1988), Chile, New Zealand 
(Munday, Zilberg & Findlay, 2001), Scotland (Young, Dykova, Snekvik, Nowak & 
Morrison, 2007b) and Norway (Steinum, Kvellestad, Ronneberg, Nilsen, Asheim, Fjell, 
Nygard, Olsen and Dale). AGD also affects marine-farmed turbot, Psetta maxima L., 
(Dykova, Figueras & Novoa, 1995; Dykova, Figueras, Novoa & Casal, 1998) and 
Neoparamoeba spp. have been isolated from the gill tissues of moribund European sea 
bass, Dicentrarchus labrax L., from farms experiencing AGD (Dykova, Figueras & 
Perie, 2000). 
Based on morphological observation, the aetiological agent of AGD was initially 
described as Paramoeba pemaquidensis, Page 1970, (Kent, et al., 1988; Roubal, Lester & 
Foster, 1989). However these gill-derived amoebae did not possess microscales (Kent, et 
al., 1988; Dykova, et al., 2000) as described for members of the Paramoebidae family and 
this species was re-assigned to the Vexilliferidae family (Page, 1987) and was 
subsequently referred to as Neoparamoeba pemaquidensis. Species of marine 
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Neoparamoeba are not known to have different life stages. Reproduction is by binary 
fission and Neoparamoeba spp. are not known to produce resting stages. 
Molecular analysis of 18S rDNA from cultured strains of gill-isolated Neoparamoeba 
spp. provided further support for N. pemaquidensis as the causative agent of AGD 
(Wong, Carson & Elliot, 2004). However, as amoebae isolated from AGD-affected gill 
tissues of Atlantic salmon in Tasmania include N. branchiphila (Dykova, Nowak, 
Crosbie, Fiala, Peckova, Adams, Machackova & Dvorakova, 2005a) AGD was possibly a 
disease of mixed etiology. More recently, analysis of 18S and 28S rDNA from wild-type 
Neoparamoeba spp. contributed to the identification of a new species, Neoparamoeba 
perurans (Young, Crosbie, Adams, Nowak & Morrison, 2007a). 
N. perurans is the predominant agent of AGD of Atlantic salmon (Young, et al., 2007b ). 
Furthermore, molecular assessment of gill histology, using oligonucleotide in situ 
hybridisation probes, of marine cultured Atlantic salmon from Australia, Ireland, 
Scotland and the USA, Chinook salmon, Oncorhynchus tshawytscha Walbaum, from 
New Zealand, rainbow trout, Oncorhynchus mykiss Walbaum, from Australia and turbot 
from Spain confirmed the presence of N. perurans in association with AGD lesions 
(Young, et al., 2007 a; Young, et al., 2007b ). These data provide compelling evidence that 
N. perurans is the predominant aetiological agent of AGD globally. While there is a 
possibility that a range of Neoparamoeba species may be present in gill-isolated 
preparations, it is most likely that the majority of the gill-isolated amoebae are N. 
5 
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perurans as this is the species consistently associated with AGD-affected gill tissue 
(Young, Dykova, Snekvik, Nowak & Morrison, 2008b ). Throughout this thesis where 
analysis of the binding of serum antibodies to wild-type Neoparamoeba spp. was 
conducted, binding of serum antibodies to N. Branchiphila and N. pemaquidensis was 
assessed using clonal cultured strains of these amoebae. 
While a range of Neoparamoeba species may be present in gill-isolated preparations, it is 
most likely that the majority of the gill-isolated amoebae are N. perurans as this is the 
species consistently associated with AGD-affected gill tissue (Young, et al., 2008). 
Throughout this thesis where analysis of the binding of serum antibodies to wild-type 
Neoparamoeba spp. was conducted, binding of serum antibodies to N. Branchiphila and 
N. pemaquidensis was assessed using clonal cultured strains of these amoebae. 
While N. pemaquidensis are detectable by PCR in gill-isolated amoebae from AGD-
affected Atlantic salmon (Young, et al., 2007), in situ hybridisation with species-specific 
18S rRNA oligonucleotide probes identified only N. perurans in gill-isolated amoebae 
preparations (Young, et al., 2007; Young, et al., 2008). 
Wild-type Neoparamoeba consistently elicit AGD in the laboratory (Attard, Crosbie, 
Adams and Nowak, 2006), and there is no indication that virulence is altered over time. 
N. perurans is the causative agent of AGD in the field globally and in the laboratory 
(Young, et al., 2007; Young, et al., 2008). Cultured gill-derived amoebae tested to date 
6 
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do not cause AGD (Kent, Sawyer and Hedrick, 1988; Findlay, 2001; Morrison, Crosbie, 
Cook, Adams and Nowak, 2005; Vincent, Adams, Crosbie, Nowak and Morrison, 2007). 
There is a possibility that there may be differences between gill-isolated amoebae 
obtained from the laboratory and the field. There may also be differences between the 
relative abundence of different amoebae that can be isolated from gill tissues depending 
on season. However, these factors have not been studied. Assessment of these factors 
would be difficult due to the fact that the level of AGD is closely controlled in the field 
by fresh water bathing and a relatively low number of amoebae can be isolated from a 
single fish. 
The characteristic gross sign of AGD is the presence of white, raised lesions. In the 
absence of other conditions that present similar gross gill anomalies, gross gill pathology 
is a reasonable indicator of AGD (Adams, Ellard & Nowak, 2004). However the 
assessment of gill histopathology is required for a diagnosis. Hyperplasia of gill 
epithelium juxtaposed to Neoparamoeba spp. trophozoites produces gill lesions by the 
fusion of secondary gill lamellae (Roubal, et al., 1989; Zilberg & Munday, 2000; Adams 
& Nowak, 2001). Following colonisation of wild-type Neoparamoeba spp. on the gill 
tissues of Atlantic salmon, infiltration of leukocytes can be observed in the surrounding 
gill tissues (Adams & Nowak, 2001; Adams & Nowak, 2003; Bridle, Morrison, Cupit 
Cunningham & Nowak, 2006). Lesions may progress along the filament and at times, 
lamellar fusion of up to 50% of the gill filament can be observed (Adams & Nowak, 
2004b). 
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Fresh water bathing remains the only commercially viable treatment for AGD of Atlantic 
salmon. While fresh water bathing significantly reduces the abundence of amoebae 
present on the gills, Neoparamoeba spp. may not be completely eliminated. After 
bathing, Neoparamoeba spp. continue to proliferate and the gross sign of AGD may be 
observed within one week (Clark, Powell & Nowak, 2003). Currently, fresh water 
bathing contributes to up to 20% of production costs equating to $15-20 Million annually 
(Pheroze Jungalwalla, personal communication). Therefore development of an alternative 
to fresh water bathing, such as vaccination, is a priority for Tasmanian salmon growers. 
Fish can become resistant to parasitism and the induction of resistance of Atlantic salmon 
to AGD may provide relief from fresh water bathing. 
Resistance to ectoparasites in fish 
The development of resistance in fish against ectoparasites in terms of reduced parasitism 
may be observed over time. For example, a substantial decline in parasite abundance was 
seen over time as rainbow trout that developed resistance to the monogenean 
Gyrodactylus derjavini Mikailov, (Lindenstrom & Buchmann, 2000). Similarly, 
measured by a reduction in parasite abundance winter flounder, Pseudopleuronectes 
americanus Walbaum, demonstrated resistance to Gyrodactylus pleuronecti Cone, and/or 
Trichodina murmanica Poljansky, (Barker, Cone & Burt, 2002). Measured by survival, 
some Atlantic salmon demonstrated resistance to AGD after prolonged exposure to wild-
type Neoparamoeba spp. (Bridle, Carter, Morrison & Nowak, 2005). Immunisation of 
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Atlantic salmon with wild-type Neoparamoeba spp. antigens administered by bath 
(Morrison & Nowak, 2005), or by intraperitoneal (i.p) injection (Zilberg & Munday, 
2001) failed to elicit resistance to AGD. 
In some cases, secondary exposure to the parasite is required before resistance is 
observed. Pompano, Trachinotus marginatus Cuvier, re-exposed to the monogenean 
Bicotylophora trachinoti MacCallum, displayed a reduced mean abundance of parasites 
after 30 days while the abundence of parasites on fish exposed a single time increased 
(Chaves, Luvizzotto-Santos, Sampaia, Bianchini & Martinez, 2006). Atlantic salmon 
developed resistance to AGD in terms of reduced gill pathology after secondary exposure 
to wild-type Neoparamoeba spp. (Findlay, Helders, Munday & Gurney, 1995; Findlay & 
Munday, 1998). However, in the study described by Gross, Morrison, Butler and Nowak, 
(2004b ), previous exposure to wild-type Neoparamoeba spp. did not influence the 
survival or gill pathology of Atlantic salmon subsequently challenged with AGD. There 
were notable differences in the experimental designs applied in these studies. In the 
studies described by Findlay et al., (1995; 1998) water temperatures were maintained at 
14°C compared to the l 7°C applied by Gross et al., (2004a). In addition to salinity, water 
temperature is a key factor in the development of AGD (Clark & Nowak, 1999). The 
higher water temperature may have influenced results presented by Gross et al., (2004a) 
and while some resistance to Neoparamoeba spp. was observed in a group of Atlantic 
salmon that were maintained in sea water, the fresh water bath treatment failed to 
completely remove Neoparamoeba spp. from the gills. Therefore during the period 
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before challenge, AGD progressed resulting in ongoing mortalities prior to challenge, 
perhaps removing the most susceptible fish. Demonstration of resistance in Atlantic 
salmon to AGD must precede further study into the development of prophylactic 
measures. The development ofresistance of Atlantic salmon to wild-type Neoparamoeba 
spp. requires further investigation and represents the starting point for this thesis. 
Resistance of fish to ectoparasites has, in some cases, been associated with the 
development of an antibody response, suggesting that development of adaptive immunity 
may be beneficial for guarding against ectoparasitic infestations. 
Development of an antibody response in fish to ectoparasites 
Parasite-specific antibodies have been detected in the serum and mucus of some fish after 
exposure to ectoparasites (Table 1.1). For example, bluegill sunfish, Lepomis 
macrochirus Rafinesque, developed serum and mucosal antibodies after repeated 
exposure to the larvae of the fresh water mussel Utterbackia imbeciliis (Rogers-Lowery, 
Dimock & Kuhn, 2007). Serum antibodies are detected in largemouth bass, Micropterus 
salmoides Lacepide, after repeat exposure to the broken rays mussel, Lampsilis reeveiana 
(Dodd, Barnhart, Rogers-Lowery, Fobian & Dimock, 2006). Modest antibody activity 
has been reported in serum from AGD-affected Atlantic salmon cultured in sea-cages 
(Gross, Carson and Nowak, 2004) and in the serum offish exposed to wild-type 
Neoparamoeba spp. in the laboratory (Akhlaghi, Munday, Rough and Whittington, 
1996). However in both cases, antibodies were detected after binding to antigens of 
cultured N. pemaquidensis. Cultured Neoparamoeba spp. assessed to date failed to elicit 
10 
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AGD in Atlantic salmon (Kent, et al., 1988; Howard, Carson & Lewis, 1993; Findlay, 
2001; Morrison, et al., 2005; Vincent, et al., 2007a). Therefore, antibody binding to 
cultured amoebae antigen(s) may not represent antigens expressed by wild-type 
Neoparamoeba spp. in vivo. The development of a serum antibody response in AGD-
affected Atlantic salmon to wild-type Neoparamoeba spp. has not yet been determined. 
The development of a serum antibody response to wild-type Neoparamoeba spp. is 
plausible. Amoebae entrapped within interlamellar cysts are often seen in association 
with leucocytes in gill sections of AGD-affected fish (Kent, et al., 1988; Munday, Foster, 
Roubal & Lester, 1990; Rodger & McArdle, 1996; Adams & Nowak, 2001; Bridle, 
Butler & Nowak, 2003; Dykova, Nowak, Crosbie, Fiala, Peckova, Adams, Machackova 
& Dvorakova, 2005). Interlamellar cysts provide the environment for interaction of 
Neoparamoeba spp. with immune cells (Fig. 1.1 ). Furthermore, antigen processing may 
occur at the site of infection as cells expressing MHC II have been observed throughout 
AGD lesions present in Atlantic salmon gill tissues (Morrison, Koppang, Hordvik & 
Nowak, 2006). Assessment of the serum antibody response of AGD-affected Atlantic 
salmon to wild-type Neoparamoeba spp. contributes the majority of work presented in 
this thesis. 
The detection of antibodies has been reported for fish affected by ectoparasites. For 
example, an antibody response towards Amyloodinium ocellatum is detectable in the 
serum of tomato clown fish, Amphiprion frenatus Bloch, that demonstrate resistance to 
11 
Chapter 1 
General Introduction 
A. ocellatum after repeated exposure (Cobb, Levy & Noga, 1998). Goldfish, Carassius 
auratus L., immunised with live Ichthyophthirius multifiliis or Tetrahymena pyriformis 
Lwoff, developed a parasite-specific serum and mucosa! antibody response and were 
cross-protected against Oodinium spp., Ichthyobodo spp. or Chilodonella spp. (Ling, Sin 
& Lam, 1993). Rainbow trout immunised with Discoctyle sagittata developed a serum 
antibody response and demonstrated resistance in terms of reduced parasitism (Rubio-
Godoy, Sigh, Buchmann & Tinsley, 2003b). Secondary exposure oflargemouth bass to 
the molluscan parasite Lampsilis reeveiana conferred resistance in association with the 
development of a serum antibody response (Dodd, et al., 2006). Antibodies were detected 
in the serum of Atlantic salmon demonstrating resistance to wild-type Neoparamoeba 
spp. following secondary exposure, however antibodies were detected after binding to 
cultured N. pemaquidensis (Findlay & Munday, 1998). While in the majority of these 
cases, an antibody response has been induced by immunisation; parasite-specific 
antibodies can be detected after fish are infected (Table 1.1). 
12 
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Figure 1.1. Neoparamoeba spp. trophozoites can become entrapped in interlamellar cysts 
where interaction with leucocytes may be observed. Histological section of gill tissues 
from an AGD-affected Atlantic salmon featuring an interlamellar cyst containing a 
Neoparamoeba spp. trophozoite (white arrow) surrounded by leucocyte-like cells (I-le). 
Central venous sinus (CVS). Hyperplastic epithelium (he). Photo taken by the author. 
13 
Chapter] 
General Introduction 
Table 1.1 Marine and fresh water fish can develop resistance to a range of parasites and in some cases this may be associated with an 
antibody response. Host resistance demonstrated after surface exposure or vaccination with ectoparasites, duration of exposure, the 
detection of an antibody response and the method used to assess presence of antibodies are summarised. 
Ectoparasite Host Host Temperature Duration Antibody Method Reference 
resistance+ (OC) of response of 
A 
exposure antibody 
Exposure Vaccination (w-weeks detection 
d- da;ys) 
Protozoa 
Trichodina Winter flounder +p2 10-14 lOw nd (Barker, et 
murmanica, Pseudopleuronectes al., 2002) 
Poljansky americanus 
Walbaum 
Amyloodinium Tomato clown fish + np 30min +Serum IF (Cobb, et 
ocellatum Amphiprion frenatus exposure, WB al., 1998) 
Bloch 3d 
infection, 
repeated x 
4 
Oodinium spp. Goldfish + 28-30 np + Serum E (Ling, et 
Carassius auratus L. +Mucus al., 1993) 
Jchthyobodo Goldfish + 28-30 np +Serum E (Ling, et 
spp. +Mucus al., 1993) 
Chilodonella Goldfish + 28-30 np + Serum E (Ling, et 
spp. +Mucus al., 1993) 
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Table 1.1 continued 
Ectoparasite Host Host Temperature Duration Antibody Method Reference 
resistance+ (°C) of response of 
exposure" antibody 
Exposure Vaccination (w-weeks detection 
d- da!S) 
Protozoa 
Neoparamoeba Atlantic salmon +p 16 72d nd (Bridle, et 
spp. Salmo salar L. al., 2005) 
+s 14 4w + Serum6 E (Findlay, et 
al., 1995) 
+s 14 4w nd (Findlay & 
Munday, 
1998) 
Monogenea 
+p2 Gryodactylus Winter flounder 10-14 lOw nd (Barker, et 
pleuronecti al.,2002) 
Cone 
Discocotlye Rainbow trout + 13 4w +Serum E (Rubio-
sagittata Oncorhynchus WB Godoy, et 
mykiss al., 2003b) 
(Walbaum) 
Discocotlye Rainbow trout -p np Sampled +Serum E (Rubio-
sagittata fish from Godoy, 
0+, 1+ and Sigh, 
2+year Buchmann 
classes & Tinsley, 
2003a) 
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Table 1.1 continued 
Ectoparasite Host Host Temperature 
resistance+ (OC) 
Exposure Vaccination 
Monogenea 
Gyrodactylus Atlantic salmon nd 10 
salaris 
Neobenedenia Japanese flounder nd np 
girellae Paralichthys 
Hargis olivaceus 
Temminck and 
Schlegel 
Microcotyle Rockfish + 18 
sebastis Sebastes 
schlegelii 
Hilgendorf 
Crustacea 
Lepeophtheirus Atlantic salmon nd N 
salmonis 
Kroyer 
Duration Antibody 
of response 
exposure"' 
(w-weeks 
d- da!:S} 
6w - Serum 
-Mucus 
107 d +Serum 
+Mucus 
lw nd 
exposure, 
assessed 
after7 w 
104w +Serum 
F 
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Method Reference 
of 
antibody 
detection 
WB (Buchmann, 
Madsen& 
Dalgaard, 
2004) 
E (Hatanaka, 
WB Umeda, 
Yamashita& 
Hirazawa, 
2005) 
(Kim, 
Hwang, Cho 
&Park, 
2000) 
E (Grayson, 
WB Jenkins, 
Wrathmell& 
Harris, 1991) 
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Table 1.1 continued 
Ectoparasite Host Host Temperature Duration Antibody Method of 
resistance+ (OC) of response antibody 
exposure A detection 
Exposure Vaccination (w-weeks 
d- da!s} 
Mollusca 
Larvae of the Largemouth bass +s 22-23 52w +Serum WB 
broken rays Micropterus 
mussel salmonides 
Lampsilis Lacepide 
reeveiana 
Larvae of the Bluegill sunfish nd 20-21 80 d +serum E,WB, 
freshwater Lepomis 100 d +mucus1 IF 
mussel macrochirus E 
Utterbackia Rafinesque 
imbecillis 
+positive, - negative, nd - not determined, np - not provided, p - prolonged, s - secondary, L - laboratory, F - field, E - ELISA, 
WB - Western blot, IF - immunofluorescence, + Resistance in terms of reduced parasitemia or increased survival. 
Reference 
(Dodd, et 
al., 2006) 
(Rogers-
Lowery, et 
al., 2007) 
"Duration of exposure = total exposure time or time secondary exposure or post-booster vaccination. 1 - titre higher than control at a single point 
over time. p2 - experiment conducted with fluctuations in water temperature and salinity. 6 antibodies detected after binding to cultured antigen. 
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Vaccination against fish parasites 
Vaccination of fish provides an attractive alternative to chemical or pharmaceutical 
treatment of fish diseases. For many bacterial and viral fish pathogens, candidate vaccine 
antigens have been identified by immunisation studies. A serum antibody response can be 
elicited in fish following immunisation of purified or crude parasite antigen(s) 
(Table 1.2). For example, channel catfish, Ictalurus punctatus Rafinesque, immunised 
with live or purified I. multifiliis antigens develop an antibody response (Wang, Clark, 
Noe & Dickerson, 2002; Wang & Dickerson, 2002; Swennes, Findly & Dickerson, 
2007). Rainbow trout developed a modest serum antibody response after immunisation 
with cultured N. pemaquidensis in Freund's Complete Adjuvant (FCA). Peak antibody 
responses were observed after 6 weeks following a single immunisation of 1 mg total 
protein (TP) (Akhlaghi, Munday, Rough & Whittington, 1996) and 4 weeks post booster 
when two immunisations of0.01 mg TP were administered (Bryant, Lester & 
Whittington, 1995) (Table 1.2). However, a disadvantage of performing immunisation 
studies is the requirement for high quantities of antigen and this, in many cases, is not 
practical. 
Cultured Neoparamoeba spp. tested to date are avirulent (Kent, et al., 1988; Howard, et 
al., 1993; Findlay, 2001; Morrison, et al., 2005; Vincent, et al., 2007a). Furthermore, 
immunisation of Atlantic salmon with cultured N. pemaquidensis did not elicit resistance 
to AGD (Akhlaghi, et al., 1996; Zilberg & Munday, 2001). Therefore, cultured 
Neoparamoeba spp. antigens are not considered suitable for the assessment ofresistance 
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of Atlantic salmon to AGD or for identifying candidate AGD vaccine antigens. Bath 
immersion (Morrison & Nowak, 2005) or i.p immunisation (Zilberg & Munday, 2001) of 
Atlantic salmon with low numbers of wild-type Neoparamoeba spp. also failed to confer 
protection to AGD although low numbers of parasites were administered. The only 
source of wild-type Neoparamoeba spp. is from A GD-affected Atlantic salmon. At the 
University of Tasmania, Australia, wild-type Neoparamoeba spp. are isolated from the 
gill tissues of AGD-affected Atlantic salmon following the protocol described by 
Morrison, Crosbie and Nowak, (2004). The average yield of wild-type Neoparamoeba 
spp. is 106 cells (equivalent to around 140 µg TP) from up to seven AGD-affected fish. It 
is difficult to determine the amount of wild-type Neoparamoeba spp. antigen that would 
be required to elicit an antibody response in Atlantic salmon. A modest antibody response 
was detected in rainbow trout immunised with 1 mg TP of sonicated N. pemaquidensis 
with Freund's complete adjuvant (Akhlaghi, et al., 1996). Rainbow trout develop a serum 
antibody response to sea lice, Lepeophtheirus salmonis Kroyer, after immunisation with 
1.5 mg TP/fish of sea lice antigens in adjuvant (Table 1.2). To obtain 1.5 mg TP from 
wild-type Neoparamoeba spp., approximately 107 wild-type Neoparamoeba spp. from an 
estimated 50-60 AGD-affected Atlantic salmon would be required to immunise a single 
fish. Immunisation studies with wild-type Neoparamoeba spp. to assess an antibody 
response and/or protection of Atlantic salmon against AGD are impractical due to the 
time associated with isolating wild-type Neoparamoeba spp. and the large numbers of 
donor fish required. 
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Table 1.2. Conditions applied for the i.p immunisation offish against parasites. The parasite antigen and total protein concentration, 
use of adjuvant, antibody activity and the time post-booster (PB) when the antibody response reaches its peak are summarised (where 
more than one booster is given the time is post-final booster). 
Fish species 
Channel catfish 
Ictalurus punctatus 
Rafinesque 
Rainbow trout 
Oncorhynchus 
my kiss 
(Walbaum) 
Parasite Antigen 
(Total protein - µg) 
[parasite number] 
Ichthyophthirius 
multifiliis 
Live theronts (12.5) 
1 multifiliis 
i-antigens (10) 
1 multifiliis 
i-antigens (10) 
1 multifiliis 
Live theronts 
(20 then 25)4 
1 multifiliis 
Live theronts (2) 
Immunisation Temperature 
schedule (weeks) (oC) 
and use of 
adjuvant 
0, 19 np 
O+ FCA, 2+ FCA 20-23 
0 + FCA, 2 + FIA 20-23 
0,5 20-23 
0 20 
Antib~ 
activi 
(fold 
increase2) 
ImmA 
(80-2560) 
ImmA 
(2.5-3) 
ImmA 
(640) 
ImmA 
(480) 
ImmA 
(>10) 
Peak 
antibody 
response 
{weeks) 
14 
PB 
2 
PB 
5 
PB 
7 
PB 
14 
Reference 
(Swennes, et 
al., 2007) 
(Wang, et al., 
2002) 
(Wang& 
Dickerson, 
2002) 
(Wang& 
Dickerson, 
2002) 
(Alishahi& 
Buchmann, 
2006) 
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Table 1.2 continued 
Fish species 
Rainbow trout 
Japanese flounder 
Paralichthys 
olivaceus 
Temminck and 
Schlegel 
Grouper 
Epinephelus 
coioides 
Hamilton 
Parasite Antigen 
(Total protein - µg) 
[parasite number] 
Lepeophtheirus 
salmonis 
(500) 
Neoparamoeba 
pemaquidensis 
(1000) 
Neoparamoeba 
pemaquidensis 
(10) 
Neobenedenia girellae 
Hargis 
(27-53)2 
Cryptocaryon irritans 
Brown 
[30,000] 
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Immunisation Temperature Antibodl Peak 
schedule (weeks) (°C) activity antibody 
and use of (fold response 
ad~vant __ increase2) (weeks) 
0 + FCA, 3 + 12-14 ELISA 4 
FCA, 6 +FIA (>4) PB 
O+FCA 15 
0 + FCA, 4 + FCA 15 
0 + FCA, 2 + FCA np 
0,2 np 
ELISA 
(<3) 
ELISA 
(4-7.3)5 
ELISA 
(>3) 
ELISA 
(300}3 
6 
4 
PB 
6 
PB 
2 
PB 
Reference 
(Grayson, et al., 
1991) 
(Akhlaghi, et al., 
1996) 
(Bryant, et al., 
1995) 
(Hatanaka, et al., 
2005) 
(Luo, Xie, Zhu & 
Li, 2006) 
1
antibody activity assessed by immobilisation assay (ImmA) or enzyme linked immunosorbent assay (ELISA). 2fold increase expressed as the 
increase in activity compared to the control measured by optical density (ELISA) or cell agglutination (ImmA). 2 fish immunised with cilia 
antigens 500 µg/kg fish. 3peak response was highly variable and declined rapidly over time. 4 protein concentration based on protein concentration 
oftheronts described by Alishahi and Buchmann, (2006). 5data variable and from only 3 fish. FCA: Freund's Complete Adjuvant, FIA: Freund's 
Incomplete Adjuvant, PB: post-booster, np: detail not provided. 
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Other research groups are currently undertaking AGD vaccine research. 
Monoclonal antibodies (MAbs) are being developed to identify antigens specific 
to wild-type Neoparamoeba spp. (Villavedra, Lemke, To, Broady, Wallach & 
Raison, 2007). Inhibitory action of monoclonal antibodies can be assessed in 
vitro and subsequently the protective qualities of these MAbs can be assessed in 
vivo. For example, passive immunisation of channel catfish with 
Ichthyophthirius multifiliis immobilising monoclonal antibodies confers 
protection to I. multifiliis challenge (Lin, Clark & Dickerson, 1996). A 
combination ofbioinformatics and cDNA expression library immunisation 
(ELI) represents another approach of AGD vaccine research (Cook, Campbell, 
Patil, Elliott & Prideaux, 2007). ELI has produced promising results in animal 
models against a range of pathogens (Talaat & Stemke-Hale, 2005). In addition 
to the above-mentioned approaches, immune sera can be exploited to identify 
parasite antigens that are expressed in vivo. 
Identifying candidate vaccine antigens 
Serum antibodies as a tool for identifying candidate vaccine antigens 
Antigen discovery for human pathogens has advanced with increasing 
development of molecular techniques and where cDNA expression libraries are 
available, immune sera can be used to screen recombinant proteins. In vivo 
induced antigen technology (IVIAT) utilises serum from infected individuals to 
screen antigens against expression library antigens from the pathogen of interest 
(Handfield, Brady, Progulske-Fox & Hillman, 2000). IVIAT has been-used to 
identify vaccine candidate antigens of Plasmodiumfalciparum, the causative 
agent of falciparum malaria (Nixon, Friedman, Knopf, Duffy & Kurtis, 2005); 
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Leishmania donovani, the causative agent ofkala azar (visceral leishmaniasis) 
(Arora, Pal & Mujtaba, 2005) and Escherichia coli 0157 responsible for a range 
of potentially fatal human conditions (John, Kudva, Griffin, Dodson, McManus, 
Krastins, Sarracino, Progulske-Fox, Hillman, Handfield, Tarr & Calderwood, 
2005). 
Immune sera can also be screened against crude or purified pathogen antigens to 
identify candidate vaccine antigens. Antibodies in human immune sera binds the 
Gal/GalNAc inhibitable lectin of Entamoeba histolytica Schaudinn, (Petri, Joyce, 
Broman, Smith, Murphy & Ravdin, 1987; Abd Alla, Jackson, Soong, Mazanec & 
Rav din, 2004) and this lectin has shown promise as a vaccine candidate in animal 
models (Zhang, Cieslak & Stanley, 1994; Soong, Kain, Abd-Alla, Jackson & 
Ravdin, 1995; Dodson, Lenkowski, Eubanks, Jackson, Napodano, Lyerly, 
Lockhart, Mann & Petri, 1999). 
The discovery of immobilisation antigens of the ciliate I. multifiliis is the most 
notable example of using immune sera for antigen discovery for a fish parasite. 
Immobilisation of I. multifiliis theronts by immune sera was first observed by 
Hines and Spira (1974). Subsequently, it was shown that antibody binding 
resulted in parasite immobilisation by binding to ciliary and cell-surface antigens 
(Clark, Dickerson & Findlay, 1988; Clark & Dickerson, 1997). Immunisation 
trials have since shown that purified immobilisation antigens (Wang & Dickerson, 
2002) or live theronts (Alishahi & Buchmann, 2006; Swennes, et al., 2007) induce 
serotype-specific antibody-mediated protection to white spot, caused by I. 
Multifiliis, in channel catfish. 
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In this project, sera from AGD-affected Atlantic salmon were screened against 
cultured and wild-type Neoparamoeba spp. with the aim of identifying candidate 
vaccine antigens. This approach provides another complementary arm to the AGD 
vaccine research effort. 
Parasite attachment receptors as candidate vaccine antigens 
Parasite cell-surface lectins are commonly associated with attachment of 
pathogenic amoebae to host tissues. The binding specificity of the carbohydrate 
recognition domain (CRD) of the parasite lectin used for attachment to host 
tissues may be inferred by screening monoclonal antibodies (MAbs ), saccharides, 
host tissues or other compounds for inhibitory activity in vitro (Table 1.3). Once 
identified, the regions associated with cell attachment may be produced by 
recombinant technology and assessed in vivo as candidate vaccine antigens. 
Recombinant proteins representing regions of the CRD of the Gal/GalNAc 
inhibitable lectin of E. histolytica confer protection against amoebic liver abscess 
in gerbils (Gaucher & Chadee, 2003). In addition, collagen-binding proteins 
(CBP) are also implicated in E. histolytica attachment. Immunisation of hamsters 
with recombinant CBP provides protection against liver abscess (Jimenez-
Delgadillo, Chaudhuri, Baylon-Pacheco, Lopez-Monteon, Talamas-Rohana & 
Rosales-Encina, 2004). 
There have been very few studies that compare surface antigens of closely 
related amoebae. However, antigenic similarities in closely related parasites that 
affect humans, cattle and avian species have been studied, predominately on a 
molecular level. 
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Antigenic similarities can be retained throughout evolution. For example,different 
species of amoebae can have similar antigenic properties, particularly if they are 
closely related as is seen with Hartmannella vermiformis and Entamoeba 
histolytica (Venkataraman, Haack, Bondada & Kwaik, 1997). Mechanisms 
associated with attachment of wild-type Neoparamoeba spp. are unknown, cell-
surface receptors may represent novel candidate vaccine antigen(s) for an AGD 
vaccine. In this project, the effect of mucus and a range of saccharides on the 
ability of wild-type Neoparamoeba spp. to colonise the gill tissues of Atlantic 
salmon in vivo were assessed. 
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Table 1.3. The attachment of pathogenic amoebae can be inhibited in vitro by 
saccharides, host tissues or antibodies. Inhibition of attachment of a range of 
pathogenic amoebae to a substrate or cell line by saccharides or host target 
tissues are summarised. 
Parasite Substrate Inhibitor Reference 
Acanthamoeba Rabbit corneal Mannose (Yang, Cao & Panjwani, 1997; Cao, 
castellanii epithelial cells Jefferson & Panjwani, 1998) 
Acanthamoeba Human brain Mannose (Alsam, Kim, Stins, Rivas, Sissons & 
spp. endothelial Khan, 2003) 
cells 
Acanthamoeba Madin-Darby Human (Campos-Rodriguez, Oliver-Aguillon, 
polyphaga canine kidney slgA Vega-Perez, Jarillo-Luna, Hernandez-
cells Martinez, Rojas-Hernandez, 
Contact lens Rodriguez-Monroy, Rivera-Aguilar & 
Gonzalez-Robles, 2004) 
Ent amoeba CHO cells MAbs (Ravdin, Petri, Murphy & Smith, 
histolytica 1986) 
CHO cells Mucins (Chadee, Petri, Innes & Ravdin, 1987) 
CHO cells MAbs (Abd Alla, et al., 2004) 
Giardia 96-well plate Mucin (Roskens & Erlandsen, 2002) 
lamb Zia 
Caco-2 cells Mannose (Katelaris, Naeem & Farthing, 1995) 
Naegleria Collagen 1 Human (Shibayama, Serrano-Luna, Rojas-
fowleri slgA Hernandez, Campos-Rodriguez & 
Rabbit Tsutsumi, 2003) 
IgG 
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For the development of an alternative to fresh water bathing for AGD of Atlantic 
salmon, such as vaccination, it is essential to first determine if Atlantic salmon 
are able to develop resistance to wild-type Neoparamoeba spp .. Secondly, 
suitable candidate vaccine antigens for an anti-AGD vaccine must be identified 
before the subsequent assessment of their protective qualities can be made. 
Therefore the specific aims of this project are as follows: 
~ Assess the ability of Atlantic salmon to develop resistance to AGD. 
~ Assess the development of a serum antibody response in Atlantic salmon 
to wild-type Neoparamoeba spp .. 
~ Identify potential AGD vaccine candidate antigen(s) by screening sera 
from AGD-affected Atlantic salmon against cultured and wild-type 
Neoparamoeba spp. antigens. 
~ Assess potential mechanisms of attachment employed by Neoparamoeba 
spp. to colonise Atlantic salmon gill tissues by screening mucus and a 
range of saccharides in vivo. 
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Chapter 2 
Amoebic gill disease (AGD) affected Atlantic salmon 
(Salmo salar L.) are resistant to subsequent AGD challenge 
This chapter is published, in part, in the Journal of Fish Diseases: 
Vincent, B. N., Morrison, R. N. and Nowak, B. F., (2006) Amoebic gill disease (AGD)-
affected Atlantic salmon, Salmo salar L., are resistant to subsequent AGD challenge. 
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Abstract 
There is inconsistent evidence of resistance of Atlantic salmon, Salmo salar L., 
to amoebic gill disease (AGD). Here, evidence is presented that Atlantic salmon 
exposed and subsequently challenged with AGD are more resistant in terms of 
reduced mortality than naive control fish. Seventy three percent of Atlantic 
salmon previously exposed to AGD survived to day 35 post-challenge compared 
to 26% exposed to Neoparamoeba spp. for the first time, yet the gill pathology of 
surviving naive control or previously exposed fish was not significantly 
different. Anti-Neoparamoeba spp. antibodies that were detectable in serum of 
50% of surviving Atlantic salmon previously exposed to AGD. However, anti-
Neoparamoeba spp. antibodies were not detectable in cutaneous mucus of 
resistant fish. Reduced mortality of Atlantic salmon after secondary 
Neoparamoeba spp. infection and detection of specific serum antibodies 
provides support for the development of a vaccine for AGD. 
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Vaccines developed against a range of bacterial fish pathogens have provided the 
aquaculture industry with relief from the use of antibiotics. Perhaps the most 
notable instance was the drastic reduction in antibiotic use in Norway that 
followed the introduction of vaccines against vibriosis and furunculosis during 
the late 1980s (Sommerset, Krossoy, Biering & Frost, 2005). This resulted in a 
significant increase in the production of farmed fish. However, the development 
of vaccines against parasitic pathogens of fish has proven more difficult. There is 
an increasing amount of evidence for the role of adaptive immunity in protection 
against fish parasites and this provides encouragement for future development of 
anti-parasitic vaccines. For example, resistance to the monogenean Discocotyle 
sagittata (Rubio-Godoy, et al., 2003a), dinoflagellate Amyloodinium ocellatum 
(Cobb, et al., 1998) and haemoflagellate Cryptobia salmositica (Chin & Woo, 
2005) has been associated with specific serum antibody. In addition the response 
of channel catfish to infection with the protozoan I. multifiliis has been widely 
studied and there is strong support for the protective role of both mucosal and 
systemic antibody (Wang & Dickerson, 2002; Xu & Klesius, 2002). Further, 
antibodies that bind immobilization antigens mediate resistance to /. multifiliis 
infection (Clark, Lin & Dickerson, 1996; Lin, et al., 1996). 
The aetiological agent of amoebic gill disease (AGD) of Atlantic salmon is 
Neoparamoeba spp. (Adams & Nowak, 2004a; Dykova, et al., 2005a). In 
Tasmania, Australia, AGD is most prevalent during summer months and is 
associated with increased water temperature and 35%0 salinity (Clark & Nowak, 
1999; Adams & Nowak, 2003). The characteristic gross sign of Neoparamoeba 
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spp. infection is white raised mucus patches on infected gill surfaces. 
Histologically, infection with Neoparamoeba spp. results in hyperplasia of 
epithelial cells leading to fusion of secondary gill lamellae (Roubal, et al., 1989; 
Zilberg, Findlay, Girling & Munday, 2000; Adams & Nowak, 2001). To date, the 
only effective treatment for AGD is freshwater bathing and developing an 
alternative treatment such as a vaccine is a priority for Tasmanian salmon 
growers. 
Resistance of Atlantic salmon to AGD after secondary exposure has been 
previously reported on the basis of gill pathology (Findlay, et al., 1995; Findlay 
& Munday, 1998) and more recently, enhanced survival of a sub-population of 
Atlantic salmon to AGD infection has been documented in association with a 
marked reduction in gill pathology (Bridle, et al., 2005). While there is evidence 
that Atlantic salmon are able to develop resistance to AGD, conflicting results 
also exist. Resistance to AGD challenge was not seen after Atlantic salmon were 
previously exposed to Neoparamoeba spp. (Gross, et al., 2004b ). However, 
results from this study may have been influenced by mortalities that were 
recorded prior to AGD challenge and further by the presence of an ongoing AGD 
infection in one treatment group. Due to inconsistent reports, the need remains 
for further study to identify if Atlantic salmon can develop resistance to AGD. 
Identifying a protective antibody response against wild-type Neoparamoeba spp. 
is central to the development of a successful vaccine treatment for AGD. As 
Neoparamoeba spp. are found predominately in association with the surface of 
gill lesions, the role of antibodies in resistance to AGD had been largely 
dismissed. However, Neoparamoeba spp. can be found entrapped within 
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interlamellar vesicles in association with inflammatory cells (Adams & Nowak, 
2001 ). The subsequent processing of entrapped antigen may be facilitated by 
MHC II+ cells that are present in gill lesions of AGD-affected Atlantic salmon 
(Morrison, et al., 2006) resulting in production of specific antibody. While 
detectable, yet modest systemic antibody has been previously reported in 
Atlantic salmon after contracting AGD (Akhlaghi, et al., 1996; Gross, Carson & 
Nowak, 2004a), these antibodies were detected after binding to cultured amoebae 
antigens. Cultured gill-derived Neoparamoeba spp. are avirulent (Morrison, et 
al., 2005) and antibodies that bind cultured amoebae may not be relevant in vivo. 
It is essential that the antibody response of Atlantic salmon to wild-type 
Neoparamoeba spp. be assessed if antigens associated with virulence are to be 
discovered. The present study investigates the effect of Neoparamoeba spp. 
infection on the development of a detectable systemic antibody response and 
survival of Atlantic salmon. Results presented here show that Atlantic salmon are 
able to develop resistance, in terms ofreduced mortality, to AGD and systemic 
antibody is associated with some AGD-resistant fish. 
Materials and methods 
Fish and experimental conditions 
Atlantic salmon with an average weight of95.2 ± 4.5g were obtained from the 
Saltas hatchery, Wayatinah, Tasmania. These fish had only been maintained in 
fresh water and therefore had not been exposed to Neoparamoeba spp .. Fish 
were held in 3000 L temperature controlled recirculating systems, each with an 
individual protein skimmer and biofilter. Prior to experimental procedures, fish 
were acclimated to 35%0 salinity by multiple sea water exchanges over a 10 d 
period. Sea water was filtered to 1 µm. During experimental procedures, tanks 
were subjected to twice-weekly water exchange of approximately 30% volume. 
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Fish were fed once daily to satiation using a commercial 3 mm pellet (Skretting, 
Tasmania). 
This study involved two independent trials. The first exposed Atlantic salmon to 
Neoparamoeba spp. infection at 12°C for a period of 4 weeks and was performed 
to obtain serum and mucus samples. The second trial was conducted to assess 
resistance of Atlantic salmon to AGD challenge. The initial infection period was 
conducted at 12°C to maintain the infection for 4 weeks at a non-lethal level. 
This was to ensure that fish in trial 2 could proceed to challenge and that the 
survival of these fish was not influenced by a heavy Neoparamoeba spp. 
infection when exposed to challenge conditions. 
Trial 1- Induction of amoebic gill disease 
Two tanks of30 Atlantic salmon were acclimated from 12°C to 16°C by 
increasing the water temperature by 1°C per day. To establish infection, gill-
derived amoebae (Morrison, et al., 2004) were introduced to one tank at 500 
cells/L. After 7 d at l 6°C, the water temperature of both tanks was reduced by 
I °C per day to 12°C and fish were monitored for a period of 4 weeks. These fish 
were terminally sampled after the 4 week infection period. 
Trial 2- Induction of amoebic gill disease and challenge 
Two tanks of 40 fish were subjected to the same regime as trial 1. After the 
initial 4 week infection period at 12°C, 10 fish from each tank were randomly 
sampled following the sampling protocol outlined below. The remaining 30 fish 
from each tank were transferred into a freshwater bath for 24 hat 14°C. After 
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bathing, one group was tagged by sub-dermal injection with Alcian blue (Sigma-
Aldrich) and all 60 fish (30 fish previously exposed and 30 na'ive fish) were 
returned to the system that was previously inoculated with Neoparamoeba spp .. 
No further amoebae were added and the temperature was adjusted to 15°C then 
to 16°C the following day. The currently accepted criterion used to assess the 
efficacy of vaccines administered by immersion is that the relative percent 
survival of treated fish is >60% and the control mortality is 60% or greater, 21 
days after onset of disease (Midtlyng, 2005). This criterion was adopted to 
identify if Atlantic salmon previously exposed to Neoparamoeba spp. displayed 
resistance when subsequently challenged with AGD. 
Sampling and assessment of gill pathology 
Fish were killed by overdose of Aqui-S (Aqui-S NZ Ltd, Lower Hutt, New 
Zealand). Cutaneous mucus was collected from each fish using a cotton swab 
and placed into an Eppendorftube containing 400 µL PBS and 100 µL anti-
protease cocktail (Sigma-Aldrich). The tubes were vortexed to elute the mucus 
and excess liquid was removed from the swab by pressing against the side of the 
tube. Samples were centrifuged at 16 OOOx g for 15 min to separate mucus from 
particulate contamination and the supernatant was removed and stored at -20°C. 
Blood was taken from the caudal vein, allowed to clot overnight at 4°C, 
centrifuged at lOOOx g for 10 min and serum was removed and stored at -20°C. 
The entire gill basket was excised and placed in seawater Davidson's fixative 
(SWD). Gills were transferred to 70% ethanol after 24 h. To view gross 
pathology, the second left gill arch was photographed (Olympus C5050, Tokyo, 
Japan) and then the same gill arch was processed and embedded following 
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routine histological protocols. Sections (5 µm) were stained with hematoxylin 
and eosin (Hand E).The proportion of filaments affected by Neoparamoeba spp. 
was assessed by light microscopy at 400x magnification. Filaments were counted 
when the central venous sinus was visible in at least two-thirds of the filament 
length (Adams & Nowak, 2003). 
Cultured and wild-type amoebae 
Wild-type amoebae were isolated as described by Morrison et al., (2004) from 
Neoparamoeba spp. infected Atlantic salmon housed at the University of 
Tasmania aquaculture research centre. To discriminate between antibody binding 
to cultured and wild-type Neoparamoeba spp. antigens, two previously 
characterised clonal strains of cultured Neoparamoeba spp. were included for 
Western blot analysis. These were Neoparamoeba pemaquidensis (NP251002) 
(Morrison, et al., 2005) isolated from AGD-affected Atlantic salmon, and 
Neoparamoeba branchiphila (SEDMHl) (Dykova, et al., 2005a) isolated from 
marine sediment. Amoebae were maintained on seawater malt yeast agar; 75% 
(v/v) coarse filtered seawater (35%0), 25% (v/v) distilled water, 0.01 % (w/v) 
Malt, 0.01% (w/v) yeast (Oxoid, Hampshire, England), 2% (w/v) Bacto agar 
(Becton, Dickson and Co., USA). Cells were harvested by washing from the agar 
with sterile sea water using a transfer pipette. Wild-type and cultured cells were 
concentrated by centrifugation at 500x g for 5 min and enumerated by 
hemacytometer. Amoebae were washed twice with PBS and the cell pellet was 
stored at -80° C until use. 
Detection of anti-Neoparamoeba spp. antibodies in serum and mucus 
Positive and negative control serum 
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Serum was obtained from an Atlantic salmon that had been exposed to 
Neoparamoeba spp. and displayed overt signs ofresistance. This fish presented a 
low level of gross gill pathology and prolonged survival in challenge conditions. 
Serum antibodies bound to wild-type Neoparamoeba spp. in an indirect enzyme 
linked immunosorbent assay (ELISA) and this serum was further characterised 
and used as a positive control in subsequent Western blot and ELISA assays. 
Negative control sera was pooled from 5 fish maintained in fresh water and 
therefore these fish were naive to AGD. 
SDS-PAGE and Western blot 
To identify the binding activity and specificity of serum antibody against 
cultured and wild-type amoebae antigens, all serum samples taken (at the end of 
trial 1, prior to freshwater bathing in trial 2 and at the termination of trial 2) were 
first processed by Western blot. Initially, pools of serum from 5 fish were 
screened and serum from pools returning a positive result were subsequently 
screened individually. Amoebae antigens were reduced in buffer containing 
~-mercaptoethanol by boiling for I 0 min, separated through 6% polyacrylamide 
gels with 4 x 104 cell equivalents were loaded in each lane (5.5 µg total protein 
per lane). Antigens were transferred to nitrocellulose membrane (Hybond-C 
extra, Amersham Biosciences, UK) using a semi-dry transfer apparatus (Hoefer 
Scientific Instruments, San Francisco, CA). Membranes were blocked in casein 
solution (Vector, Burlingame, CA, USA). Blocking and antibody incubation 
steps were for 30 mins and in between incubation steps, membranes were 
washed 3 x 4 min with tris-buffered saline (TBS, pH 7 .2). Atlantic salmon serum 
was applied at 1: 100 (pooled) and 1 :500 (individual). Bound antibodies were 
detected with rabbit anti-salmon IgM at 1 :5000 followed by alkaline phosphatase 
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(AP)-conjugated sheep anti-rabbit lgG (Chemicon, Australia) at 1 :5000. For 
analysis of mucus, antigen concentration was increased to 8 x 104 cells per lane 
and mucus supernatant was diluted 1:1 in casein solution. Each sample of mucus 
was assessed for the presence of mucosa! anti-wild-type Neoparamoeba spp. 
Bound antibodies were detected with rabbit anti-salmon lgM at 1 :500 and AP-
conjugated sheep anti-rabbit lgG 1:2000. Mucus collected from 5 Atlantic 
salmon held only in fresh water was pooled and used as a negative control. 
Following the final antibody incubation, membranes were washed 3 x in TBS 
and then in O.lM tris (pH 9.5) for 5 min. The binding ofpolyclonal rabbit anti-
salmon IgM to Atlantic salmon lgM was initially assessed by western blotting. 
Normal Atlantic salmon serum and mannan-binding protein (MBP)-purified 
Atlantic salmon serum IgM were separated through a 12% gel. Proteins were 
transferred and the membrane was blocked as outlined above. The membrane 
was probed with polyclonal rabbit anti-salmon lgM and bound antibodies 
detected with AP-conjugated sheep anti-rabbit IgG as outlined above. All 
incubation and wash steps were conducted at 20°C. Western blots were 
developed by enhanced chemiluminescence (ECL) using DuoLuX (Vector), 
Kodak BioMax Light Film and Kodak GBX developing and fixing reagents 
(Sigma, Castle Hills, NSW, Australia) following the manufacturer's instructions. 
45 
Chapter2 
A GD-affected Atlantic salmon are resistant 
Enzyme-linked immunosorbent assay (ELISA) 
The activity of anti-Neoparamoeba spp. antibodies was determined by an 
ELISA. Wild-type Neoparamoeba spp. suspended in PBS were sonicated then 
centrifuged for 10 min at 16 OOOx g and the supernatant stored at -20°C. Protein 
concentration of the sonicated amoebae was determined by a colorimetric assay 
(Pierce, Rockford, USA). Optimal conditions for ELISA were determined 
empirically. Briefly, 96-well flat bottom plates (Sarstdet, Australia) were coated 
with 50 µL sonicated wild-type Neoparamoeba spp. (0.24 µg total protein/well) 
in coating buffer (50 mM NaHC03, pH 9.5) at 4°C overnight. Antigen was 
discarded and wells were blocked for 30 min at 37°C with 0.3 % casein-PBS 
(Sigma). All serum samples were serially diluted in 0.3 % casein-PBS in 
duplicate from 1:100 to 1:3200, (50 µL/well) and plates were incubated for 1 hat 
20°C. Bound antigen was detected with polyclonal rabbit anti-salmon lgM at 
1:500 and horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG at 
1:1000 for 30 min at 37°C. The reaction was developed with 50 µL 
o-phenylenediamine (OPD) (Sigma) and stopped with an equal volume of 3M 
HCI. Positive and negative control serum was titrated from 1: 100 to 1 :3200 on 
each plate in duplicate. 
Immunocytochemistry and flow cytometry 
Wild-type amoebae were fixed in seawater Davidson's fixative (SWD) for 1 hat 
20°C and washed by four cycles ofre-suspending cells in PBS and concentrating 
cells by centrifugation at 500 x g for 5 min. Amoebae were placed in wells of 96-
well U-bottomed microplates (Sarstdet) and blocked in 0.1 % BSA-PBS for 30 
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min at 4 °C. Cells were probed with normal Atlantic salmon serum and serum 
that contained anti-Neoparamoeba spp. antibodies. Cells were incubated with 
salmon serum at 1:10 and bound antibodies were detected with rabbit anti-
salmon IgM at 1:100 and FITC-conjugated sheep anti-rabbit IgG (Chemicon, 
Australia) at 1:50. Cells were washed 3x in PBS following each antibody 
incubation step and a sub-sample of cells were photographed (Leica DC300F, 
Leica Microsystems, Wetzlar, Germany) using light and fluorescent microscopy. 
Using the remaining probed cells, the proportion of wild-type Neoparamoeba 
spp. expressing epitope(s) to which the salmon anti-Neoparamoeba spp. 
antibodies bound was quantified by flow cytometry (Coulter Epics, Beckman 
Coulter, USA). Ten thousand cells were assessed per treatment and data were 
analysed using WinMDI 2.8 software (Joseph Trotter, Scripps Research Institute, 
La Jolla, California, USA). 
Data analysis 
Survival data were analysed by Kaplan Meyer survival analysis with differences 
in survival between treatment groups determined using the log-rank test 
(MedCalc). Differences in gill pathology between groups were assessed by t-test. 
Data were initially tested for homogeneity using Levene's test (SPSS) and 
differences were considered significant at P < 0.05. 
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Results 
Trial 1- Induction of amoebic gill disease 
No mortalities occurred in the Neoparamoeba spp. inoculated or control systems 
during the 4 week infection period. Neoparamoeba spp. were not detected on 
gills of Atlantic salmon from the control tank. 
Trial 2 - Induction of amoebic gill disease and subsequent AGD challenge 
During the initial 4 week infection period of the second trial there were no 
mortalities recorded in either the inoculated or control tank. Prior to freshwater 
bathing, gill histology from a sub-population of 10 fish from the inoculated 
group confirmed AGD. Neoparamoeba spp. were not found on gills of Atlantic 
salmon from the naive control group. No mortalities occurred during the 24 h 
freshwater bath treatment. After induction of challenge conditions, morbidity 
resulting from AGD occurred in the naive control group after 23 d and after 26 d 
in the group previously exposed to Neoparamoeba spp .. Trial 2 was terminated 
at day 36 post-challenge by which time 73% of the naive control 
group had succumbed to AGD. Cumulative morbidity of naive fish was 
significantly greater (P = 0.001) than that of Atlantic salmon experiencing 
secondary exposure to Neoparamoeba spp. (Fig. 2.1 ). Gross and histological 
observation of gills of surviving fish from the naive control (n = 8) and 
previously exposed (n = 22) groups was consistent with AGD infection (Fig. 2.2) 
and there was no significant difference (P = 0.182) in the proportion of AGD-
affected gill filaments between groups (Fig. 2.3). 
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Figure 2.1. Atlantic salmon previously infected with Neoparamoeba spp. show 
reduced mortality to a subsequent AGD challenge. Previously exposed fish 
(n = 30) were inoculated with Neoparamoeba spp. at 500 cells/L for 4 weeks 
while naive control fish (n = 30) were maintained in seawater. Both groups were 
bathed in fresh water for 24 h and challenged in the previously inoculated system 
with no further Neoparamoeba spp. added.* P = 0.001. 
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Figure 2.2. Atlantic salmon previously infected with Neoparamoeba spp. show 
similar gross and histopathology as na'ive control fish after AGD challenge. 
Gross (left) and histological (right) pathology associated with na'ive control and 
previously exposed Atlantic salmon following Neoparamoeba spp. challenge. 
Pathology is representative of all surviving fish from the respective groups. 
Histological sections ( 400x magnification) show the central venous sinus ( cvs) 
and Neoparamoeba spp. trophozoites in association with lesion margins 
(arrows). 
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Figure 2.3. Previous exposure to Neoparamoeba spp. did not influence the 
proportion of gill filaments affected after subsequent AGD challenge. Analysis 
of gill histology of surviving fish from the naive control group (n = 8) and 
previously exposed group (n = 22) showed similar levels of pathology. Error bars 
represent SEM. 
Detection of anti-Neoparamoeba spp. antibodies by Western blot and ELISA. 
Serum obtained from a putatively resistant Atlantic salmon that had been 
exposed to AGD for greater than 3 months contained anti-Neoparamoeba spp. 
antibodies but these antibodies did not bind to cultured amoebae antigens. 
Normal serum did not contain antibodies reactive with wild-type or cultured 
antigens (Fig. 2.4). Optical density determined by ELISA of the positive and 
negative control serum at a dilution of 1: 100 was 0.66 ± 0.02 and 0.19 ± 0.02 
respectively (Fig. 2.5). 
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Figure 2.4. Anti-Neoparamoeba spp. antibodies present in the positive control 
serum bind specifically to wild-type Neoparamoeba spp. (WT). Antibodies do 
not bind to cultured Neoparamoeba pemaquidensis (NP251002) or 
Neoparamoeba branchiphila (SEDMHl). Antigens were reduced in sample 
buffer containing 13-mercaptoethanol, separated through a 6% polyacrylamide gel 
and each lane was loaded with 4 x 104 cell equivalents. Antigens were 
transferred to nitrocellulose and probed with positive salmon serum (left) and 
AGD-naive salmon serum (right). Bound antibodies were detected with rabbit 
anti-salmon lgM, AP-conjugated sheep anti rabbit IgG and ECL. Positive 
control serum was obtained from an Atlantic salmon that survived AGD for 
approximately 3 months. AGD-na'ive serum was pooled from 5 fish held in fresh 
water. 
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Figure 2.5. Positive control serum produces an optical density substantially 
higher than normal Atlantic salmon serum in ELISA at a dilution of 1: 100. 
ELISA plates were coated with sonicated wild type antigen (0.24 µg total 
protein/well). Positive and normal serum was titrated from 1:100 to 1:3200 in 
duplicate. Bound antibody was detected with rabbit anti-salmon lgM, HRP-
conjugated goat anti rabbit lgG and OPD. Titration curves represent the mean± 
standard error optical density at 492nm. Positive control serum was obtained 
from an Atlantic salmon that survived AGD for approximately 3 months. Normal 
sera was pooled from 5 fish held in fresh water and therefore AGD-na'lve. 
Western blot analysis of serum pooled from fish at the end of the 4 week 
infection period oftrial 1 was negative with no antibody binding to wild-type or 
cultured Neoparamoeba spp. Similarly, in trial 2 anti-Neoparamoeba spp. 
antibodies were not detected by Western blot in pooled serum taken from the 10 
infected Atlantic salmon after the initial 4 week infection period. At the end of 
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trial 2 the serum from all surviving fish (naive control n = 8, and previously 
exposed n = 22) was analysed by Western blot. No anti-Neoparamoeba spp. 
antibodies were detected in pooled serum of naive control Atlantic salmon. 
However, all serum pools from previously exposed fish were positive for anti-
wild-type Neoparamoeba spp. antibodies. Western blot analysis of individual 
samples from these positive pools identified antibodies specific to wild-type 
amoebae in the serum of 11 of the 22 (50%) surviving fish that had been 
previously exposed to AGD. The binding profile of all positive samples was 
consistent, producing an intense smear between 45 and > 200 kDa (Fig. 2.6). 
This serum was also tested by ELISA but no antibody activity was detected. The 
average optical density in ELISA of the Western blot positive samples at 1:100 
was 0.20 ± 0.01, while the negative control reading was 0.19 ± 0.02. 
Immunocytochemistry and flow cytometry 
Wild-type Neoparamoeba spp. were fixed prior to incubation of antibodies to 
avoid the potential false negative results produced by pinocytosis of antibodies 
prior to detection. Bpi-fluorescent microscopy identified that anti-
Neoparamoeba spp. antibodies present in a pooled sample of the sero-positive 
Atlantic salmon serum bound cell-surface antigen(s) of wild-type Neoparamoeba 
spp .. Flow cytometry quantified binding to cell-surface antigen(s) with 85% of 
the analysed events producing fluorescence intensity an order of magnitude 
greater than that of the normal serum control (Fig. 2.7). 
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Figure 2.6. Serum from an Atlantic salmon previously exposed to 
Neoparamoeba spp. contains antibodies specific to wild-type Neoparamoeba 
spp. (WT). Binding profile of salmon anti-NP serum is representative of 50% of 
surviving fish that had been exposed to Neoparamoeba spp. twice. Antibodies in 
previously exposed salmon serum do not bind cultured antigens of 
Neoparamoeba pemaquidensis (NP25 l 002) or Neoparamoeba branchiphila 
(SEDMHI). Antigens were reduced in sample buffer containing 
~-mercaptoethanol. Each lane was loaded with 4 x 104 cell equivalents and 
antigens were separated through a 6% polyacrylamide gel. Antigens were 
transferred to nitrocellulose and probed with serum from Atlantic salmon 
exposed twice to Neoparamoeba spp. (left) and normal Atlantic salmon serum 
(right). Bound antibodies were detected with rabbit anti-salmon lgM, AP-
conjugated sheep anti rabbi IgG and ECL. Normal serum was pooled from 5 fish 
held in fresh water and therefore AGD-na"ive. 
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Figure 2.7. Anti-Neoparamoeba spp. antibodies in pooled positive serum bind cell-
surface epitope(s) of wild-type Neoparamoeba spp. producing fluorescence intensity 
significantly higher than that of the normal serum control. Wild- type Neoparamoeba 
spp. were fixed and probed with normal salmon serum (A and C) or pooled positive 
serum (B and D) at 1: 10. Bound antibodies were detected with rabbit anti-salmon lgM 
at I: 100 and HTC-conjugated sheep anti-rabbit lgG at 1 :50. Normal salmon serum was 
pooled from 5 fish maintained in fresh water and was therefore from AGD-na"ive fish. 
The shaded area of the histogram represents cells probed with normal salmon serum. 
Cells were photographed under epi-fluorescence and light microscopy . Fluorescence 
intensity of probed cells was analysed by flow cytometry reading a total of 104 events. 
The gated region analysed is shown in the dot plot (inset). Flow cytometry data were 
analysed and presented using WinMDl software. 
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Western blot analysis of individual cutaneous mucus samples collected from 
Atlantic salmon showing resistance to challenge did not identify any anti-
Neoparamoeba spp. antibodies. In general, antibody levels detected in mucus are 
substantially lower than levels detected in corresponding serum. Given that anti-
Neoparamoeba spp. antibodies were not detected in mucus from A9D-resistant 
fish no further analysis of cutaneous mucus was conducted. Rabbit anti-salmon 
IgM bound crude and purified Atlantic salmon serum IgM (Fig. 2.8). Binding of 
rabbit anti-salmon lgM to a band at around 70 kDa in cutaneous mucus samples 
corresponded with the band produced against MBP purified mucosal IgM (Fig. 
2.9). This demonstrated that lgM in cutaneous mucus samples had not degraded, 
that rabbit anti-salmon lgM was able to detect mucosal IgM of Atlantic salmon 
and the assay was sensitive enough to detect total mucus lg. 
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Figure 2.8. Polyclonal rabbit anti-salmon lgM binds crude and mannan binding 
protein (MBP)-purified Atlantic salmon serum IgM. Antigens were reduced in 
sample buffer containing 13-mercaptoethanol, separated through a 12% 
polyacrylamide gel and transferred to nitrocellulose membrane. Membranes were 
probed with polyclonal rabbit anti-salmon lgM (A) or normal rabbit serum (B). 
Bound antibodies were detected with AP-conjugated sheep anti-rabbit lgG and 
ECL. 
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Figure 2.9. Polyclonal rabbit anti-salmon lgM binds mannan binding protein 
(MBP) purified mucosa! lgM from Atlantic salmon however anti-Neoparamoeba 
spp. antibodies were not detected in cutaneous mucus of AGD resistant fish . (A) 
Binding of rabbit anti-salmon lgM to MBP purified mucosa[ IgM from Atlantic 
salmon. (B) Anti-Neoparamoeba spp. antibody was not detected in cutaneous 
mucus collected from AGD na'ive or previously exposed Atlantic salmon. (C) 
Detection of total IgM in cutaneous mucus (pooled 4 samples) collected from 
Atlantic salmon after AGD challenge. Antigens were reduced in sample buffer 
containing [3-mercaptoethanol, separated through a 6% polyacrylamide gel and 
transferred to nitrocellulose membrane. (A) MBP purified Atlantic salmon 
mucosa! lgM (B) wild-type Neoparamoeba spp. (8 x 104 cell equivalents per lane) 
and (C) cutaneous mucus collected from Atlantic salmon with demonstrated 
systemic antibody. Membrane strips A and C were probed with polyclonal rabbit 
anti-salmon IgM and bound antibodies detected with AP-conjugated sheep anti-
rabbit IgG and ECL. Membrane B was probed with cutaneous mucus from 
Atlantic salmon that were not exposed (AGD na'ive) and Atlantic salmon that 
were previously exposed to Neoparamoeba spp. and showed increased resistance 
to subsequent AGD challenge (AGD resistant), bound antibodies detected with 
AP-conjugated sheep anti-rabbit IgG and ECL. AGD na'ive mucus was pooled 
from 5 fish held in fresh water and therefore na'ive to AGD. 
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Discussion 
This study has shown that primary infection of Atlantic salmon with 
Neoparamoeba spp. enhances protection against subsequent AGD challenge in 
association with systemic antibodies. The survival of fish that were previously 
exposed to Neoparamoeba spp. for 4 weeks was 47% higher than that of fish that 
were AGD-na'ive. While the approach adopted here to assess resistance of 
Atlantic salmon that were previously affected by AGD was based on a 
commonly used model for testing efficacy of vaccines (Midtlyng, 2005), a more 
pronounced level of resistance may have been seen had the challenge period 
been extended. The substantial reduction in mortality of fish previously exposed 
to Neoparamoeba spp. presented here is in contrast with the findings of Gross et 
al., (2004b ). Results obtained in the latter study may have been influenced by 
mortalities that occurred during primary infection, possibly introducing bias into 
the challenge. In addition, the freshwater bath treatment administered after the 
primary AGD infection was not effective and as a result, fish maintained in sea 
water after primary exposure remained infected and further mortalities occurred. 
Consequently, at the time of AGD challenge, fish maintained in seawater were 
actively infected, introducing bias to the challenge model. 
Fish that were previously exposed to Neoparamoeba spp. and demonstrated 
resistance in terms of substantially lower mortality presented similar gill 
pathology to AGD-na'ive fish after challenge. This is in contrast with earlier 
studies that have reported resolution of gross gill lesions during secondary 
exposure (Findlay, et al., 1995; Findlay & Munday, 1998). However, in both 
aforementioned studies, fish were allowed to recover for a period of four weeks 
in fresh water after primary infection while in the current study, fish were bathed 
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for 24 hours. A prolonged period of infection may be important for development 
of resistance in terms of lesion resolution. This was more recently observed in 
Atlantic salmon that had been constantly exposed to Neoparamoeba spp. for 10 
weeks (Bridle, et al., 2005). Similarly, the Atlantic salmon from which the 
positive control serum was obtained displayed a low level of gross pathology and 
had been exposed to AGD for over 3 months. These observations suggest that 
resistance can develop over time and had the challenge period been extended in 
the current study, further resistance in the form of reduced gill pathology may 
have been seen. 
Following AGD challenge, anti-Neoparamoeba spp. antibodies were only 
detected in serum from 50% of the surviving Atlantic salmon that had been 
previously exposed to Neoparamoeba spp .. This suggests that secondary 
exposure, or the collective duration of primary and secondary exposure may be 
important for developing a systemic response. Increasing antibody titre is often 
seen after 4 weeks in fish vaccinated with parasitic antigens. For example, levels 
of specific antibody in serum after injection with Cryptobia salmositica increase 
substantially in Atlantic salmon after 5 weeks (Mehta & Woo, 2002) and after 6 
weeks in rainbow trout (Chin, Glebe & Woo, 2004) post-vaccination. Further, 
specific antibody titre increases dramatically in channel catfish, 7 weeks post-
vaccination with I. multifiliis theronts (Wang & Dickerson, 2002). While specific 
antibody was detectable in only 50% of the resistant population in the current 
study, individual variation in the development of an adaptive response in fish is 
common (Lobb, 1987; Akhlaghi, et al., 1996; Steine, Melingen & Wergeland, 
2001; Maki & Dickerson, 2003). A modest antibody response has been 
previously detected in serum of Atlantic salmon affected by AGD (Akhlaghi, et 
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al., 1996; Gross, et al., 2004a), however in contrast with these studies, antibodies 
identified here are specific to wild-type amoebae and are possibly directed 
against epitopes that are associated with virulence of Neoparamoeba spp. The 
binding profile of positive serum was consistent, producing a smear across a 
broad molecular range, similar to that seen with antibody binding to 
proteoglycan antigens (Fischer, Haubeck, Eich, Klohe-Busch, Stocker, Stuhlsatz 
& Greiling, 1996; Yeh, Chen, Li, Espana, Ouyang, Kawakita, Kao, Tseng & Liu, 
2005). However, without further analysis, no assumption can be made of the 
nature of the epitope(s). While clearly detectable by Western blot and flow 
cytometric analysis, specific antibody was undetectable in the same samples by 
ELISA suggesting that titre was extremely low. Atlantic salmon serum used for 
the positive control in both Western blot and ELISA was obtained from a fish 
that had survived AGD infection for over 3 months and had a significant ELISA 
optical density at a dilution of 1: 100. Binding of the positive control serum is 
also specific to wild-type Neoparamoeba spp. antigen(s) and produced a similar 
binding profile suggesting that titre may positively correlate with increased 
duration of infection. 
Western blot analysis of cutaneous mucus samples that were taken from fish that 
had developed a systemic response did not identify anti-Neoparamoeba spp. 
antibodies. Stability oflgM in mucus samples was confirmed by Western blot 
indicating that the negative result was not influenced by sample degradation, the 
ability of the rabbit anti-salmon antibody to bind mucosal IgM or the sensitivity 
of the assay. Specific antibodies against I. multifiliis have been detected in 
cutaneous mucus of channel catfish 3 weeks after bath treatment (Maki & 
Dickerson, 2003). Similar responses have been documented after i.p. 
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immunisation of rainbow trout with FITC conjugated keyhole limpet 
haemocyanin (Cain, Jones & Raison, 2000) or Flavobacterium psychrophilum 
(LaFrentz, LaPatra, Jones, Congleton, Sun & Cain, 2002) with mucosal antibody 
in all cases measurable in 3 to 4 weeks after immunisation. The antibody 
response in cutaneous mucus is often substantially lower than the systemic 
response to a range of antigens (Cain, et al., 2000; LaFrentz, et al., 2002; Maki & 
Dickerson, 2003). In the current study, failure to detect anti-Neoparamoeba spp. 
antibodies in cutaneous mucus may be the result of very low titre. The cotton 
swab method used to collect mucus was chosen over a scraping method to reduce 
the potential level of contamination of mucus with host cells. Further, while the 
mucus collection method used in this study was successful in that total mucosal 
lgM could be detected, collecting in a volume of 500 µL may have diluted 
specific antibody levels to below the limit of detection. The antibody response to 
Neoparamoeba spp. may be more localised in the gill epithelium or gill mucus as 
gill-associated antibodies can exceed levels of systemic antibody (Lumsden, 
Ostland, MacPhee & Ferguson, 1995). However, a failure to develop a mucosal 
antibody response to Neoparamoeba spp. must also be considered. 
In summary, the results presented here provide further evidence that Atlantic 
salmon can develop resistance, in terms ofreduced mortality, to AGD. Duration 
of exposure may be significant to the development of resistance and to the 
detection of a systemic antibody response. Further study of the role of systemic 
antibody in protection against AGD and characterisation of the target epitope(s) 
is required and is the focus of ongoing studies. 
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Detection of serum anti-Neoparamoeba spp. antibodies 
in amoebic gill disease-affected Atlantic salmon 
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In some cases, amoebic gill disease (AGD)-affected Atlantic salmon develop a 
serum antibody response to wild-type Neoparamoeba spp .. Here, sera from 
AGD-affected and AGD-na'ive Atlantic salmon were screened against wild-type 
and cultured Neoparamoeba spp. antigens. Only 5of103 AGD-affected Atlantic 
salmon produced detectable antibodies that bound wild-type Neoparamoeba spp .. 
Western blotting revealed two distinctly different binding profiles. Anti-
Neoparamoeba spp. antibodies present in the serum of four fish bound to 
periodate oxidation-sensitive antigens across a broad molecular weight range 
producing a smear. In contrast, binding of antibodies present in the serum of the 
remaining fish bound two antigenic determinants Mr >200 kDa that were 
periodate oxidation resistant. These data suggest that Atlantic salmon have the 
capacity to develop a serum antibody response to wild-type Neoparamoeba spp. 
infection although the development of an antibody response with measurable 
activity in an ELISA is rare. 
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Introduction 
Amoebic gill disease (AGD) affects sea-farmed salmonids in Tasmania, 
Australia (Munday, 1986; Munday, et al., 1990; Munday, Lange, Foster, Lester 
& Handlinger, 1993), Ireland (Rodger & McArdle, 1996; Palmer, et al., 1997) 
the USA (Kent, et al., 1988), Chile, New Zealand (Munday, et al., 2001) and 
Scotland (Young, et al., 2007b ). In Tasmania, AGD is a particularly serious 
health concern as recurrent epizootics occur (Munday, et al., 1990). At present, 
fresh water bathing is the only commercially viable treatment for AGD and 
contributes 10-20% of production costs (Munday, et al., 2001). Therefore the 
development of an alternative to freshwater bathing, such as an AGD vaccine, is 
a priority for many salmon growers. 
Several efficacious fish vaccines, including those for vibriosis, yersiniosis and 
furunculosis (Hastein, Gudding & Evensen, 2005), are composed of whole cell 
preparations. These vaccines were developed by simply immunising fish with 
inactivated cells with or without adjuvant. As an alternative to this immunisation 
approach, host immune sera may be used to identify candidate vaccine antigens. 
Fish immune sera have been used to identify protective antigens of the protozoan 
fish parasite Ichthyophthirius multi.filiis. Immobilization of I. multifiliis theronts 
was first observed in vitro using immune sera from fish that had survived an 
initial I. multi.filiis infection (Hines & Spira, 1974). Subsequently, it was shown 
that parasite immobilization is associated with antibody binding to cell-surface 
ciliary antigens (Clark, et al., 1988; Clark & Dickerson, 1997) and that protection 
of channel catfish, lctalurus punctatus Rafinesque, against white spot in viva is 
antibody-mediated (Wang & Dickerson, 2002). 
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There is preliminary evidence for the development of a serum antibody response 
in AGD-affected Atlantic salmon (Vincent, Morrison & Nowak, 2006). 
Therefore this may be exploited to identify wild-type Neoparamoeba spp. 
antigens expressed in vivo. In the current study, we opportunistically screened 
sera from AGD-affected Atlantic salmon with the aim of identifying antigen(s) 
specific to wild-type Neoparamoeba spp .. Sera from very few Atlantic salmon 
affected by AGD contained anti-Neoparamoeba spp. antibodies. Of those sera 
with demonstrable antibody activity in an ELISA, anti-Neoparamoeba spp. 
antibodies were predominately directed towards cell-surface carbohydrate 
residues unique to wild-type Neoparamoeba spp .. However no causal 
relationship between serum antibodies and resistance to AGD could be 
established. 
Materials and methods 
Fish history and blood sampling 
Sera assessed for anti-Neoparamoeba spp. antibodies in the current study were 
taken from a total of 103 A GD-affected and 44 AGD-narve Atlantic salmon. 
At present, a source of wild-type Neoparamoeba spp. are maintained via 
co-habitation of AGD-narve Atlantic salmon with AGD-affected Atlantic salmon 
(UTAS co-habitation tank) at the University of Tasmania, Australia. The AGD-
affected Atlantic salmon assessed for serum anti-Neoparamoeba spp. antibodies 
in the current study were exposed to wild-type Neoparamoeba spp., either in the 
UTAS co-habitation tank or by inoculation of the fish holding systems with 
wild-type Neoparamoeba spp. (Table 3.1). AGD-affected fish included 17 fish 
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collected from the UTAS co-habitation tank and of these 15 were collected as 
they became moribund from AGD. The remaining two fish from the UTAS co-
habitation tank were larger than the tank cohort (range 80-150 g) and at the time 
of sampling weighed 580 and 340 g. These fish are herein referred to as fish one 
and fish two respectively. Due to their size, fish one and fish two were easily 
observed in the tank and it was estimated that fish one and fish two had been in 
the UTAS co-habitation tank for six and four months respectively. Fish 
transferred to the UTAS co-habitation tank generally become moribund from 
AGD within four weeks. Blood was taken from fish one once while fish two was 
bled four times at 4 week intervals during the 4 month period. A further two 
groups of AGD-affected Atlantic salmon were assessed for serum anti-
Neoparamoeba spp. antibodies. These included 23 Atlantic salmon exposed to 
wild-type Neoparamoeba spp (500 cells/L) for 34 days and 63 AGD-affected 
Atlantic salmon exposed to wild-type Neoparamoeba spp. (1152 cells/L) for 72 
days in the experiment described by Bridle Carter, Morrison, and Nowak, 
(2005). Neoparamoeba spp. are obligate marine organisms, therefore sera from 
44 Atlantic salmon maintained only in fresh water were tested to assess if natural 
antibodies present in the sera of AGD-na'ive Atlantic salmon bound amoeba 
antigens. The holding conditions and duration of exposure of Atlantic salmon to 
wild-type Neoparamoeba spp. of the fish from which the sera were assessed in 
the current study are summarised in Table 3.1. 
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Table 3.1. Serum from AGD-affected and AGD-nalve Atlantic salmon was 
assessed for anti-Neoparamoeba spp., antibodies. The number offish sampled, 
the duration of exposure to wild-type Neoparamoeba spp. and fish holding 
conditions are summarised. 
Number of Mode of Weeks Salinity Water 
fish exposure exposed (%0) Temperature 
(oC) 
17 Co-habitation 3-24+ 35 16 
23 Inoculation 4.8 35 16 
(500 cells/L) 
63 Inoculation 1 10.3 35 16 
(1152 cells/L) 
44 Not ex:eosed NIA 0 14-16 
1 Fish sampled from the experiment described by (Bridle, et al., 2005), +Estimated exposure time, 
NI A - not applicable. 
Cultured and wild-type Neoparamoeba spp. 
Amoebic gill disease (AGD) of Atlantic salmon is predominantly associated with 
the amphizoic marine amoebae, Neoparamoeba perurans (Young, et al., 2007a; 
Young, et al., 2007b ). While N. pemaquidensis and N. branchiphila have also 
been isolated from AGD-affected gill tissues of Atlantic salmon by culture 
(Dykova, et al., 2005a) neither N. pemaquidensis nor N. branchiphila have been 
identified in association with AGD lesions. Despite this, amoebae isolated from 
gill tissues of AGD-affected Atlantic salmon may include all the above-
mentioned Neoparamoeba species and gill-derived amoebae are therefore 
described as wild-type Neoparamoeba spp .. Wild-type Neoparamoeba spp. were 
isolated as described by Morrison, Crosbie and Nowak (2004) from AGD-
affected Atlantic salmon maintained in the UTAS co-habitation tank. Clonal 
strains of cultured N. pemaquidensis and N. branchiphila tested to date are 
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avirulent (Kent, et al., 1988; Howard, Carson and Lewis, 1993; Findlay, 2001; 
Morrison, Crosbie, Cook, Adams and Nowak, 2005; Vincent, Adams, Crosbie, 
Nowak and Morrison, 2007). Therefore, to discriminate between reactive 
epitope(s) of cultured and wild-type Neoparamoeba spp., two previously 
characterised clonal strains (Dykova et al., 2005) of cultured Neoparamoeba sp. 
were used as negative controls. These were N. pemaquidensis (NP251002) 
(Morrison, et al., 2005) isolated from AGD-affected Atlantic salmon, and N. 
branchiphila (SEDMHl) isolated from the sediment of Macquarie Harbour, 
Tasmania. Amoebae were maintained on seawater malt yeast agar consisting of 
75% (v/v) coarse-filtered seawater (35%0), 25% (v/v) distilled water, 0.01 % 
(w/v) Malt, 0.01% (w/v) yeast (Oxoid, Hampshire, England) and 2% (w/v) Bacto 
agar (Becton, Dickson and Co., USA). Cells were harvested by washing the agar 
with sterile sea water. Cells were concentrated by centrifugation at 500x g for 5 
min and enumerated by hemacytometer. Amoebae were washed twice with 
phosphate buffered saline (PBS, pH 7.2) and the cell pellet was stored at -80°C. 
Presence of serum anti-Neoparamoeba spp. antibodies 
SDS-PAGE and Western blot 
The binding of Atlantic salmon serum antibodies to cultured or wild-type 
Neoparamoeba spp. antigens was assessed by Western blotting. Wild-type 
Neoparamoeba spp. were thawed, resuspended in buffer containing 
~-mercaptoethanol and reduced by boiling for 10 min. Reduced antigen was 
centrifuged at 16 OOO x g and the supernatant stored at - 20°C. Amoebae antigens 
were separated by SDS-PAGE through 6% polyacrylamide gels. In addition, 
cutaneous mucus was obtained from AGD-na'ive Atlantic salmon by gently 
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scraping the skin with the edge of a glass slide. Mucus was centrifuged for 5 min 
at 500 x g to separate mucus from cellular debris, reduced, as outlined above, 
centrifuged and the supernatant stored at -20°C. Mucus was included as an 
antigen control at I 4 µg total protein/lane. Antigens were transferred to 
nitrocellulose membrane (Hybond-C extra, Amersham Biosciences, UK) using a 
semi-dry transfer apparatus (Hoefer Scientific Instruments, San Francisco, 
California, USA) and blocked in Ix casein solution (Vector, Burlingame, 
California, USA). Blocking and antibody incubation steps were for 30 min and in 
between incubation steps, membranes were washed 3 x 4 min with tris-buffered 
saline (TBS, pH 7.2). Atlantic salmon test serum, serum previously identified to 
contain anti-Neoparamoeba spp. antibodies (Vincent, et al., 2006), or normal 
Atlantic salmon serum was applied at I :500 in Ix casein solution and bound 
antibodies were detected with rabbit anti-salmon lgM at I :500 followed by 
alkaline phosphatase (AP)-conjugated sheep anti-rabbit lgG (Chemicon, Boronia, 
Australia) at I:2000. Following the final antibody incubation, membranes were 
washed 3x in TBS and then Ix in 100 mM tris (pH 9.5) for 5 min. All incubation 
and wash steps were conducted at 20°C. Western blots were developed by 
enhanced chemiluminescence (ECL) using DuoLuX (Vector), Kodak BioMax 
Light Film and Kodak GBX developing and fixing reagents (Sigma, Castle Hills, 
NSW, Australia) following the manufacturer's instructions. Binding of the 
polyclonal rabbit anti-salmon lgM to purified and crude Atlantic salmon serum 
IgM was initially confirmed by Western blotting (refer to Chapter 2, Figure 2.8). 
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Sodium periodate oxidation of carbohydrate epitope(s) of wild-type 
Neoparamoeba spp. 
Wild-type Neoparamoeba spp. antigens were transferred to nitrocellulose 
membrane as outlined above. From the same membrane, bound antigens on 
adjacent strips were either oxidised with 20 mM sodium periodate (Merck Pty 
Ltd., Victoria) and 50 mM sodium borohydride (Sigma-Aldrich) or incubated in 
50 mM sodium acetate (pH 4.5, Sigma) following the method outlined by 
Woodward et al., (1985). Membranes were then washed 3x with PBS, probed 
and developed as above. 
Enzyme-linked immunosorbent assay (ELISA) 
Binding of anti-Neoparamoeba spp. antibodies was quantified by an ELISA. 
Wild-type Neoparamoeba spp. were isolated as outlined above, stored at -20°C 
and re-suspended in PBS. Wild-type Neoparamoeba spp. were sonicated on ice 
until complete disruption of cells was observed. The sonicated suspension of 
wild-type Neoparamoeba spp. antigens was then centrifuged for 10 min at 16 
OOOx g and the supernatant removed. Protein concentration of the sonicated 
Neoparamoeba spp. supernatant was determined by colorimetric assay (Pierce, 
Rockford, USA). The ELISA antigen was then divided into aliquots suitable for 
coating a single 96-well plate and stored at -20° C. Optimal conditions for the 
ELISA were determined empirically. Briefly, antigen was thawed, re-suspended 
in coating buffer (50 mM NaHC03, pH 9.5) and 96-well flat-bottom plates 
(Sarstedt, Australia) were coated with 50 µL sonicated wild-type Neoparamoeba 
spp. (0.24 µg total protein/well) in coating buffer at 4°C overnight. Excess 
antigen was discarded and wells were blocked for 30 min at 37°C with 0.3 % 
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casein-PBS (Sigma). Serum samples were serially diluted in 0.3 % casein-PBS in 
duplicate from 1: 100 to 1 :3200, ( 50 µL/well) and plates were incubated for 1 h at 
20°C. Bound antigen was detected with polyclonal rabbit anti-salmon IgM at 
1 :500 and horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (Sigma) 
at 1:1000 for 30 min at 37°C. The reaction was developed with 50 µLo-
phenylenediamine (OPD) (Sigma) and stopped with an equal volume of 3M HCL 
AGD-nalve Atlantic salmon serum was included in each assay as the negative 
control. AGD-nalve serum was pooled from five fish that were maintained in 
fresh water and therefore AGD-nalve as Neoparamoeba spp. are obligate marine 
organisms. Positive and negative control serum was titrated from 1: 100 to 1 :3200 
on each plate in duplicate. Following the method described by Arkoosh and 
Kaattari (1990), further analysis was performed on the data obtained from serum 
samples containing anti-Neoparamoeba spp. antibodies with activity measurable 
by the ELISA. Arkoosh and Kaattari (1990) describe a method to calculate 
antibody activity by utilising a standard positive control serum across all ELISAs 
and correcting for variation in optical density that is inherent between assays. 
This method enables comparison of antibody activity across assays. 
Immunocytochemistry and flow cytometry 
Wild-type amoebae were fixed in seawater Davidson's fixative (SWD) for 1 hat 
20°C and washed by four cycles ofre-suspending cells in PBS and concentrating 
cells by centrifugation at 500 x g for 5 min. Amoebae were placed in the wells of 
96-well U-bottomed microplates (Sarstedt) and blocked in 0.1 % BSA-PBS for 30 
min at 4°C. Cells were probed with AGD-nalve Atlantic salmon serum or serum 
that contained anti-Neoparamoeba spp. measured by both the ELISA and 
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Western blotting. Bound antibodies were detected with rabbit anti-salmon lgM at 
1: 100 and FITC-conjugated sheep anti-rabbit lgG (Chemicon) at 1 :50. Cells were 
washed 3x in PBS following each antibody incubation step. A sub-sample of 
cells was photographed (Leica DC300F, Leica Microsystems, Wetzlar, 
Germany) using light and epi-fluorescent microscopy. Using the remaining 
probed cells, the proportion of wild-type Neoparamoeba spp. expressing 
epitope(s) to which the salmon anti-Neoparamoeba spp. antibodies bound was 
quantified by flow cytometry (Coulter Epics, Beckman Coulter, USA). Ten 
thousand cells were assessed per treatment and data were analysed using 
WinMDI 2.8 software (Joseph Trotter, Scripps Research Institute, La Jolla, 
California, USA). 
Glycoprotein staining of wild-type Neoparamoeba spp. antigens 
ProteoProfile PTM markers (Sigma, St Louis, MO, USA) and two lanes of wild-
type Neoparamoeba spp. antigens (8 x 104 cell equivalents/lane) were separated 
through a 4-15% polyacrylamide gel. One lane of wild-type Neoparamoeba spp. 
antigen was cut from the gel, silver stained and photographed. The remaining gel 
was stained for glycoproteins using the GlycoProfile III fluorescent glycoprotein 
detection kit following the manufacturer's instructions (Sigma). Following 
staining, the glycoprotein stained gel was viewed under UV light and 
photographed. 
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Results 
Presence of serum anti-Neoparamoeba spp. antibodies 
By Western blotting, antibodies that bound wild-type Neoparamoeba spp. 
antigens were detected in the sera of five out of 103 fish. These included samples 
obtained from two fish from the UTAS co-habitation tank (fish one and fish two) 
and three fish from the experiment described by Bridle et al., (2005). Fish one 
and fish two serum antibodies were specific to wild-type Neoparamoeba spp. yet 
distinctively different binding profiles were produced in Western blot. Binding of 
serum antibodies offish one by Western blot produced two bands >200 kDa and 
serum antibodies of fish two produced a smear across a broad molecular weight 
range (Fig. 3.1). Sodium periodate oxidation of wild-type antigens was 
performed to assess the binding of anti-Neoparamoeba spp. antibodies to peptide 
or carbohydrate epitope(s). Antibodies present in the serum offish one were 
directed towards epitope(s) that were not sensitive to periodate oxidation while 
antibodies in the serum of fish two failed to bind periodate-treated wild-type 
Neoparamoeba spp. antigens (Fig. 3.1). Similarly, antibodies present in the three 
sero-positive fish from the experiment described by Bridle et al., (2005) were 
specific to wild-type Neoparamoeba spp. and produced a smear across a broad 
molecular weight range. In addition, these antibodies failed to bind wild-type 
Neoparamoeba spp. antigens after periodate oxidation (data not shown). In the 
experiment described by Bridle et al., (2005), p-glucan diets were administered 
and there was no effect of diet on the susceptibility of Atlantic salmon to AGD. 
The sero-positive fish identified here were from the control group and were fed 
c~mmercial Atlantic salmon feed. The five sero-positive samples were also 
screened against Atlantic salmon cutaneous mucus supernatant obtained from 
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AGD-na'ive Atlantic salmon to identify potential cross-reactivity with normal 
flora residing in the host mucus and no binding was observed (data not shown). 
In addition to the normal serum controls ran in parallel with the test sera, sera 
from a further 44 AGD-na'ive Atlantic salmon were assessed for presence of 
natural antibodies that may bind Neoparamoeba spp. antigens. Antibodies 
present in the sera of 44 AGD-na'ive Atlantic salmon did not bind wild-type or 
cultured Neoparamoeba spp. antigens (data not shown). 
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Figure 3.1. Binding of serum anti-Neoparamoeba spp. antibodies from fish one 
and fish two to wild-type Neoparamoeba spp. (WT) produces distinctly different 
profiles. Anti-Neoparamoeba spp. antibodies in fish one serum bind two bands 
(arrows) >200 kDa (A) of wild-type antigen (WT) and these epitope(s) are not 
sensitive to periodate oxidation (D). In contrast, binding of anti-Neoparamoeba 
spp. antibodies in fish two serum produce a smear across a broad molecular 
range (B) and these epitope(s) are sensitive to periodate oxidation (E). 
Antibodies present in the serum of fish one and fish two do not bind cultured N. 
pemaquidensis (NP25 l 002) or N. branchiphila (SEDMH 1) and antibodies 
present in serum from AGD-na"ive fish do not bind wild-type or cultured 
Neoparamoeba spp. (C). Antigens were reduced in sample buffer containing 
P-mercaptoethanol, separated through a 6% polyacrylamide gel and each lane 
was loaded with 8 x 104 cell equivalents/lane. Wild-type antigens were 
transferred to nitrocellulose and treated with sodium periodate (Nal04 WT) (lanes 
D and E).Membranes were probed with serum from fish one (A and D), fish two 
(B and E) and normal salmon serum (C).Bound antibodies were detected with 
rabbit anti-salmon IgM, AP-conjugated sheep anti-rabbit IgG and 
chemiluminescence. AGD-na"ive serum was pooled from five fish held in fresh 
water and therefore was from AGD-na"ive fish . 
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The only samples containing anti-Neoparamoeba spp. antibodies with 
measurable activity according to the method outlined by Arkoosh and Kaattari 
(1990) by an ELISA were those offish one and fish two. Due to the larger 
volume of serum attained from fish two, fish two serum was used as the positive 
control. Binding of anti-Neoparamoeba spp. antibodies present in the serum of 
fish one produced an optical density similar to the positive control sera 
(Fig. 3.2). At a serum dilution of 1: 100, the mean optical density produced by the 
AGD-nalve serum was 0.19 (± SEM 0.00), at the same serum dilution, 
antibodies present in the serum offish one and fish two (the positive control 
serum) produced optical densities of0.79 (± SEM 0.03) 0.68 (± SEM 0.02) 
respectively. Whilst the optical density produced at the serum dilution of 1: 100 
was higher for fish one, anti-Neoparamoeba spp., the antibody activity of both 
fish one and fish two serum was equal at 7.7 units/µ1 of serum. Further analysis 
of anti-Neoparamoeba spp. antibodies was restricted to the serum samples from 
fish one and fish two with measurable antibody activity. 
Immunocytochemistry and flow cytometry 
Fish one and fish two anti-Neoparamoeba spp. antibodies bound cell-surface 
epitope(s) of wild-type Neoparamoeba spp. producing intense fluorescence 
around the cell margin (Fig. 3.3). Binding of fish one and fish 2 anti-
Neoparamoeba spp. antibodies was quantified by flow cytometry and 
fluorescence intensity significantly greater than the normal serum control was 
observed. Fluorescence intensity ten-fold greater than the normal serum control 
was produced by the binding offish one and fish 2 antibodies to 94.7% and 
94.6% of the wild-type Neoparamoeba spp. analysed respectively (Fig. 3.3). 
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Figure 3.2. Anti-Neoparamoeba spp. antibodies present in serum offish one and 
fish two produce a significant optical density in ELISA. Wells were coated with 
sonicated wild-type Neoparamoeba spp. antigen (0.24 µg total protein/well). 
Serum was titrated from 1: 100 to 1 :3200 in triplicate. Bound antibodies were 
detected with rabbit anti-salmon IgM, HRP-conjugated goat anti-rabbit lgG and 
OPD. Titration curves represent the mean± SEM of the optical density at 
492nm. AGD-na'ive serum was pooled from five Atlantic salmon held in fresh 
water and therefore was from AGD-na'ive fish. The dilution used to calculate the 
antibody activity offish one and fish two serum (extrapolated from the optical 
density (OD) that represented 50% of the OD of the positive serum control) were 
equal for both fish at 1 :375. Antibody activity was calculated by the method 
described by Arkoosh and Kaattari (1990). 
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Log fluorescence intensity 
Figure 3.3. Anti-Neoparamoeba spp. antibodies present in the serum of fish one 
and fish two bind cell-surface epitope(s) of wild-type Neoparamoeba spp .. 
Adjacent images are the corresponding light micrographs. Fluorescence intensity 
significantly higher than the AGD-na"ive serum control (A) is produced by 
binding of fish one (C) and fish two (E) anti-Neoparamoeba spp. antibodies to 
94.7% and 94.6% of the analysed wild-type Neoparamoeba spp. cell suspension. 
Wild-type Neoparamoeba spp. were fixed and probed with AGD-na"ive serum, 
fish one or fish two serum. Bound antibodies were detected with rabbit anti -
salmon IgM and FITC-conjugated sheep anti-rabbit IgG. The shaded area of the 
histogram represents cells probed with AGD-na"ive serum (A). Data presented 
includes cells within the gated region shown in the dot-plot (inset). Flow 
cytometry data were analysed and presented using WinMDI 2.8 software. Scale 
bars= 50 µm. 
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Glycoprotein staining of wild-type Neoparamoeba spp antigens 
Wild-type Neoparamoeba spp. glycoproteins were observed under UV 
illumination after glycoprotein staining of the gel. Glycoprotein staining of wild-
type Neoparamoeba spp. antigens produced a smear across a broad molecular 
weight range. Silver staining of wild-type Neoparamoeba spp. antigens similarly 
presented as a smear with no distinguishable banding (Fig. 3.4). 
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Figure 3.4. Wild-type Neoparamoeba spp. glycoproteins present as a smear 
across a broad molecular weight range. Amoebae antigens (8 x 104 cell 
equivalents) and glycoprotein markers were separated by SDS-PAGE through a 
4-15% gel. One lane of wild-type Neoparamoeba spp. antigen was separated and 
silver stained (B).The remaining gel was stained for glycoproteins (A). The 
glycoproteins ovalburnin ( 45 kDa) and RNaseB (17 kDa) are indicated. The 
glycoprotein stained gel section (A) was viewed and photographed under UV 
light. 
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Discussion 
Sera from AGD-affected and AGD-nai"ve Atlantic salmon were screened for the 
presence of anti-Neoparamoeba spp. antibodies against wild-type and cultured 
Neoparamoeba spp. antigens, however few sero-positive samples were 
identified. The predominant antibody-binding profile observed here presented as 
a smear by Western blotting. Similarly, anti-Neoparamoeba spp. antibodies 
detected in the sera of AGD-affected Atlantic salmon in the study described by 
Vincent et al., (2006) produced a smear in Western blot. Presentation of a smear 
by Western blotting is characteristic of antibody binding to carbohydrate 
residues. For example, antibody binding to the proteoglycan agrin (Groffen, 
Ruegg, Dijkman, van de Velden, Buskens, van den Born, Assman, Monnens, 
Veerkamp and van den Heuvel, 1998), carbohydrate antigens of the mould, 
Aspergillus versicolor, (Rydjord, Hetland and Wilker, 2005) and mucin-like 
glycoproteins (Hong, Jang, Kong, Song, Park, Kim, Chung, Lee, Paik and 
Chung, 2001) produced a smear by Western blotting. Certainly, the profile 
produced by glycoprotein staining suggests that wild-type Neoparamoeba spp. 
express abundant glycosylated molecules. The loss of antibody binding following 
periodate oxidation, as seen here, is indicative of antibody binding to 
carbohydrate residues (Woodward, Young and Bloodgood, 1985). 
Monoclonal antibodies produced against wild-type Neoparamoeba sp. are 
predominately directed towards cell-surface carbohydrate epitopes (Villavedra, 
Lemke, To, Broady, Wallach and Raison, 2007). Similarly, results presented here 
suggest that cell-surface carbohydrate epitope(s) of wild-type Neoparamoeba 
spp. may also be immunodominant in Atlantic salmon. In contrast to the 
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predominant antibody binding profile that presented as a smear by Western 
blotting, the serum antibodies of fish one bound two high molecular weight 
epitope(s) of wild-type Neoparamoeba spp .. These high molecular weight 
epitope(s) are likely to be peptide(s) as antibody binding was observed after 
sodium periodate oxidation. Ideal vaccine candidate antigen(s) for an AGD 
vaccine would be peptide(s) that are easily produced by recombinant DNA 
technology. Further characterisation of these high molecular weight peptide 
epitope(s) is warranted and these epitope(s) are currently under further 
investigation in our laboratory. 
In some cases, natural antibodies may bind antigens of pathogens. For example 
natural antibodies present in serum of goldfish, Carassius auratus L., bind the A-
layer proteins of Aeromonas salmonicida (Sinyakov, Dror, Zhevelev, Margel and 
A vtalion, 2002) and natural antibodies in the serum of rainbow trout bind the 
monogenean Discocotyle sagittata (Rubio-Godoy, Sigh, Buchmann and Tinsley, 
2003). Serum antibodies from 44 AGD-naive Atlantic salmon did not bind wild-
type or cultured Neoparamoeba spp. antigens suggesting that natural antibodies 
do not bind Neoparamoeba spp. antigen(s). However, AGD-affected fish 
assessed in the current study were not sampled prior to exposure to 
Neoparamoeba spp .. Therefore it cannot be discounted that the serum antibodies 
described here may be natural antibodies. 
The development of a detectable serum antibody response in Atlantic salmon to 
wild-type Neoparamoeba spp. may rely on a range of factors. Here, fish one and 
fish two developed a serum antibody response with measurable activity after 
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exposure to wild-type Neoparamoeba spp. by co-habitation for an estimated six 
and four months respectively. In the study by Vincent et al., (2006), 50% of 
AGD-affected Atlantic salmon developed a serum antibody response 5 weeks 
following secondary exposure to wild-type Neoparamoeba spp. (9 weeks after 
initial exposure). While this suggests that the duration of exposure may be 
important for the development of a serum antibody response to Neoparamoeba 
spp., just 3 of the 63 fish exposed to wild-type Neoparamoeba spp. for 72 days in 
the experiment described by Bridle et al., (2005) developed a detectable serum 
antibody response. Entrapment of Neoparamoeba spp. within interlamellar 
vesicles (Adams and Nowak, 2001) may provide the environment for interaction 
with immune-like cells. MHC rt cells are present throughout AGD lesions of 
Atlantic salmon gill tissues (Morrison, Koppang, Hordvik and Nowak, 2006). 
Antigen processing may be restricted to opportunistic interactions between wild-
type Neoparamoeba spp. entrapped in interlamellar vesicles and MHC II+ cells 
and this may influence the development of a serum antibody response. While fish 
one and fish two survived for a significant length of time in the UTAS co-
habitation tank, these are isolated observations and results presented here provide 
no evidence to suggest that serum antibodies may be associated with AGD 
resistance in Atlantic salmon. 
It is interesting that antibodies present in the sera of five fish were detectable by 
Western blotting yet in an ELISA, antibody activity was only measurable in the 
serum offish one and fish two. The ELISA conditions applied here and by 
Vincent et al., (2006) were the same and in both instances, antibodies were 
detectable by Western blotting but not by ELISA.. In all cases, negative and 
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positive control sera were included on each plate and titration curves were 
observed for the positive control serum in each ELISA. Processing of wild-type 
antigen may damage or eliminate reactive epitope(s). However, each ELISA 
assay was conducted with an independent aliquot of wild-type Neoparamoeba 
spp. antigen from the same antigen pool. Furthermore, fish two antibodies were 
measurable by the ELISA and appear to bind the same carbohydrate epitope(s) as 
the three sero-positive fish from the experiment described by Bridle et al., 
(2005). Given this, the failure to detect antibodies by ELISA suggests that 
denaturation prior to Western blotting may enhance access to the relevant 
epitopes or that antibody levels are simply very low. 
In summary, 2of103 AGD-affected Atlantic salmon developed a serum 
antibody response with measurable activity towards cell-surface epitope(s) of 
wild-type Neoparamoeba spp .. Carbohydrate epitope(s) of wild-type 
Neoparamoeba spp. appear to be immunodominant in Atlantic salmon and the 
development of anti-peptide antibodies specific to wild-type Neoparamoeba spp. 
is, at this point, an isolated finding. The current study has focused on Atlantic 
salmon that were experimentally affected by AGD under relatively aggressive 
infection conditions in comparison to that experienced by sea-cage cultured 
Atlantic salmon. Atlantic salmon cultured in Southern Tasmania are exposed to 
wild-type Neoparamoeba spp. multiple times throughout the grow-out cycle and 
AGD is closely regulated by fresh water bathing. The duration of exposure 
(or multiple exposures) to wild-type Neoparamoeba spp. appears to be important 
for the development of a serum antibody response in AGD-affected Atlantic 
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salmon and screening sera from sea-farmed Atlantic salmon for anti-
Neoparamoeba spp. antibodies may identify a more diverse range of antigens. 
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Chapter4 
Cell-surface carbohydrate antigen(s) of wild-type 
Neoparamoeba spp. are immunodominant in sea-cage 
cultured Atlantic salmon (Salmo salar L.) affected by 
amoebic gill disease (AGD) 
This Chapter has been submitted for publication in the journal Aquaculture: 
Vincent, B. N., Adams, M. B., Nowak, B. and Morrison, R. N., (2008) Cell-surface 
carbohydrate antigen(s) of wild-type Neoparamoeba spp. are immunodominant in sea-
cage cultured Atlantic salmon (Salmo salar L.) affected by amoebic gill disease (AGO). 
Aquaculture. 
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A small proportion of Atlantic salmon experimentally affected by amoebic gill 
disease (AGD) develop a serum antibody response to wild-type Neoparamoeba 
spp .. These antibodies bind cell-surface epitope(s) and in most cases the 
epitope(s) are sensitive to sodium periodate oxidation. Here, blood was obtained 
from Atlantic salmon after 8, 10 and 13 months of sea-cage culture and assessed 
for the presence of anti-Neoparamoeba spp. (anti-NP) antibodies. Generally, an 
increase in the proportion of fish developing a detectable antibody response to 
wild-type Neoparamoeba spp. was seen over time in culture. Reflected by the 
number of freshwater bath treatments administered, the triploid and diploid fish 
may have been affected by AGD multiple times. While the interval between bath 
treatments increased over time in culture this corresponded to the seasonal 
reduction in water temperature at the culture site. A further group of putatively 
AGD-resistant Atlantic salmon broodstock was sampled at 15 months after 
transfer to sea and anti-NP antibodies were detected in 81 % of these samples. 
The broodstock did not present any gross gill pathology and had not required 
freshwater bath treatment for over 250 days. Anti-NP antibodies in all 
sero-positive fish identified here bound cell-surface carbohydrate antigens, 
however an antibody titre was not detected in any samples by ELISA. Results 
presented here provide further evidence for the development of an antibody 
response in AGD-affected Atlantic salmon and that carbohydrate epitopes of 
wild-type Neoparamoeba spp. are immunodominant in Atlantic salmon. 
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Introduction 
Protection against fish parasites has, in some instances, been associated with 
serum antibodies. Antibody-mediated protection has predominantly been 
associated with the endoparasitic haemoflagellates Cryptobia salmositica (see 
Chin and Woo, 2005) and Trypanosoma carassii (see Lischke, Klein, Stierhof, 
Hempel, Mehlert, Almeida, Ferguson and Overath, 2000). Resistance to the 
protozoan parasites Ichthyophthirius multifiliis and Cryptocaryon irritans that 
cause white spot disease is associated with serum and skin-associated (or 
mucosal) antibodies (Wang and Dickerson, 2002; Xu and Klesius, 2002; Luo, 
Xie, Zhu and Li, 2006; Yambot and Song, 2006). Moreover there is evidence to 
suggest that serum antibodies may be associated with protection against 
ectoparasites of fish. For example, protection ofrainbow trout against the 
monogenean Discocotyle sagittata (see Rubio-Godoy, Sigh, Buchmann and 
Tinsley, 2003a; Rubio-Godoy, Sigh, Buchmann and Tinsley, 2003b) and 
protection of the tomato clown-fish, Amphiprionfrenatus Bloch, against the 
ectoparasitic dinoflagellate Amyloodinium ocellatum has in some cases been 
associated with serum antibodies (Cobb, Levy and Noga, 1998). Cross-protection 
of goldfish, Carassius auratus L., immunised with I. multifiliis or the non-
pathogenic ciliate Tetrahymena pyriformis against the ectoparasites Oodinium 
pillularis, Trichodina sp., /chthyobodo necatrix and Chilodenella cyprini is 
associated with elevated mucus and plasma antibodies (Ling, Sin and Lam, 
1993). Further, a reduction in metamorphosis of the parasitic larval stage of the 
freshwater mussel Lampsilis reeveiana is associated with the presence of serum 
antibodies in largemouth bass, Micropterus salmoides Lacepiede, (Dodd, 
Barnhart, Rogers-Lowery, Fobian and Dimock, 2006). 
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The obligatory marine amoebae, Neoparamoeba spp. cause amoebic gill disease 
(AGD) of Atlantic salmon (Adams and Nowak, 2004a; Dykova, Nowak, Crosbie, 
Fiala, Peckova, Adams, Machackova and Dvoi'akova, 2005). Atlantic salmon 
appear to develop resistance to AGD in terms ofreduced gill pathology (Findlay, 
Helders, Munday and Gurney, 1995; Findlay and Munday, 1998; Bridle, Carter, 
Morrison and Nowak, 2005) and increased survival (Vincent, Morrison and 
Nowak, 2006). However, evidence to suggest that a humoral immune response 
may be protective in Atlantic salmon affected by AGD is lacking. Serum 
antibodies have been detected in some Atlantic salmon demonstrating resistance 
to AGD in terms of increased survival and/or low-level gill pathology (Vincent, 
et al., 2006; Vincent, Nowak and Morrison, 2008). 
Atlantic salmon cultured in Southern Tasmania, Australia, are affected by AGD 
and the disease is most prevalent during summer months (Clark and Nowak, 
1999; Adams and Nowak, 2003). To alleviate this condition, fish are treated with 
fresh water and this treatment may be repeated multiple times throughout the 
grow-out period. Atlantic salmon that are experimentally exposed to 
Neoparamoeba spp. for a prolonged period and/or exposed multiple times 
develop a serum antibody response (Vincent, et al., 2006; Vincent, et al., 2008) 
and this suggests that sea-cage cultured Atlantic salmon may develop a serum 
antibody response to wild-type Neoparamoeba spp. over the culture period. 
Antibodies that bind cultured Neoparamoeba pemaquidensis have been detected 
in the serum of sea-farmed Atlantic salmon (Gross, Carson and Nowak, 2004) 
however the reactivity of these antibodies with wild-type antigen was not 
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determined. During the current study, blood from sea-farmed Atlantic salmon 
was screened for anti-Neoparamoeba spp. antibodies to 1) identify if sea-farmed 
Atlantic salmon developed an antibody response to wild-type Neoparamoeba 
spp. and, if so, 2) to use these sera to identify potential vaccine candidates. 
Results presented here indicate that cultured Atlantic salmon develop an antibody 
response to wild-type Neoparamoeba spp. and antibodies are directed towards 
cell-surface carbohydrate epitope(s). 
Materials and methods 
Fish history and sampling 
The gross sign of AGD in Atlantic salmon is raised white patches on gill 
surfaces. AGD-like lesions assessed by gross observation are in many cases 
associated with Neoparamoeba spp., however assessment may be over-estimated 
as some AGD-like lesions are not associated with Neoparamoeba spp. (Adams, 
Ellard and Nowak, 2004). Based on this gross sign, the Huon Aquaculture 
Company Pty. Ltd. (HAC) in Dover, Tasmania, applies a scoring system as a 
presumptive diagnosis of the level of AGD. Assessment of AGD-like lesions by 
gross observation is described as clear, with a gill score of 0, to heavy, that is 
assigned a gill score of3 (Adams and Nowak, 2003). On-farm monitoring of 
AGD is regularly performed by assessing the gross gill pathology of a sub-
population of fish from each pen. Freshwater bath treatments are administered 
when the average gill score for the pen approaches a level of light-medium with a 
gross gill score above 1.5. Freshwater bathing involves the transfer offish to an 
adjacent pen containing a liner of fresh water for 3-4 hours. 
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A total of 175 fish were sampled from HAC. These fish included sea-cage 
cultured triploid and diploid Atlantic salmon and a group ofbroodstock that 
demonstrated resistance to AGD in terms oflow, or no, gross gill pathology. The 
broodstock were the first progeny of a group of Atlantic salmon that were 
previously selected by HAC as being putatively resistant to AGD in terms of 
gross gill pathology. Fish were further selected from this population on the basis 
of gross gill pathology on 2 occasions and fish showing the gross sign of AGD 
were removed from the population. The broodstock was maintained at the same 
farm site as commercial culture pens that required freshwater bathing for AGD 
multiple times (J. Wells, HAC, pers. corn.). Induction oftriploidy does not 
guarantee 100% success (Galbreath, Adams, Sherrill and Martin, 2006) and 
while this group of fish is termed triploid, testing to confirm this was not carried 
out and a mixed ploidy population may exist. Table 4.1 summarises the number 
of months of sea-cage culture at the time of sampling, sampling month, pen 
allocation, number of freshwater baths administered, days elapsed post-last bath, 
average water temperature for the month of sampling, number of fish that were 
sero-positive and the total number of fish sampled. 
Blood was taken from triploid and diploid Atlantic salmon on 3 occasions, after 
8, 10 and 13 months of sea-cage culture. The triploid fish were maintained in two 
independent pens (pens 1 and 2) and 10 fish from each pen was sampled on each 
occasion. The diploid fish were initially maintained in a single pen (pen 3) and 
20 fish from this pen were sampled after 8 and 10 months of sea-cage culture. 
Following the second sampling at 10 months, the diploid fish were split across 
two pens (pens 3a and 3b) and for the final sampling at 13 months, 10 fish from 
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each pen were sampled. Blood was taken from 55 of the 75 AGD-resistant fish 
on one occasion after they had been in sea-cage culture for 15 months. Triploid 
and diploid Atlantic salmon were terminally anaesthetised while the AGD-
resistant fish were anaesthetised for blood sampling only and in all cases fish 
were anaesthetised using clove oil (0.02% w/v). Blood was taken from the caudal 
vein and stored in heparinised (triploid and diploid) and non-heparinised tubes 
(AGD-resistant) on ice overnight. The following day, blood was centrifuged at 
lOOOx g for 10 min and the plasma (triploid and diploid) and serum (AGD-
resistant) was stored at -20°C. The variation in blood collection method<:. 
described here was due to the samples from the triploid and diploid fish 
originating from an independent study where plasma had been collected. 
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Table 4.1. Sea-cage cultured Atlantic salmon assessed for anti-Neoparamoeba spp. antibodies in the current study required multiple freshwater 
baths for AGD over the grow-out period. Putatively AGD-resistant broodstock were not treated for AGD for over 250 days. Triploid fish were 
maintained in two independent pens throughout the sampling period while the diploid fish were initially held in a single pen and were split 
across two cages after 10 months in sea-cage culture. These data summarise the number of months of sea-cage culture at the time of sampling, 
sampling month and average sea water temperature, pen allocation, number of freshwater baths administered, days elapsed post-last bath, 
number of sero-positive fish and the total number of fish sampled. 
Months in Sampling month and average Pen Total Days Number Sero-Group sea-cage water temperature* 
allocation Freshwater post-last positive/total fish 
culture {°C ±SE) baths bath sampled 
A GD-affected 8 December 1 4 27 0/10 Triploid 15.5 (0.2) 
2 4 16 0/10 
10 
February 
1 4 77 3/10 17.1 (0.2) 
2 4 66 5/10 
13 May 1 5 104 5/10 12.6 (0.1) 
2 5 101 9/10 
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Table 4.1 continued 
Months in Sampling month and average Pen Group sea-cage water temperature* 
allocation 
culture (°C ±SE) 
A GD-affected 8 December 3 Diploid 15.5 (0.2) 
10 
February 
3 17.1 (0.2) 
13 May 3a 
12.6 (0.1) 
3b 
Putative AGD- 15 March NIA 
resistant 16.4 (0.1) 
broodstock 
* Average seawater temperature for the month of sampling taken at a depth of 3m. 
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Total Days Number Sero-
Freshwater post-last positive/total fish 
baths bath sampled 
4 10 5120 
4 60 17/20 
5 95 4/10 
6 15 5/10 
NIA >250 45155 
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Detection of anti-Neoparamoeba spp. antibodies 
Cultured and wild-type amoebae 
Wild-type amoebae were isolated as described by Morrison, Crosbie and Nowak, 
(2004) from AGD-affected Atlantic salmon housed at the University of 
Tasmania aquaculture center. As all cultured Neoparamoeba spp. tested to date 
are avirulent (Kent, Sawyer and Hedrick, 1988; Howard, Carson and Lewis, 
1993; Findlay, 2001; Morrison, Crosbie, Cook, Adams and Nowak, 2005; 
Vincent, Adams, Crosbie, Nowak and Morrison, 2007) two previously 
characterised clonal strains (Dykova et al., 2005) of Neoparamoeba spp. were 
used to discriminate between reactive epitope(s) of wild-type and cultured 
Neoparamoeba spp .. These were Neoparamoeba pemaquidensis (NP251002) 
(Morrison et al., 2005) isolated from AGD-affected Atlantic salmon, and 
Neoparamoeba branchiphila (SEDMHl) isolated from sediment of Macquarie 
Harbour, Tasmania. Amoebae were maintained on sea water malt yeast agar; 
75% (v/v) coarse-filtered sea water (35%0), 25% (v/v) distilled water, 0.01 % 
(w/v) malt, 0.01 % (w/v) yeast (Oxoid, Hampshire, England), 2% (w/v) Bacto 
agar (Becton, Dickson and Co., Sparks, Maryland, USA). Cells were harvested 
by washing the agar with sterile sea water using a transfer pipette. Wild-type and 
cultured cells were concentrated by centrifugation at 500x g for 5 min and 
enumerated by hemacytometer. For Western blot and ELISA assays amoebae 
were washed twice with phosphate buffered saline (PBS, pH 7.2) and the cell 
pellet was stored at -80° C. 
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SDS PAGE and Western blot 
Binding of plasma (triploid and diploid) and serum (AGD-resistant) antibodies to 
cultured and wild-type Neoparamoeba spp. was assessed by Western blot. 
Amoebae antigens were reduced in buffer containing P-mercaptoethanol by 
boiling for 10 min and separated through 6% polyacrylamide gels with 8 x 104 
cell equivalents loaded in each lane (12.4 µg total protein/lane). Antigens were 
transferred to nitrocellulose membrane (Hybond-C extra, Amersham 
Biosciences, Little Chalfant, UK) using a semi-dry transfer apparatus (Hoefer 
Scientific Instruments, San Francisco, CA) and membranes were blocked in 
casein solution (Vector, Burlingame, CA, USA). Blocking and antibody 
incubation steps were for 30 min and in between incubation steps, membranes 
were washed 3x 4 min with tris-buffered saline (TBS, pH 7.2). Following the 
final antibody incubation, membranes were washed 3x in TBS and then in O.lM 
tris (pH 9.5) for 5 min. All incubation and wash steps were conducted at room 
temperature. Initial screening of the 175 samples was conducted using pooled 
serum and plasma. Pools consisting of serum or plasma from 5 to 7 fish from the 
same sample group were incubated at 1 : 100 with membrane strips (single lane) 
of wild-type Neoparamoeba spp. antigen. Bound antibodies were detected with 
rabbit anti-salmon IgM at 1 :500 (kind gift from Dr. D. Zilberg), sheep anti-rabbit 
alkaline phosphatase (AP) (Chemicon, Boronia, Australia) at 1:1000 and 
developed with 5-bromo-4-chloro-3-indoly L phosphate/nitro blue tetrazolium 
(BCIP/NBT) (Sigma, St Louis, Missouri, USA) following the manufacturer's 
instructions. Binding of the polyclonal rabbit anti-salmon IgM to the heavy chain 
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of Atlantic salmon lgM has been previously described (Vincent, et al., 2006). 
Pooled samples that returned a positive Western blot result were subsequently 
screened individually as described above. In parallel, normal salmon plasma and 
serum pooled from 5 fish held in fresh water and therefore AGD-naive was 
included as negative controls. Finally, positive samples were pooled (5 per pool) 
and assessed for antibody binding to cultured amoebae antigens. As the detection 
limit using chemiluminescence is more sensitive than BCIP/NBT, pooled 
positive serum and plasma were incubated at 1 :500 and bound antibodies were 
detected with rabbit anti-salmon lgM at 1:500, sheep anti-rabbit AP at 1:2000 
and enhanced chemiluminescence (ECL) using DuoLuX (Vector, Burlingame, 
CA, USA), Kodak BioMax Light Film and Kodak GBX developing and fixing 
reagents (Sigma, Castle Hills, NSW, Australia) following the manufacturer's 
instructions. Binding of anti-Neoparamoeba spp. antibodies identified here was 
also assessed against cultured and wild-type antigens that were separated through 
a 12% polyacrylamide gel to identify binding to antigens of a lower molecular 
weight. 
Sodium periodate oxidation of carbohydrate epitope( s) of wild-type 
Neoparamoeba spp. 
Wild-type Neoparamoeba spp. antigens were transferred to nitrocellulose 
membrane as outlined above and from the same membrane, bound antigens on 
adjacent strips were either oxidised with 20 mM sodium periodate (Merck Pty 
Ltd., Victoria) and 50 mM sodium borohydride (Sigma-Aldrich, St Louis, 
Missouri, USA) or incubated in 50 mM sodium acetate (Sigma-Aldrich) pH 4.5, 
following the method outlined by Woodward, Young and Bloodgood, (1985). 
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Membranes were then washed 3x with PBS, blocked, probed and developed by 
ECL as outlined above. 
Enzyme-linked immunosorbent assay (ELISA), immunocytochemistry and flow 
cytometry 
Binding of anti-Neoparamoeba spp. antibodies found in serum or plasma by 
Western blotting were assessed individually by ELISA. Optimal conditions for 
ELISA were determined empirically and have been described previously 
(Vincent et al., 2006). For immunocytochemistry and flow cytometry, wild-type 
amoebae were isolated from AGD-affected Atlantic salmon as outlined above. 
Wild-type amoebae were fixed in seawater Davidson's fixative (SWD) for 1 hat 
20°C and washed by four cycles ofre-suspending cells in PBS and concentrating 
cells by centrifugation at 500 x g for 5 min. Amoebae were then placed in the 
wells (5 x 103 cells/well) ofU-bottomed 96-well microplates (Sarstedt, Ingle 
Farm, South Australia) and blocked in 0.1 % BSA-PBS for 30 min at 4°C. Cells 
were probed with normal Atlantic salmon serum (pooled from 5 Atlantic salmon 
held in fresh water and therefore was from AGD-na1ve fish) or a representative 
pool of salmon anti-Neoparamoeba spp. serum (5 fish) that tested positive for 
anti-Neoparamoeba spp. antibodies by Western blot. Cells were incubated with 
salmon serum at 1:10 (BSA-PBS) and bound antibodies were detected with 
rabbit anti-salmon lgM at 1:100 and FITC-conjugated sheep anti-rabbit lgG 
(Chemicon, Melbourne, Australia) at 1 :50. Cells were washed 3x with PBS 
following each antibody incubation step and photographed (Leica DC300F, 
Leica Microsystems, Wetzlar, Germany) using light and fluorescent microscopy. 
The proportion of wild-type Neoparamoeba spp. expressing epitope(s) to which 
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the serum anti-Neoparamoeba spp. antibodies bound was quantified by flow 
cytometry (Coulter Epics, Beckman Coulter, USA). A minimum of 104 events 
were assessed per treatment and data were analysed using WinMDI 2.8 software 
(Joseph Trotter, Scripps Research Institute, La Jolla, CA, USA). 
Results 
Atlantic salmon assessed in the current study for anti-Neoparamoeba spp. (anti-
NP) antibodies were first sampled when they had been in sea-cage culture for 8 
months. From the 20 triploid and 20 diploid fish sampled at this time, anti-NP 
antibodies were detected by Western blot in 5 samples taken from the diploid 
fish (Fig. 4.1). After 10 months in sea-cage culture, anti-NP antibodies were 
detected in samples taken from 8 of the 20 triploid fish (3 from pen 1 and 5 from 
pen 2). An increase in the proportion of diploid fish that developed a detectable 
antibody response to wild-type Neoparamoeba spp. was seen with 17 of the 20 
diploid fish sampled testing positive for anti-NP antibodies. A further increase in 
the proportion oftriploid Atlantic salmon with detectable anti-NP antibodies was 
observed after 13 months of sea-cage culture and 14 (5 from pen 1 and 9 from 
pen 2) of the 20 triploid fish sampled had developed an antibody response to 
wild-type Neoparamoeba spp .. In contrast, after 13 months in culture fewer 
positive samples from the diploid fish were identified with 9 samples ( 4 from 
pen 3a and 5 from pen 3b) testing positive for anti-NP antibodies by Western 
blot. The putatively resistant Atlantic salmon broodstock had been maintained at 
sea for 15 months at the time of sampling. Fifty-five of the 75 fish in the 
broodstock population were sampled and Western blot analysis identified 45 of 
these fish had developed an antibody response to wild-type Neoparamoeba spp. 
(Table 4.1.). 
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Figure 4.1. Antibodies that bind wild-type Neoparamoeba spp. were detected by 
Western blot in the plasma of sea-cage cultured triploid and diploid Atlantic 
salmon. The proportion oftriploid and diploid Atlantic salmon that developed an 
anti-Neoparamoeba spp. (anti-NP) antibody response increased after 10 months 
in sea-cage culture. A further increase in the proportion oftriploid fish with 
detectable anti-NP antibodies was seen after 13 months in sea-cage culture. In 
contrast, a decline in the proportion of diploid fish with detectable anti-NP 
antibodies was seen after 13 months. The frequency of sero-positive diploid (2N) 
and triploid fish (3N) are presented. Samples from 20 diploid and 20 triploid fish 
were assessed by Western blot at each sampling. 
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After 8 months in sea-cage culture, the gross gill assessment of the triploid and 
diploid fish sampled was predominantly 0 (clear-very light). The gross 
pathological sign of AGD was more pronounced in some fish that were sampled 
after 10 months in sea-cage culture. The gross gill assessment of sero-positive 
and sero-negative fish ranged from 0 to 3 (heavy) and the majority of sero-
positive diploid fish displayed a light level of AGD with a gross gill score of 1 
(Fig. 4.2a). Gross gill scores of sero-positive triploid fish from pen 1 ranged 
between 0 and 2 while in pen 2 scores ranged from 0 to 3. After 13 months of 
sea-cage culture, the majority oftriploid and diploid fish assessed as having a 
clear to very light AGD and were assigned a gross gill score of 0 to 1. No diploid 
fish displayed moderate-heavy AGD as the highest gill score assigned was 1. 
While there was a higher proportion of sero-positive triploid fish with a gross gill 
score ofO, the proportion of sero-positive and sero-negative diploid fish with a 
gross gill score of 0 and 1 was similar. No triploid or diploid fish sampled after 
13 months in sea-cage culture displayed heavy AGD infection as the highest gill 
score assigned was 2 (Fig 4.2b ). Gross gill scores of sero-positive triploid fish 
from pen 1 ranged between 0 and 1 while in pen 2 scores ranges from 0 to 2. The 
putatively AGD-resistant broodstock had not been treated with fresh water for 
AGD for over 250 days and the gross gill assessment prior to sampling was 
recorded as clear for all fish. 
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Figure 4.2. Assessment of AGD-like lesions on gills of Atlantic salmon from 
triploid and diploid populations ranged from clear to heavy in both sero-positive 
and sero-negative fish. After I 0 months in culture (A), a greater proportion of 
sero-positive diploid Atlantic salmon presented with light AGD infection by 
gross observation. An overall higher proportion of fish presenting with clear-
very light gross gill pathology was seen after 13 months in culture (B) and no 
fish sampled at this point were assessed with heavy AGD pathology. The 
frequency of sero-positive and sero-negative fish assigned the gross gill scores of 
0 (clear-very light), I (light), 2 (moderate) and 3 (heavy) are presented. Samples 
from 20 diploid and 20 triploid fish were assessed at each of the 3 sampling 
occasions. 
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The Western blot profile produced by binding of plasma anti-NP antibodies 
present in samples from the triploid and diploid Atlantic salmon was a smear. 
Similarly, binding of antibodies present in serum taken from the broodstock 
produced a smear from around 45 kDa to > 200 kDa. Further assessment of 
antibody binding after antigens were separated through a 12% gel showed that 
below 45 kDa less anti-NP bound to the amoebae antigens and no binding was 
seen below 31 kDa (data not shown). As the Western blot binding profile 
produced by anti-NP antibodies detected in the abovementioned samples was 
consistent, the remaining analysis was performed using a pooled sub-group (n=5) 
of serum taken from the broodstock and will be from here on referred to as 
salmon anti-NP serum. 
Salmon anti-NP antibodies did not bind cultured Neoparamoeba sp. antigen and 
no binding occurred following periodate oxidation of wild-type antigen, 
suggesting that these antibodies are directed towards carbohydrate epitope(s) of 
wild-type Neoparamoeba spp. (Fig. 4.3). Binding of salmon anti-NP antibodies 
to wild-type Neoparamoeba spp. was quantified by flow cytometry, producing a 
fluorescence intensity significantly higher than the normal serum control (Fig. 
4.4). While binding was detected by Western blot and flow cytometry, salmon 
anti-NP serum failed to produce an optical density in excess of the normal serum 
control in an ELISA (data not shown). 
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Figure 4.3. Binding of salmon anti-Neoparamoeba spp. (anti-NP) antibodies 
produces a smear across a broad molecular weight range (A) and reactive 
epitope(s) are sensitive to periodate oxidation (B). Anti-NP antibodies bind wild-
type Neoparamoeba spp. (WT) and do not bind cultured Neoparamoeba 
pemaquidensis (NP251002) and Neoparamoeba branchiphila (SEDMHI ) (A) 
and antibodies present in normal Atlantic salmon serum from AGD-na"ive fish do 
not bind wild-type or cultured Neoparamoeba spp. (C). Antigens were reduced 
in sample buffer containing f3-mercaptoethanol , separated through a 6% 
polyacrylamide gel and each lane was loaded with 8 x 104 cell equivalents ( 12.4 
µg total protein). Wild-type antigens were transferred to nitrocellulose and 
treated with sodium periodate (Na104 WT) (B) . Membranes were probed with 
pooled (5 fish) salmon anti-NP (A) and normal Atlantic salmon serum (C). 
Bound antibodies were detected with rabbit anti-salmon IgM, AP-conjugated 
sheep anti-rabbit IgG and chemiluminescence. Normal serum was taken from 
Atlantic salmon held in fresh water and the fish were therefore AGD-narve. 
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Figure 4.4. Serum anti-Neoparamoeba spp. (anti-NP) antibodies bind cell-
surface epitope(s) of wild-type Neoparamoeba spp .. The light micrographs 
correspond to the adjacent epi-fluorescent images. A sub-sample of cells probed 
with either anti-NP of normal sera were photographed before quantitative 
analysis of the remaining sample by flow cytometry. Wild-type Neoparamoeba 
spp. were fixed and probed with normal salmon serum (Normal serum) or anti-
NP serum (Salmon anti-NP). Bound antibodies were detected with rabbit anti-
salmon IgM and FITC-conjugated sheep anti-rabbit IgG. Normal serum and 
salmon ant i-NP serum was pooled from 5 fish. Normal serum was taken from 
Atlantic salmon held in fresh water and these fish were therefore AGD-na'ive. 
Data are representative of cells within the gated region shown in the dot-plot 
(inset). The proportion of cells producing a fluorescence intensity significantly 
higher than the normal serum control (A) are presented on the histogram and 
represent data assessed within the marked region (m). Flow cytometric data were 
analysed and presented using WinMDI 2.8 software. 
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Discussion 
In some cases, sea-fanned Atlantic salmon develop an antibody response to wild-
type Neoparamoeba spp. and anti-NP antibodies detected in the current study are 
directed towards cell-surface carbohydrate epitope(s). Antibodies that bind cell-
surface carbohydrate epitope(s) of wild-type Neoparamoeba spp. have also been 
detected in some Atlantic salmon experimentally inoculated with wild-type 
Neoparamoeba spp. (Vincent, et al., 2006; Vincent, et al., 2008). In addition, 
monoclonal antibodies produced against cell-surface antigens of wild-type 
Neoparamoeba spp. are predominantly directed towards carbohydrate epitope(s) 
(Villavedra, Lemke, To, Broady, Wallach and Raison, 2007). Together, these 
results suggest that cell-surface carbohydrate epitopes of wild-type 
Neoparamoeba spp. are immunodominant. Carbohydrate antigens are abundant 
on the cell-surface of many protozoan parasites and some of these structures are 
important for attachment to the host (Mendonca-Previato, Todeschini, Heise and 
Previato, 2005). While the mechanism(s) that mediate attachment of 
Neoparamoeba spp. to Atlantic salmon gill tissues are unknown, the dominance 
of cell-surface carbohydrate epitope(s) suggests that attachment may be mediated 
by cell-surface glycoconjugates. 
While anti-NP antibodies have been detected in many fish, both in the current 
and previous studies (Vincent, et al., 2006; Vincent, et al., 2008), antibody titre 
in the majority of cases, was not detectable in an ELISA. The same Western blot 
binding profile (smear) as reported in the current study was produced by binding 
of anti-NP antibodies present in serum of some Atlantic salmon that were 
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exposed to wild-type Neoparamoeba spp. twice (Vincent, et al., 2006) and anti-
NP antibodies present in the serum of 4 fish that were exposed to wild-type 
Neoparamoeba spp. for a prolonged period (Vincent, et al., 2008). Despite 
producing similar Western blot binding profiles, a significant serum anti-NP 
antibody titre was only measured by an ELISA in one of these samples (Vincent, 
et al., 2008). This suggests that failure to measure antibody titre by an ELISA in 
the current study or the study by Vincent et al., (2006) is not associated with the 
ELISA conditions but rather with very low antibody levels. 
Wild-type Neoparamoeba spp. are occasionally entrapped in interlamellar 
vesicles containing immune-like cells (Adams and Nowak, 2001) and antigen 
processing may be facilitated by MHC Ii+ cells present in AGD gill lesions 
(Morrison, Koppang, Hordvik and Nowak, 2006). The level of antigen 
processing may therefore be restricted by the number of Neoparamoeba spp. that 
become entrapped, perhaps influencing serum anti-NP antibody titre. Results 
presented here suggest that the presence oflow-level plasma anti-NP antibodies 
does not appear to be related to the level of gross gill pathology. After 10 months 
of sea-cage culture there was a substantially higher proportion of sero-positive 
diploid fish with a gross gill score of 1, however sero-positive and sero-negative 
fish from both triploid and diploid populations were represented across the range 
of gross gill pathology with scores from 0 to 3. An overall reduction in gill 
pathology was seen after 13 months with no fish displaying heavy AGD and 
although no sero-positive diploid fish were assessed higher than a gill score of 1, 
the proportion of sero-negative and sero-positive diploid fish with gill scores of 0 
and 1 were similar. There was a slight variation in the level of gross pathology of 
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the sero-positive fish between triploid pens 1 and 2 and the diploid pens 3a and 
3b however little can be concluded from this due to the low sample size. 
The number of fish that developed an anti-NP response increased over time with 
the exception of the diploid fish at the final sampling after 13 months in culture. 
As only 10 fish were sampled from each cage, the decline in the number of sero-
positive diploid fish identified at the final sampling may have been influenced by 
the low numbers of fish sampled. It has been hypothesised that the duration of, or 
multiple exposure to, wild-type Neoparamoeba spp. may influence the 
development of an antibody response in Atlantic salmon (Vincent, et al., 2006; 
Vincent, et al., 2008). The development of a serum antibody response to the 
ectoparasitic copepod, Lepeophtheirus salmonis, appears to be influenced by the 
duration of exposure and/or parasite abundance. Rainbow trout naturally exposed 
to a low-level L. salmonis infection for 8 weeks (Grayson, Jenkins, Wrathmell 
and Harris, 1991) and Atlantic salmon exposed to a moderate Caligus elongatus 
infection for 12 months do not develop a serum antibody response (MacKinnon, 
1993). While Atlantic salmon exposed to a high-level L. salmonis infection for 
up to 2 years develop a serum antibody response (Grayson, et al., 1991). 
Similarly for A GD-affected Atlantic salmon, the level of infection and 
potentially, the subsequent increase in antigen processing events may influence 
the development of a serum antibody response in AGD-affected Atlantic salmon. 
While data presented here provide some support for this, the same fish weren't 
assessed over time. Therefore any relationship between the length of time fish 
were exposed to wild-type Neoparamoeba spp., or the time post last bath, and 
the development of a serum antibody response cannot be drawn from results 
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presented in this study. Furthermore, there is no relationship between the level of 
gill pathology and presence of serum antibodies. 
The time elapsed between freshwater bath treatments increased over time in 
culture with the exception of one pen of diploid fish. An increase in the period 
between freshwater bathing for AGD may be interpreted as an indication of 
resistance. However, environmental conditions including increased salinity and 
temperature are key factors that influence AGD (Clark and Nowak, 1999; Adams 
and Nowak, 2003; Adams and Nowak, 2004b). The greatest period between 
freshwater bath treatments occurred between the second and third sampling that 
coincided with the period between late summer and late autumn where a seasonal 
reduction in seawater temperature occurred. In addition, it is common practice 
during marine culture of salmon to move sea cages to allow for fallowing of the 
site and to facilitate fresh water bathing. The Atlantic salmon sampled in the 
current study were held in cages that were routinely moved around the sites for 
fresh water bathing. It is therefore possible that fish were exposed to different 
levels/timing of infection, however due to the low sample size and the fact that 
individual fish were not sampled over time, no relationship between the sero-
positive fish (either diploid or triploid) and the level of infection or length of 
time exposed can be drawn. 
Freshwater bathing is conducted on the basis of gross gill pathology and gill 
score data collected after 13 months in sea-cage culture suggests that at this time 
fish were experiencing a lower level of AGD. The putatively AGD-resistant 
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Atlantic salmon broodstock did not require a freshwater bath for over 8 months 
yet the development of a serum antibody response in a large proportion of these 
fish indicates that they were exposed to Neoparamoeba spp .. These fish were 
housed in a single sea-cage at a very low stocking density and this may have 
attributed to the low-level of infection Alternatively, as these Atlantic salmon 
were the first progeny ofbroodstock that were previously selected by HAC on 
the basis of gross gill pathology, resistance to AGD in terms of gross gill 
pathology may be inherent. 
There are many challenges associated with the development of anti-parasite 
vaccines and this is reflected by the few anti-parasite vaccines commercially 
available. Vaccines for the cattle tick, Boophilus microplus, were introduced in 
1994 and are currently the only commercially available ectoparasitic vaccines 
(Nuttall, Trimmel, Kazimirova and Labuda, 2006). Identification of protective 
peptide antigens is important for the development of an economically viable 
AGD vaccine. To date, reactivity of salmon anti-NP antibodies to putative 
peptide epitope(s) remains an isolated case (Vincent, et al., 2008) and 
carbohydrate epitope(s) are predominantly recognised by Atlantic salmon serum 
anti-NP antibodies. In addition, monoclonal antibodies produced against 
deglycosylated wild-type cell-surface antigens react with very few cell-surface 
peptide epitope(s) that are unique to wild-type Neoparamoeba spp. (Villavedra, 
et al., 2007). Together, this suggests that the identification of peptide candidate 
vaccine antigens by screening serum against wild-type Neoparamoeba spp. is 
unlikely. Mucosa! antibodies have been associated with resistance of fish against 
protozoan parasites such as I. multifiliis (Wang and Dickerson, 2002; Xu and 
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Klesius, 2002) and Cryptocaryon irritans (see Luo, et al., 2006; Yambot and 
Song, 2006). While anti-NP antibodies were not detected in cutaneous mucus of 
putatively AGD-resistant Atlantic salmon (Vincent, et al., 2006), resistance of 
Atlantic salmon to Neoparamoeba spp. may be associated with a more localised 
response. The potential that a more localised antibody response, in the gill mucus 
or epithelium, may play a role in resistance of Atlantic salmon to AGD warrants 
further investigation. 
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Cutaneous mucus and saccharides reduce the ability of 
wild-type Neoparamoeba spp. to elicit amoebic gill 
disease (AGD) in Atlantic salmon 
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Abstract 
Attachment of parasites to host tissues is in many cases mediated by parasite 
cell-surface lectins. Wild-type Neoparamoeba spp. were incubated in Atlantic 
salmon, Salmo salar L., cutaneous mucus or a range of saccharides prior to 
inoculation of sea water systems containing amoebic gill disease (AGD)-naYve 
Atlantic salmon. The ability of wild-type Neoparamoeba spp. to elicit AGD was 
significantly reduced by Atlantic salmon cutaneous mucus and all saccharide 
treatments including galactose and GalNAc. It was therefore hypothesised that 
wild-type Neoparamoeba spp. may express an orthologue of the Entamoeba 
histolytica Gal/GalNAc inhibitable lectin. Antibodies that bind the Gal/GalNAc 
inhibitable lectin of E. histolytica were assessed for their ability to bind cell-
surface antigen(s) of wild-type Neoparamoeba spp .. These antibodies bound live 
wild-type Neoparamoeba spp., yet glucose or galactose enhanced, rather than 
inhibited antibody binding. Results presented here suggest that the ability of 
wild-type Neoparamoeba spp. to elicit AGD may be associated with lectin-
mediated attachment. 
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Introduction 
Neoparamoeba perurans is the agent of amoebic gill disease (AGD) in sea-
farmed Atlantic salmon, Salmo salar L., in southern Tasmania, Australia (Young, 
Crosbie, Adams, Nowak and Morrison, 2007). Gill-derived Neoparamoeba are 
isolated from the gill tissues of AGD-affected Atlantic salmon by plastic 
adherance (Morrison, Crosbie and Nowak, 2004). N. pemaquidensis and N. 
branchiphila have also been isolated by culture from gill tissues of AGD-affected 
Atlantic salmon (Dykova, Nowak, Crosbie, Fiala, Peckova, Adams, Machackova 
and Dvofakova, 2005). Therefore, amoebae obtained from gill tissues of AGD-
affected Atlantic salmon are referred to as wild-type Neoparamoeba spp .. AGD 
is a global health concern for Atlantic salmon growers and has been reported in 
Ireland (Rodger and McArdle, 1996; Palmer, Carson, Ruttledge, Drinan and 
Wagner, 1997), the USA (Kent, Sawyer and Hedrick, 1988), Chile, New 
Zealand, Australia (Munday, 1986; Munday, Zilberg and Findlay, 2001) Scotland 
(Young, Dykova, Snekvik, Nowak and Morrison, 2008) and Norway (Steinum, 
Kvellestad, R0nneberg, Nilsen, Asheim, Fjell, Nygard, Olsen and Dale, 2008). 
AGD is the greatest health concern of Atlantic salmon growers in southern 
Tasmania, Australia and to date, freshwater bathing is the only commercially 
applied treatment for AGD. In southern Tasmania, the prevalence of AGD 
increases during summer months in association with warmer sea water 
temperatures and salinity of35%o (Clark and Nowak, 1999; Adams and Nowak, 
2003) and during this period, fish require repetitive freshwater baths. Freshwater 
bathing is labor and cost-intensive, therefore the development of an alternative 
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measure for alleviating AGD, such as an anti-AGD vaccine, is a priority for 
salmon growers in Tasmania. 
Attachment of a range of parasites to host cells, in some cases, may be mediated 
by the binding of parasite lectins to carbohydrate residues of host tissues. In 
many instances, these interactions can be inhibited by blocking the carbohydrate 
recognition domain (CRD) of the lectin with target saccharides, host tissues or 
with antibodies that bind the CRD. For example, attachment of Giardia lamblia 
trophozoites to Caco-2 cells is mediated by a mannose binding lectin (Katelaris, 
Naeem and Farthing, 1995) and inhibited by mucin (Roskens and Erlandsen, 
2002). Acanthamoeba castellanii attachment in vitro to corneal epithelial cells is 
mediated by a mannose binding lectin and this interaction is inhibited by 
mannose (Yang, Cao and Panjwani, 1997; Cao, Jefferson and Panjwani, 1998). 
The human pathogenic amoebae, Entamoeba histolytica, utilise the Gal/GalNAc 
inhibitable lectin for attachment to colonic mucins (Ravdin and Guerrant, 1981; 
Ravdin, John, Johnston, Innes and Guerrant, 1985; Chadee, Petri, Innes and 
Ravdin, 1987). Either monoclonal antibodies that bind the E. histolytica 
Gal/GalNAc inhibitable lectin, galactose or GalNAc block lectin-mediated 
attachment of E. histolytica to target carbohydrate residues (Ravdin, Petri, 
Murphy and Smith, 1986; Venkataraman, Haack, Bondada and Kwaik, 1997; 
Kwaik, Venkataraman, Harb and Gao, 1998). The Gal/GalNAc inhibitable lectin 
has shown potential as a vaccine antigen against amebiasis in animal models 
(Zhang, Cieslak and Stanley, 1994; Soong, Kain, Abd-Alla, Jackson and Ravdin, 
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1995; Dodson, Lenkowski, Eubanks, Jackson, Napodano, Lyerly, Lockhart, 
Mann and Petri, 1999). Hartmannella vermiformis also express an orthologue of 
the Gal/GalNAc inhibitable lectin (Venkataraman, et al., 1997) and H. 
vermiformis are ancestrally related to N. pemaquidensis and N. aestuarina 
(Peglar, Amaral Zettler, Anderson, Nerad, Gillevet, Mullen, Frasca, Silberman, 
O'Kelly and Sogin, 2003). It was therefore hypothesised that wild-type 
Neoparamoeba spp. may also express an orthologue of the Gal/GalNAc 
inhibitable lectin. 
In the current study, wild-type Neoparamoeba spp. were incubated in a range of 
saccharides or Atlantic salmon cutaneous mucus prior to induction of AGD. In 
addition, monoclonal and polyclonal antibodies that bind the Gal/GalNAc 
inhibitable lectin of E. histolytica were assessed for their ability to bind 
antigen(s) of wild-type Neoparamoeba spp .. Incubation of wild-type 
Neoparamoeba spp. with either Atlantic salmon cutaneous mucus or each of the 
saccharides assessed, significantly reduced the ability of these amoeba to elicit 
AGD in nai"ve Atlantic salmon. Both the monoclonal and polyclonal anti-
Gal/GalNAc inhibitable lectin antibodies bound live wild-type Neoparamoeba 
spp., yet binding was not inhibited by galactose. 
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Materials and methods 
Induction of AGD in Atlantic salmon by inoculation with wild-type Neoparamoeba 
spp. pre-treated with carbohydrate preparations. 
Amoebae preparations 
Wild-type Neoparamoeba spp. were isolated from AGD-affected Atlantic salmon 
housed at the University of Tasmania Aquaculture Centre as described by 
Morrison et al., (2004). Wild-type Neoparamoeba spp. were incubated with a 
range of saccharides, Atlantic salmon cutaneous mucus or PBS prior to the 
inoculation of fish-holding systems (Table 5.1.). Mucus was obtained from 
AGD-naYve Atlantic salmon that were acclimitised to sea water (1 µm-filtered) 
and had not been exposed to wild-type Neoparamoeba spp .. Fish were 
anaesthetised with Aqui-S (Aqui-S NZ Ltd, Lower Hutt, New Zealand) and 
mucus was collected by gently scraping the skin with the edge of a glass slide. 
Anti-protease cocktail (Sigma) was added to the mucus suspension according to 
the manufacturer's instructions. Mucus was then vortexed, spun at 16 OOO xg for 
15 min and the supernatant removed. The mucus supernatant was 0.2 µm-
filtered, concentrated and dialysed against PBS using a 10 kDa molecular weight 
cut-off filtration column (Amicon Ultra, Millipore, Carrigtwohill, County Cork, 
Ireland) following the manufacturer's instructions. The total protein 
concentration of the mucus suspension was quantified by a colorimetric assay 
(Pierce, Rockford, USA). Wild-type Neoparamoeba spp. were exposed to each 
of the saccharides (all purchased from Sigma), Atlantic salmon cutaneous mucus 
supernatant or PBS alone (Table 5.1.). For each of the treatments, wild-type 
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Neoparamoeba spp. were incubated in a volume of 1 mL at 4°C for 20 min. Cells 
were washed 1 x in PBS, concentrated and resuspended in 0.2 µm-filtered sea 
water. Cells were then directly transferred to experimental systems within 10 min 
of re-suspension. To assess the viability of cells after treatment, an aliquot of 10 
µL was taken from each treatment, placed on a glass slide and overlayed with 
200 µL 0.2 µm-filtered sea water (35%0). After 15 min, cell viability was 
confirmed after observing cell adherence to the glass slide. 
Table 5.1. Summary of the saccharides and inoculating concentration ofwild-
type Neoparamoeba spp. used for the induction of AGD. Wild-type 
Neoparamoeba spp. were exposed to the following treatments in PBS for 20 min 
at 4°C. Cells were then re-suspended in sterile sea water and directly transferred 
to experimental systems. All saccharides were diluted in PBS and the mucus 
supernatant was dialysed against PBS. 
Trial and concentration of inoculum 
(cells/L) 
1 (8500) 
2 (8500) 
Treatment 
PBS 
Galactose (500mM) 
Glucose (500mM) 
GalNAc (50mM) 
Atlantic salmon cutaneous mucus 
supernatant* 
PBS 
1Vlannose(500mM) 
Fucose (500mM) 
Xylose (500mM) 
Atlantic salmon cutaneous mucus 
supernatant* 
*540 µg/mL total protein. The mucus supernatant used in trial 1 and 2 was taken from 
the same preparation. 
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Atlantic salmon (100-150 g) were obtained from the Saltas hatchery, Wayatinah, 
Tasmania. These fish had only been maintained in fresh water and therefore had 
not been exposed to wild-type Neoparamoeba spp .. Fish were held in a single 
3000 L recirculation system and acclimated to 35%0 salinity by multiple sea 
water (1 µm-filtered) exchanges over a 10 d period. For exposure to wild-type 
Neoparamoeba spp., groups of 5 fish were transferred to 80 L tanks containing 
40 L sea water (35 %0 at 16.5°C) with aeration. Two tanks were used for each 
treatment (10 fish/treatment). A further 2 groups of 5 fish were maintained under 
the same conditions but were not exposed to wild-type Neoparamoeba spp .. Two 
independent infection trials were conducted. Positive (wild-type Neoparamoeba 
spp. incubated in PBS alone) and negative (no amoebae) infection controls were 
included in each trial. In trial 1 and 2, the mucus supernatant treatment was 
replicated using mucus from the same preparation. Both trials were conducted 
according to the protocol developed by Crosbie, Adams, Attard and Nowak, 
(2007) with one minor alteration. After the initial 6 h exposure to wild-type 
Neoparamoeba spp., each treatment group of 10 fish (2 tanks of 5 fish each) was 
transferred to individual 350 L recirculating systems (35 %0 at 16.5°C) for 3 d. 
During the 3 d, water changes of approximately 30% of the system volume were 
conducted for each treatment system after 24 and 48 h and at all times the total 
ammonia levels were 0.25-1.5 mg/L. Fish were not fed during the experimental 
period. Mortality not associated with AGD, or loss due to fish jumping out of 
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tanks was experienced in some experimental systems in both trial 1 and 2. 
Therefore, 8 fish were randomly sampled from each experimental system at the 
end of the 3 d trial. 
Assessment of gill pathology 
Fish were terminally anaesthetised with Aqui-S and the entire gill basket was 
excised and placed in seawater Davidson's fixative (SWD). The second, left gill 
arch was processed and embedded following routine histological protocols and 
sections (5 µm) were stained with haematoxylin and eosin (Hand E).Gill 
sections were assessed by light microscopy at 400x magnification. Gill lesions 
were designated as AGD related when amoebae trophozoites with visible nucleus 
and Perkinsiella amoebae-like organisms (PLOs) (Dykova et al., 2005) were 
seen in association with hyperplastic tissues (Adams and Nowak, 2001). 
Filaments were included in the assessment of the number of AGD lesions when 
the central venous sinus was visible in at least two-thirds of the filament length 
(Adams and Nowak 2003), a minimum of 10 gill filaments per section were 
assessed. 
Data analysis 
Differences in gill pathology between treatment groups were assessed by analysis 
of variance. Data were initially tested for homogeneity of variances using 
Levene's test. Means were compared by Tukey's HSD test and due to non-
homogeneous variances, differences were considered significant at P < 0.01. 
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Data were analysed using SPSS statistical software (Version 13.0, SPSS Science, 
Chicago, IL,USA). 
Binding of anti-GaUGalNAc inhibitable lectin antibodies to wild-type 
Neoparamoeba spp •• 
SDS-PAGE and Western blot 
Amoebae antigens were reduced by boiling for 10 min in buffer containing 
~-mercaptoethanol and 8 x 104 cell equivalents/lane were separated through 6% 
polyacrylamide gels. Antigens were transferred to nitrocellulose membranes 
(Hybond-C extra, Amersham Biosciences, Little Chalfont, UK) using a semi-dry 
transfer apparatus (Hoefer Scientific Instruments, San Francisco, CA) and 
membranes were blocked in casein solution (Vector, Burlingame, CA, USA). 
Blocking and antibody incubation steps were for 30 min and in between 
incubation steps, membranes were washed 3 x 4 min with tris-buffered saline 
(TBS, pH 7.2). Following the final antibody incubation, membranes were washed 
3 x in TBS and then in 100 mM tris (pH 9.5) for 5 min. All incubation and wash 
steps were conducted at 20°C. Membranes were probed with Staphylococcal 
protein A-purified monoclonal (3F4, 100 µg/mL) or rabbit polyclonal ("Shiro", 
0.6 µg/mL) antibodies that bind the Gal/GalNAc inhibitable lectin of Entamoeba 
histolytica (a kind gift from Prof. William A. Petri Jr.). Mouse IgG (100 µg/mL) 
or rabbit IgG (0.6 µg/ml) were used as negative controls. All antibodies were 
diluted in casein solution. Bound antibodies were detected with alkaline 
phosphatase (AP)-conjugated goat anti-mouse (Sigma) or AP-conjugated sheep 
anti-rabbit IgG (Chemicon, Boronia, Australia) at 1:1000 and enhanced 
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chemiluminescence (ECL) using DuoLuX (Vector, Burlingame, CA, USA), 
Kodak BioMax Light Film and Kodak GBX developing and fixing reagents 
(Sigma, Castle Hills, NSW, Australia) following the manufacturer's instructions. 
Immunocytochemistry and flow cytometry 
Binding of3F4 or Shiro to live and SWD fixed wild-type Neoparamoeba spp. 
was assessed. Wild-type Neoparamoeba spp. were isolated as outlined above. 
Cells were fixed in SWD for 20 min at 20°C and washed 3 x with PBS. Live 
cells were harvested, re-suspended in 5mLof0.2 µm-filtered sea water and 
maintained in suspension by gentle rocking. Prior to incubation with antibodies, 
all cells were washed 1 x in PBS. Amoebae were placed in wells (5 x 104 
cells/well) of U-bottomed 96-well microplates (Sarstedt, Ingle Farm, South 
Australia) and incubated in 50 µL Shiro or rabbit IgG isotype control (Sigma, St 
Louis, MO, USA) at 0.6 µg/mL or 3F4 or monoclonal IgG isotype control 
(Sigma) at 100 µg/mL for 20 min at 4°C. All antibodies were diluted in 0.1 % 
BSA-PBS. After incubation with primary antibodies, cells were washed 2 x in 
PBS. Live cells were then fixed in SWD for 20 min at RT and washed 3 x with 
PBS. Cells that were fixed before incubation with primary antibodies were 
washed 2 x with PBS. The binding of Shiro or purified rabbit IgG to wild-type 
Neoparamoeba spp. was detected with FITC-conjugated sheep anti-rabbit IgG 
(Chemicon, Boronia, Australia) and binding of 3F4 or purified murine IgG 
antibodies was detected with FITC-conjugated goat anti-mouse IgG (Sigma) 
following the manufacturer's instructions. Cells were washed a further 2 x in 
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PBS. The effect of galactose or glucose on the binding of 3F4 to live wild-type 
Neoparamoeba spp. was assessed by incubating cells in 500 mM galactose or 
glucose (Sigma) in PBS for 20 min at 4°C. Wild-type Neoparamoeba spp. were 
then washed 1 x in PBS, probed with 3F4 and FITC-conjugated goat anti-mouse 
lgG as outlined above. A sub-sample of cells from each treatment were 
photographed (Leica DC300F, Leica Microsystems, Wetzlar, Germany) using 
light and epi-fluorescence microscopy. The proportion of wild-type 
Neoparamoeba spp. expressing epitope(s) to which the anti-Gal/GalNAc 
inhibitable lectin antibodies bound was quantified using flow cytometry (Coulter 
Epics, Beckman Coulter, USA). Ten thousand cells were assessed per treatment 
and data were analysed using WinMDI 2.8 software (Joseph Trotter, Scripps 
Research Institute, La Jolla, CA, USA). 
Results 
Induction of AGD in Atlantic salmon by inoculation with wild-type Neoparamoeba 
spp. pre-treated with carbohydrate preparations. 
Wild-type Neoparamoeba spp. may colonise Atlantic salmon gill tissues via 
lectin-mediated attachment. To assess this hypothesis, wild-type Neoparamoeba 
spp. were incubated in a range of saccharides or Atlantic salmon cutaneous 
mucus supernatant before inoculating fish-holding tanks containing AGD-naYve 
Atlantic salmon. After incubation in suspension with each of the saccharides or 
mucus supernatant, wild-type Neoparamoeba spp. from all treatments of the 2 
independent trials adhered to glass confirming their viability (Fig. 5. lA). Cell 
nuclei and Perkinsiella amoebae-like organisms (PLOs) were visible in many 
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adhered cells (Fig. 5. 1 B) and mitotic division of amoebae was observed 
(Fig. 5. IC). No agglutination of Neoparamoeba spp. was observed after 
incubation in mucus supernatant or any of the saccharides assessed. 
Figure 5.1. The viability of wild-type Neoparamoeba spp . was not affected after 
incubation with mucus supernatant or saccharide preparations. Trophozoites 
readily adhered to glass slides within 15 min (A). The above images of cells after 
treatment with 500 mM galactose is representative of wild-type Neoparamoeba 
spp. ce ll adherence after exposure to all saccharide treatments, Atlantic salmon 
cutaneous mucus supernatant or PBS alone. The cell nuclei (n) and Perkinsiella 
amoebae-like organisms (PLO) were easily recognised in adhered cells (B) and 
cells undergoing mitotic division (d) were seen (C).Scale bars= 40 µm. 
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AGD lesions were present on gills of all fish exposed to wild-type 
Neoparamoeba spp. (Fig. 5.2). Wild-type Neoparamoeba spp. with visible cell 
nuclei and PLOs were seen in association with lesions formed by hyperplasia of 
gill epithelium (Fig. 5.2E). AGD lesions did not develop in the gills of fish that 
were not exposed to wild-type Neoparamoeba spp. and normal gill structure was 
observed (data not shown). In both trials there was a significant reduction in the 
number of AGD lesions that developed across all treatments in comparison with 
the positive infection control (wild-type Neoparamoeba spp. incubated in PBS 
before inoculation). In trial 1 there was a significant reduction (P = 0.001) in the 
average number of AGD lesions/filament in comparison to the infection control 
after wild-type Neoparamoeba spp. was incubated with glucose, galactose, 
GalNAc or mucus supernatant prior to inoculating systems (Fig. 5.3A). There 
was no significant difference (P = 0.597) between the saccharide treatments in 
trial 1. Similarly, incubation of wild-type Neoparamoeba spp. in mannose, 
xylose, fucose or mucus supernatant prior to inducing AGD significantly reduced 
(P = 0.000) the development of AGD pathology in trial 2 (Fig. 5.3B). Treatments 
applied in trial 2 included mannose, fucose, xylose and mucus supernatant. All 
trial 2 treatments were equally effective in reducing the development of AGD 
lesions (P = 0.541 ). The Atlantic salmon cutaneous mucus supernatant treatment 
was included in both trial 1 and trial 2 and was obtained from AGD-nalve 
Atlantic salmon. The mucus supernatant used in trial I and trial 2 was from the 
same preparation. The number of AGD lesions on fish exposed wild-type 
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Neoparamoeba spp. incubated in mucus supernatant were 58.8% and 71.7% 
lower than the corresponding infection control in trial I and 2 respectively. 
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Figure 5.2. Atlantic salmon exposed to a high-density inoculum of wild-type 
Neoparamoeba spp. for 6 h develop AGO lesions (arrows) within 3 d. Very few 
AGO lesions were found on the majority of fish that were exposed to wild-type 
Neoparamoeba spp. that were pre-incubated in saccharide or mucus treatments 
(B). The number of AGO lesions was substantially higher on gills of fish that 
were exposed to wild-type Neoparamoeba spp. that were treated with PBS alone 
(A). Areas of hyperplastic cells (he) associated with trophozoites were confirmed 
to be AGO-lesions after observation of the nucleus (n) and Perkinsiella amoebae-
like organism (PLO) in lesion associated trophozoites. Images C-E show the 
sequential enlargement of an AGO lesion that developed on the gills of a fish 
exposed to the infection control inoculum (Neoparamoeba spp. incubated in 
PBS). The above images are representative of gill pathology of fish exposed to 
the infection control inoculum of wild-type Neoparamoeba spp. (A) or any of the 
saccharide or mucus supernatant preparations (B) listed in Table 5. l. 
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Figure 5.3. Incubation of wild-type Neoparamoeba spp. with a range of 
saccharides or mucus supernatant prior to inoculating fish-holding systems 
significantly (P = 0.000) reduced the number of AGD lesions that developed on 
the gills of exposed Atlantic salmon. These data are from 2 independent trials. In 
trial 1, wild-type Neoparamoeba spp. were incubated in glucose or galactose at 
500 mM in PBS, GalNAc-PBS at 50 mM, Atlantic salmon cutaneous mucus 
supernatant (540 µg/mL total protein) or PBS alone (A). In trial 2, wild-type 
Neoparamoeba spp. were incubated in fucose, mannose or xylose at 500 mM in 
PBS, Atlantic salmon cutaneous mucus supernatant (540 µg/mL total protein) or 
PBS alone (B). Atlantic salmon mucus was collected from AGD-na"ive fish 
maintained in 35 %0 sea water. The supernatant was concentrated by 
centrifugation (10 kDa MW filtration unit) and dialysed against PBS. Tanks were 
inoculated at 8.5 x 103 cells/L and Atlantic salmon were exposed to these 
conditions for 6 h. Fish were then transferred to independent systems for 3 d. The 
average number of lesions/filament is presented(± SEM, n=8 fish) for each 
treatment group. 
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Binding of anti-GaVGaINAc inhibitable lectin antibodies to wild-type 
Neoparamoeba spp •• 
Binding of either monoclonal (3F4) or polyclonal (Shiro) anti-Gal/GalNAc 
inhibitable lectin antibodies to reduced wild-type Neoparamoeba spp. antigen(s) 
was not detected by Western blot (data not shown). By immunocytochemistry, 
3F4 and Shiro bound live, wild-type Neoparamoeba spp. (Figs. 5.4 and 5.5), yet 
these antibodies did not bind to cells that were fixed with SWD. Interestingly, 
incubation of live trophozoites with galactose or glucose enhanced, rather than 
inhibited, binding of 3F4 (Fig. 5.4). 
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Figure 5.4. The monoclonal anti-Gal/GalNAc 
inhibitable lectin antibody 3F4 bound live (G) but not 
fixed (A) wild-type Neoparamoeba spp. and binding 
was enhanced by glucose (K) and galactose (I). The 
light micrographs correspond to the adjacent epi-
fluorescent images. A sub-sample from each treatment 
was photographed before quantitative analysis of the 
remaining sample by flow cytometry. Therefore the 
histogram labels correspond to the images above. 
Analysis of binding of 3F4 to wild-type 
Neoparamoeba spp. by flow cytometry confirmed that 
3F4 does not bind fixed cells (A) and fixed cells 
produce a fluorescence intensity similar to the isotype 
control of either fixed (C, shaded) or live (E) cells . 
Binding of 3F4 to live wild-type Neoparamoeba spp. 
produces a fluorescence intensity significantly higher 
than the isotype control (G) and the intensity increases 
by approximately 10-fold when cells were incubated 
in galactose (I) or glucose (K) prior to incubation with 
3F4. Bound antibodies were detected with FITC-
conjugated goat anti-mouse lgG. Data are 
representative of cells within the gated region shown 
in the dot plot (inset). The proportion of cells 
producing a fluorescence intensity significantly higher 
than the isotype control of live cells (C) are presented 
on the histogram and represent data assessed within 
the marked region (m). Flow cytometric data were 
analysed and presented using WinMDI 2.8 software. 
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Figure S.S. The polyclonal anti-Gal/GalNAc inhibit~ble lectin antibody "Shiro" bound 
live (G) but not fixed (A) wild-type Neoparamoeba spp .. The light micrographs 
correspond to the adjacent epi-fluorescent images. A sub-sample from each treatment 
was photographed before quantitative analysis of the remaining sample by flow 
cytometry. Flow cytometry confirmed binding of Shiro to live and not fixed wi ld-type 
Neoparamoeba spp .. A fluorescence intensity similar to the isotype control of fixed (C, 
shaded) or live cells (E) is produced by fixed cells probed with Shiro (A). Binding of 
Shiro to live wild-type Neoparamoeba spp. (G) produces a fluorescence intensity 
significantly higher than the isotype controls. Bound antibodies were detected with 
FITC-conjugated goat anti-mouse IgG. Data are representative of cells within the gated 
region shown in the dot plot (inset). The proportions of cells producing a fluorescence 
intensity significantly higher than the isotype control of live cells (C) are presented on 
the histogram and represent data assessed within the marked region (m). Flow 
cytometric data were analysed and presented using WinMDI 2.8 software. 
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Discussion 
The ability of wild-type Neoparamoeba spp. to elicit AGD after incubation with 
Atlantic salmon cutaneous mucus was significantly reduced. This suggests that 
components present in the mucus supernatant may include residues with binding 
affinity to wild-type Neoparamoeba spp. cell-surface constituents. Initial 
adherence to mucus via the Gal/GalNAc inhibitable lectin in the case of E. 
histolytica provides the first interaction necessary for invasion of the mucosa! 
layer. The interaction of E. histolytica with Chinese hamster ovary (CHO) cells 
(measured by rosette formation) was significantly reduced when amoebae were 
incubated in crude rat or human colonic mucus (Chadee, et al., 1987). The 
specificity of the Gal/GalNAc inhibitable lectin of E. histolytica for galactose or 
GalNAc suggests that these sugar residues are present in the colonic mucus. 
Saccharides are often effective in blocking amoebae attachment in vitro. For 
example, adherence of E. histolytica and E. dispar to erythrocytes is significantly 
reduced in the presence of 55 mM galactose (Boettner, Huston, Sullivan and 
Petri, 2005). Hartmannella vermiformis express an orthologue of the E. 
Histolytica Gal/GalNAc inhibitable lectin (Venkataraman, et al., 1997). The 
interaction between H. vermiformis and L. pneumophila is inhibitable by anti-
Gal/GalNAc inhibitable lectin antibodies and galactose and GalNAc at 
concentrations of 10 to 100 mM, identifying that the interaction is likely to be 
mediated by the Gal/GalNAc lectin (Venkataraman, et al., 1997). In the current 
study, high concentrations (500 mM) of treatment saccharides were applied to 
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saturate any cell-surface receptors that bound the saccharides. GalNAc (50 mM), 
was an exception as the Gal/GalNAc inhibitable lectin of E. histolytica has a 
significantly higher affinity for this saccharide than galactose or galactose 
containing oligosaccharides (Petri, Haque and Mann, 2002). Increasing 
saccharide concentration may be associated with a reduction in specificity of the 
lectin for a particular saccharide. For example, galactose or GalNAc binds 
specifically to the Gal/GalNAc inhibitable lectin of E. histolytica, however 
agglutination of human erythrocytes induced by E. histolytica membrane lectins 
is inhibited by high concentrations (250 mM) of other saccharides including 
fucose and mannose (Adler, Wood, Lee, Lee, Petri and Schnaar, 1995). Trapping 
of live nematodes by the microcamivorous fungi Arthrobotrys conoides is lectin-
mediated. Nematode trapping is inhibitable by glucose, mannose, arabinose and 
maltose at 200 mM yet with an increase in saccharide concentration to 400 mM; 
GalNAc, GlcNAc, fructose and melbiose also inhibit trapping of nematodes and 
the authors suggested this may be due to the high saccharide concentration 
(Rosenzweig and Ackroyd, 1983). To identify ifthe reduction in AGD pathology 
observed in the current study was influenced by high concentrations of 
saccharides, further research is needed and should include applying a lower 
range of saccharide concentrations than assessed in the current study. 
For some parasites, attachment to host tissues may be mediated by a range of 
lectins or by lectins with multiple binding affinities. For example, agglutination 
of sheep erythrocytes by the cellular slime mould Distyostelium discoideum 
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lectin ( discoidin II) is significantly inhibited by a range of saccharides at 5 mM 
including D-fucose, D-galactose and GalNAc (Frazier, Rosen, Reitherman and 
Barondes, 1975). It is possible that high saccharide concentrations may have 
masked lectin specificity, alternatively wild-type Neoparamoeba spp. may 
employ multiple lectins, or lectins with multiple carbohydrate recognition 
domains, to colonise Atlantic salmon gill tissues. Further characterisation of 
ligand(s) that may reduce the ability of wild-type Neoparamoeba spp. to colonise 
Atlantic salmon gill tissues is warranted. 
Western blot analyses failed to detect binding of 3F4 or Shiro to reduced wild-
type Neoparamoeba spp. antigens and this may suggest that antibodies recognise 
conformational epitopes. Indeed, immunoprecipitation studies indicate that 3F4 
binds a conformational epitope of the Gal/GalNAc inhibitable lectin of E. 
histolytica (Pillai, Wan, Yau, Ravdin and Kain, 1999). Western blot was used to 
confirm the binding of the anti-Gal/GalNAc inhibitable lectin antibody 1G7 to an 
orthologue of the Gal/GalNAc inhibitable lectin expressed by H. vermiformis 
(Venkataraman, et al., 1997). However the Western blot performed in the current 
study applied an antigen concentration (cell equivalents) over 100-fold lower 
than the aforementioned study. Wild-type Neoparamoeba spp. are obtained from 
AGD-affected Atlantic salmon gill tissues. Currently, an AGD co-habitation tank 
is maintained at the University of Tasmania to supply wild-type Neoparamoeba 
spp. for experimental studies. AGD-naYve Atlantic salmon are regularly 
introduced to the co-habitation tank and become infected by wild-type 
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Neoparamoeba spp .. Wild-type Neoparamoeba spp. are isolated from the gills of 
Atlantic salmon as they become moribund from AGD, which typically occurs in 
around 4 weeks. Following the current protocol for isolating gill-derived 
amoebae (Morrison, et al., 2004), an average of 106 cells may be obtained from 
3-4 AGD-affected Atlantic salmon. Applying comparable numbers of wild-type 
Neoparamoeba spp. to that of H. vermiformis (107/lane) for Western blotting 
would require up to 40 donor fish for Western blot analysis of a single lane, 
therefore replicating the method of Venkataraman et al., (1997) is impractical. 
While failure to detect antibody binding may be due to the conformational 
structure of the epitope(s), it must also be considered that the Western blot 
conditions applied in the current study may not have been sensitive enough to 
detect binding. 
By immunocytochemistry, both anti-Gal/GalNAc inhibitable lectin antibodies, 
Shiro and 3F4 failed to bind fixed wild-type Neoparamoeba spp .. It has been 
previously discussed that 3F4 binds a conformational epitope of the 
Gal/Gal/NAc inhibitable lectin of E. histolytica. However, fixation of cells can, 
in some cases, reduce antibody binding (Van Ewijk, Van Soest, Verkerk and 
Jongkind, 1984). Atlantic salmon antibodies bind to wild-typeNeoparamoeba 
spp. fixed following the same protocol used here (Vincent, Adams, Nowak and 
Morrison, 2008; Vincent, Nowak and Morrison, 2008) yet the effect of fixation 
on those target epiotpe(s) is unknown. If binding of 3F4 or Shiro to wild-type 
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Neoparamoeba spp. is dependent on epitope conformation then fixation may 
influence antibody binding. 
Cell-surface molecule(s) of live wild-typeNeoparamoeba spp. are recognised by 
the Gal/GalNAc inhibitable lectin antibodies 3F4 and Shiro. Binding of 3F4 to 
E. histolytica is galactose inhibitable (Petri, Jackson, Gathiram, Kress, Saffer, 
Snodgrass, Chapman, Keren and Mirelman, 1990). In contrast, binding of 3F4 to 
live wild-type Neoparamoeba spp. was enhanced when cells were incubated in 
galactose or glucose before incubation with primary antibodies. It is unlikely that 
glucose or galactose stimulate cell-surface receptor expression during the 20 min 
incubation at 4°C. Glucose and galactose may bind region(s) of cell-surface 
molecules expressed by wild-type Neoparamoeba spp. inducing conformational 
change(s) that results in an increase of the availability of binding sites for 3F4. 
Ligand-induced conformational changes of cell-surface receptors used for 
attachment have been described. For example, antibody binding is enhanced after 
conformational change of L-selectin induced by the binding of a specific 
monoclonal antibody (Leid, Steeber, Tedder and Jutila, 2001). In addition, 
binding of galactose, GalNAc or fucose to mouse macrophage Gal/GalNAc-
specific 
C-type lectin induces conformational change leading to enhanced antibody 
binding (Hosoi, Imai and Irimura, 1998). It is possible that the same receptor(s) 
is/are associated with 3F4 binding and attachment of wild-type Neoparamoeba 
spp. to gill tissues in vivo. Ligand-induced conformational change may increase 
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the availability of binding sites for 3F4 and at the same time reduce the ability of 
the receptor(s) to bind the target carbohydrate residues present in Atlantic 
salmon gill tissues. Further investigation is needed to determine the binding site 
for 3F4 on wild-type Neoparamoeba spp .. 
In conclusion, ligand(s) present in Atlantic salmon mucus may be utilised by 
wild-type Neoparamoeba spp. for colonising the gill tissues. The observed 
reduction in gill pathology of Atlantic salmon exposed to wild-type 
Neoparamoeba spp. incubated in each of the saccharides assessed appears to be 
non-specific. While the high saccharide concentrations used here may have 
masked the specificity of attachment receptor( s ), binding of wild-type 
Neoparamoeba spp. to Atlantic salmon gill tissues may be mediated by multiple 
receptors. Further study is required to elucidate the mechanism(s) associated 
with the attachment of wild-type Neoparamoeba spp. to Atlantic salmon gill 
tissues. 
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Atlantic salmon have been reported to develop resistance to AGD in terms of 
increased survival and reduced gill pathology (Table 6.1). In isolated cases, 
resistance of Atlantic salmon to wild-type Neoparamoeba spp. under conditions that 
are favorable for the development of AGD in the laboratory has been observed (fish 
1 and fish 2, Chapter 2). However, the predominant factors associated with 
resistance of Atlantic salmon to AGD in the laboratory include water temperature 
and prolonged or previous exposure to wild-type Neoparamoeba spp .. Previous 
exposure of Atlantic salmon to wild-type Neoparamoeba spp. under conditions 
where disease is present at a level that does not result in morbidity may enhance the 
ability of the host to develop resistance. For example, resistance of Atlantic salmon 
to wild-type Neoparamoeba spp. was described in terms of reduced gross gill 
pathology following secondary exposure to wild-type Neoparamoeba spp. at 14°C 
(Findlay, Helders, Munday and Gurney, 1995; Findlay and Munday, 1998). 
Furthermore, Atlantic salmon exposed to wild-type Neoparamoeba spp. at 12°C for 
one month demonstrated increased survival to wild-type Neoparamoeba spp. 
challenge at 16°C (Chapter 1). 
Initial investigations of the potential of immunostimulants in resistance of Atlantic 
salmon to AGD showed some promising results. Activation of the innate immune 
response by immunostimulants may play a role in resistance of Atlantic salmon to 
AGD in wild-type Neoparamoeba spp .. For example, Atlantic salmon that were 
injected with CpG oligodeoxynucleotides demonstrated >30% higher survival rate 
than fish injected with PBS (Bridle, Butler and Nowak, 2003). Bath application of 
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levamisole and in-feed inclusion of 13-glucans provided some protection to Atlantic 
salmon against AGD-associated mortality (Zilberg, Findlay, Girling and Munday, 
2000). Further investigations of in-feed inclusion ofimmunostimulants as a 
prophylactic treatment for AGD have failed to provide conclusive evidence of their 
protective qualities. For example, in-feed administration of 13-glucans did not 
enhance AGD-resistance in Atlantic salmon (Bridle, Carter, Morrison and Nowak, 
2005). Similarly, in-feed inclusion of other immunostimulants including 
commercially available EcoActiva and EcoBoost, did not enhance the survival of 
Atlantic salmon exposed to wild-type Neoparamoeba spp. (Nowak, Morrison, 
Crosbie, Adam, Butler, Bridle, Gross, Vincent, Embar-Gopinath, Carson, Raison, 
Villavedra, McCarthy, Broady and Wallach, 2004). 
While resistance of Atlantic salmon to wild-type Neoparamoeba spp. may be 
observed in terms of enhanced survival, in some cases, the level of gill pathology of 
groups of putatively resistant fish is similar to groups of fish that do not demonstrate 
resistance. This suggests that resistance of Atlantic salmon to AGD may be 
associated with physiological adaptation. It has been observed that 60-70% of gill 
lamellae of rainbow trout, Oncorhynchus mykiss Walbaum, or lingcod, Ophiodon 
elongates Girard, are perfused at rest (Booth, 1979; Farrell, Daxboeck and Randall, 
1979). Utilising the remaining 40-70% of gill lamellae may provide a means of 
increased oxygen uptake by AGD-affected fish therefore off-setting the reduction of 
gill surface area due to the development of lesions. A GD-affected and AGD-
unaffected Atlantic salmon exposed to graded hypoxia demonstrated similar rates of 
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0 2 uptake (Powell, Fisk and Nowak, 2000) suggesting that the reduction of 
respiratory surface area due to AGD lesions has no adverse effect on respiratory 
function. 
Throughout this project, only two fish (fish 1 and fish 2) were identified to have 
developed a significant serum antibody response towards wild-type Neoparamoeba 
spp. antigens. Of these two fish, fish one developed serum antibodies that bound 
peptide antigens while serum antibodies of fish 2 bound carbohydrate antigens of 
wild-type Neoparamoeba spp. (Chapter 2). In the sera of several other A GD-affected 
Atlantic salmon, low-level antibodies that bound carbohydrate determinants of wild-
type Neoparamoeba spp. antigens were detected by Western blotting (Chapters 3 
and 4). 
Interlamellar cysts that develop in AGD-affected Atlantic salmon gill tissues provide 
an environment for potential interaction of wild-type Neoparamoeba spp. and 
immune cells. Macrophage-like cells have been observed within interlamellar cysts 
containing Neoparamoeba spp. (Adams and Nowak, 2003). Phagocytosis of wild-
type Neoparamoeba spp. by antigen presenting cells may result in the trafficking of 
antigens to the lymphoid tissues of the anterior kidney and/or spleen and the 
subsequent production of a serum antibody response towards antigens of wild-type 
Neoparamoeba spp .. However, given the results obtained throughout this project, 
antigen processing of wild-type Neoparamoeba spp. antigens is either highly limited, 
or antigen processing and presentation may be affected by immunosuppression. 
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Table 6.1. Comparison of studies where resistance of Atlantic salmon to AGD has been described. The experimental regimes and the 
proposed factor(s) influencing AGD resistance are summarised. 
Findlay et al., 1995 Findlay and Munday, 1998 Bridle et aL, 2003 Bridle et al., 2005 Chapter 1 Chapter2 
Salinity (%o) NP NP 37 35 35 35 
Temperature 14 14 17 16±0.5 12 (exposure 1) 15-16 
(DC) 16 (exposure 2) 
Treatment 1) Naive Experiment 1 lntraperitoneal J3-glucan diets 1) Exposed 4 w, Fish 1 
groups 2) Exposed 4 w then 1) Exposed once (4 w) with 2-3 h immunisation 1) Diet A FWbath24h Fish2 
maintained in FW 4 w FWbath l)CpG-ODN 2)DietB 2)Narve 
2)Narve 2) Non CpG-ODN 3) Diet C 
Experiment 2 3)PBS 4) Control diet 
1) Exposed twice (4 w) with 2-3 h 4) Untreated 
FW bath between each exposure 
2) Exposed once (4 w) with 2-3 h 
FWbath 
3) Exposed once (4 w) maintained 
inFW4w 
4)Narve 
Mode of Co-habitation Co-habitation Inoculation Inoculation Inoculation Co-
exposure (2460 cells/L) (1150 cells/Lover (500 cells/L) habitation 
3 d) 
Duration of 28 28 16 72 35 28-168* 
challenge 
(days) 
Resistance Yes - previously Yes - in both experiments Yes- CpG-ODN Not treatment Previously Yes-
observed exposed fish previously exposed (once or twice) 90% survival specific. Sub exposed duration of 
fish population with increased survival, 
increased survival survival. No fish 1 low 
and low gill difference in level gill 
pathology pathology pathology 
Proposed Previous exposure Previous exposure Immunostimulation Inherent resistance, Previous Prolonged 
factor(s) prolonged exposure exposure exposure 
influencing 
resistance 
NP - not provided, FW - fresh water. *estimated duration of exposure 
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The development of a serum antibody response towards exogenous peptide 
antigens may occur following a range of antigen presentation scenarios. In 
addition to the conventional presentation of exogenous peptide antigen(s) by an 
APC with MHC II, exogenous peptide(s) can be presented by MHC class I, 
reviewed by Brode and Macary (2004). MHC class I is constitutively expressed 
by all nucleated cells therefore presentation of wild-type Neoparamoeba spp. by 
MHC class I molecules may provide an alternative means of antigen 
presentation. In contrast, the development of an antibody response towards 
exogenous carbohydrate antigens is not necessarily reliant on MHC or T cells as 
in mice, a serum antibody response to a carbohydrate antigen can develop 
independently ofT cells and MHC. T cell-independent (TI) antigens consist of 
two types, TI-1 and TI-2. TI-1 antigens are mostly mitogens such as 
lipopolysaccharide (LPS), while TI-2 antigens are not mitogens and include 
highly repetitious polymeric molecules. TI antigens induce B cell activation yet 
neither TI-1 or TI-2 antigens induce immunological memory (Goldsby, Kindt, 
Osborne and Kuby, 2003) and therefore an antibody response towards TI 
antigens would not be enhanced following secondary exposure to the TI antigen. 
As an example of a T-cell independent antibody response to a carbohydrate 
antigen, T-cell deficient mice (athymic nude, TCRP-1-, MHC II-/-, and CD40-/-
) i.p injected with a carbohydrate antigen of the tapeworm, Echinococcus 
multilocularis, developed a specific antibody response to the target antigen (Dai, 
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Hemphihll, Waldvogel, Ingold, Deplazes, Mossman and Gottstein, 2001). The 
majority of carbohydrate antigens are considered TI antigens (Cobb and Kasper, 
2005). Carbohydrate residues are immunodominant cell-surface molecules of 
wild-type Neoparamoeba spp. in mice (Villavedra, Lemke, To, Broady, Wallach 
and Raison, 2007) and numerous AGO-affected Atlantic salmon possessed 
serum antibodies that bound carbohydrate antigens of wild-type Neoparamoeba 
spp .. However, there was a single case where an Atlantic salmon (fish 2) 
developed high-titre antibody response to carbohydrate antigenic determinants of 
wild-type Neoparamoeba spp. (Chapter 2). As TI antigens do not induce 
immunological memory, the development of a high-titre antibody response of 
fish 2 may have been mediated via recognition of carbohydrate residue(s) of a 
glycoprotein(s) presented by MHC II. 
The fish identified in studies throughout this project that developed a serum 
antibody response towards wild-type Neoparamoeba spp., had been exposed to 
wild-type Neoparamoeba spp. for >4 months (Table 6.2) and very few fish with 
detectable serum antibodies were identified. A serum antibody response in fish 
following an ectoparasitic infestation may be slow to develop. For example, a 
serum antibody response towards ectoparasitic mussel larvae in large mouth bass, 
Micropterus salmonides Lacepede, exposed twice to Lampsilis reeveiana 
Simpson, peaked 60 days post-initial exposure (Grayson, et al., 1991). 
Antibodies that bind the monogenean, Discocotyle sagittata Leuckart, were 
detected in the sera of rainbow trout, exposed to D. sagittata during pond culture 
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with heightened antibody responses observed in some fish after> 1 year (Rubio-
Godoy, et al., 2003a). Similarly, the development of a serum antibody response 
in sea-farmed Atlantic salmon after multiple infestations of sea lice, Caligus 
elongates Nordmann, may take up to 2 years (Grayson, et al., 1991). Similar 
results were observed in AGD-affected Atlantic salmon with detectable serum 
anti-Neoparamoeba spp. antibodies detected in some fish after 280 days of sea 
cage culture (Chapter 3). It must also be considered that the fact that few fish 
have been identified to develop a serum anti-Neoparamoeba spp. antibody 
response may be a result of the low-level exposure of wild-type Neoparamoeba 
spp. antigens to the immune system (occurring infrequently through the 
internalisation of parasites), or be due a reduction of antigen processing and 
presentation activity due to immunosuppression. Immunosuppression of AGD-
affected Atlantic salmon due to stress is unlikely. For example assessment of the 
stress response in AGD-affected Atlantic salmon provided no evidence that 
Atlantic salmon with AGD are stressed, as plasma cortisol levels were within the 
range of non-stressed fish (Fazioli, 2005). Down-regulation of genes involved in 
antigen processing and presentation is observed in gill lesions of AGD-affected 
Atlantic salmon (Young, et al., 2008a) and this may be responsible for the overall 
lack of the development of acquired immune response in A GD-affected Atlantic 
salmon. 
Serum anti-Neoparamoeba spp. antibodies with measurable activity by an 
ELISA were detected in Atlantic salmon exposed to wild-type Neoparamoeba 
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spp. by co-habitation in excess of 4 months (Table 6.2). These cases are unique 
as fish exposed to wild-type Neoparamoeba spp. in the laboratory generally 
succumb to AGD within 4 weeks (Bridle, et al., 2003; Gross, Morrison, Butler 
and Nowak, 2004; Bridle, et al., 2005; Morrison and Nowak, 2005). The 
induction of AGD in Atlantic salmon in the laboratory is relatively rapid. 
Atlantic salmon are exposed to high cell densities of wild-type Neoparamoeba 
spp. under conditions that are favorable for development of AGD. Furthermore, 
the use of recirculation systems augments the perpetual infection through 
horizontal transfer of amoebae, contributing to the level of wild-type 
Neoparamoeba spp. infection. Atlantic salmon exposed to wild-type 
Neoparamoeba spp. in the laboratory experience a short infection time before 
morbidity and this may be linked to the lack of antibody response that is 
predominately observed. In contrast, in the marine culture environment, parasite 
numbers and environmental parameters are dynamic. Sea-cage cultured Atlantic 
salmon are predominately exposed to wild-type Neoparamoeba spp. during 
summer months. During these times, wild-type Neoparamoeba spp. infection is 
maintained at a low level by fresh water bathing. While Atlantic salmon are 
exposed to wild-type Neoparamoeba spp. many times during the marine culture 
period only low-level anti-Neoparamoeba spp. antibodies were detected in the 
serum of some fish after 13 months of sea-cage culture (Table 6.2). The absence 
of significant anti-Neoparamoeba spp. antibody response in marine-cultured 
Atlantic salmon may be attributed to the infection being maintained at a low 
level. 
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Table 6.2. Atlantic salmon exposed to wild-type Neoparamoeba spp. in excess 
of 72 days may develop serum anti-Neoparamoeba spp. antibodies. The mode 
and duration of exposure, number of fish sampled and the proportion of sero-
positive samples are summarised. 
Mode of Duration of Number Number 
exposure exposure fish sero-
(da!S) assessed ~ositive** 
Chapter 1 
Exposure 1 L 28 30 0 
Exposure 2 L 35 (total 63) 22 11 
Chapter2 
UTAS infection tank L 28-168" 17 21 
Bridle et al., 2006 L 72 63 3 
AGD infection L 23 23 0 
Chapter3 
Cultured stock* F 224 40 5 
Cultured stock* F 280 40 25 
Cultured stock* F 364 40 23 
Broodstock F 420 55 45 
Overall total 330 114 
** sero-positive by Western blot,* combined data oftriploid and diploid cultured 
Atlantic salmon. L - laboratory, F - field, "estimated exposure, 1 antibody activity 
measurable in an ELISA in fish exposed >90 days. 
A heightened antibody response towards wild-type Neoparamoeba spp. may be 
observed if sea-cage cultured fish were monitored over a longer period of time. 
Extending the duration of exposure of fish to an ectoparasite may provide further 
opportunity for the development of an antibody response. Inoculating fish 
holding systems maintained at 12°C with wild-type Neoparamoeba spp. was 
successful in eliciting A_GD in AGD-naYve Atlantic salmon with no fish mortality 
over a period of28 days, while at 16°C morbidity of AGD-naYve Atlantic salmon 
can exceed 50% after 35 days (Chapter 2). Further research to assess the 
development of an antibody response in A GD-affected Atlantic salmon may 
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require fish to be exposed to wild-type Neoparamoeba spp. in excess of 12 
months under sub-lethal conditions, perhaps at a water temperature below 12°C. 
Fish gills may be considered immune-reactive, for example, immersion 
vaccination with bacterial antigens stimulates a gill-associated antibody 
response. Antibody-secreting cells were observed in abundence in the gills of sea 
bass following immersion vaccination (dos Santos, Taveme-Thiele, Barnes, van 
Muiswinkel, Ellis and Rombout, 2001). In addition, higher levels of parasite-
specific antibodies are found in gill tissues compared to antibody levels detected 
in the peripheral blood of rainbow trout following secondary immersion 
vaccination with Flavobacterium branchiophilum (see Lumsden, Ostland, 
MacPhee and Ferguson, 1995). 
While immersion of Atlantic salmon in a low concentration of wild-type 
Neoparamoeba spp. antigen, failed to provide protection against AGD (Morrison 
et al., 2005), uptake of antigens via the gills was not assessed. Antigens of wild-
type Neoparamoeba spp. may not be readily taken up by through the gills of 
Atlantic salmon. Assessment of the uptake of wild-type Neoparamoeba spp. 
antigen via the gills following immersion vaccination may provide further insight 
useful for AGD vaccine research. 
In the case of AGD-affected Atlantic salmon, immune-like cells are present 
within lesions (Adams and Nowak, 2004) although very few Ig +cells have been 
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observed (Gross, 2006). Cells expressing MHC class II are present in the gill 
tissues of AGD-affected Atlantic salmon (Morrison, Koppang, Hordvik and 
Nowak, 2006), however it appears unlikely that a localised response would 
develop at the site of infection as there is a significant down-regulation of 
antigen processing machinery in the gills of AGD-affected Atlantic salmon 
(Young et al., 2008). 
Despite the overall lack of antibody response towards wild-type Neoparamoeba 
spp. in AGD-affected Atlantic salmon, immunisation with wild-type 
Neoparamoeba spp. antigens may elicit a significant antibody response. For 
example, a modest increase in antibody titre was observed in Atlantic salmon 
immunised with an increase in concentration of N. pemaquidensis antigen 
(Bryant et al., 1995). In some cases, some level ofresistance has been observed 
in fish immunised with parasite antigen(s). Rainbow trout immunised with 
antigens of the D. sagittata conferred resistance to parasitism to over 50% of 
immunised fish (Rubio-Godoy, Sigh, Buchmann and Tinsley, 2003b ). 
Furthermore, antibody-mediated protection against white spot disease in channel 
catfish caused by I. multifiliis and grouper caused by Cryptocaryon irritans 
Brown, is associated with parasite-specific antibodies in the skin of host fish (Xu 
and Klesius, 2002; Xu and Klesius, 2003; Yambot and Song, 2006; Luo, Xie, 
Zhu and Li, 2007). 
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While at this stage we have observed only two isolated cases of Atlantic salmon 
with high-titre serum anti-Neoparamoeba spp antibodies and low-level gill 
pathology. Immunisation of Atlantic salmon with the appropriate concentration 
of N. perurans antigen(s) may elicit a high-titre antibody response. This may 
lead to resistance in terms of reduced mortality and reduced gill pathology. 
Immunisation of fish by a range of routes can result in the presence of mucosa! 
antibodies. For example, immersion of channel catfish in a bath containing 
dinitrophenylated-horse serum albumin (DNPwHoSA) elicits a mucosa! 
antibody response towards DNPwHoSA (Lobb, 1987) and bath immunisation of 
rainbow trout with F. branchiophilum stimulated a significant gill-associated 
antibody response (Lumsden, et al., 1995). Further, oral or bath immunisation of 
ayu, Plecoglossus altivelis Temminck and Schlegel, with V. anguillarum 
stimulated a significant mucosa! antibody response that inhibited adhesion ofV. 
anguillarum to ayu skin in vitro (Kawai, Kusuda and Itami, 1981). Oral 
immunisation of spotted sand bass Paralabrax maculatofasciatus Steindachner, 
with an extracellular lectin of Aeromonas veronii stimulated a secretary antibody 
response in skin mucus, intestinal mucus and bile (Merino-Contreras, Guzman-
Murillo, Ruiz-Bustos, Romero, Cadena-Roa and Ascencio, 2001). Intraperitoneal 
(i.p) immunisation can also stimulate the development of a mucosa! antibody 
response (LaFrentz, LaPatra, Jones, Congleton, Sun and Cain, 2002). 
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At times, mucosal antibodies can be detected before serum antibodies despite the 
route of antigen delivery. For example, in the European eel, Anguilla anguilla L., 
a peak antibody response was detected in mucus before sera following immersion 
vaccination with Vulnivaccine (Esteve-Gassent, Nielsen and Amaro, 2003). In 
addition, rainbow trout immunised i.p with FITC-keyhole limpet haemocyanin 
(KLH), a peak antibody response was detected in mucus before serum (Cain, 
Jones and Raison, 2000). Identified in studies with fugu, transport oflgM from 
the skin to the mucus occurs via a polymeric lg receptor (plgR) (Hamuro, 
Suetake, Saha, Kikuchi and Suzuki, 2007). Therefore, the induction of a serum 
antibody response may also result in the presence of mucosa! antibodies via 
transfer of lgM by plgR. 
While limited attempts to detect a mucosa! antibody response in AGO-affected 
Atlantic salmon have been made (Findlay, et al., 1995; Vincent, Morrison and 
Nowak, 2006), all have failed. If transport oflgM to the mucus via a plgR occurs 
in Atlantic salmon, then failure to detect mucosa! antibodies may be associated 
with the presence of low levels in the sera leading to low or no transfer oflgM to 
the mucus. It must also be considered that the methods used to detect antibodies 
in serum of AGD-affected Atlantic salmon may not be effective in detecting low-
level antibodies in mucus. Mucosa! antibodies may be detectable in Atlantic 
salmon after the development of a high-titre anti-Neoparamoeba spp. antibody 
response. However, the presence of antibodies in the mucus of the 2 fish that 
developed a high-titre antibody response towards wild-type Neoparamoeba spp. 
was not assessed. 
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While carbohydrate antigens of wild-type Neoparamoeba spp. appear 
immunodominant in AGD-affected Atlantic salmon, an antibody response 
towards peptide antigens of wild-type Neoparamoeba spp. may be elicited in the 
sera and/or mucus of Atlantic salmon by immunisation. While the activity of 
such antibodies at the site of infection remains questionable, antibodies have 
been shown to maintain the ability to bind to target epitope(s) in sea water. For 
example, monoclonal antibodies that bind the vitelline layer of the sea urchin, 
Strongylocentrotus purpuratus Stimpson, egg inhibit fertilization by blocking 
binding of sperm to the egg surface although only a small proportion of these 
monoclonal antibodies were able to bind in sea water (Gache, Niman and 
Vacquier, 1983). Serum and mucosal antibodies ofbarramundi, Lates calcarifer 
Bloch, immunised with Streptococcus iniae, bind to antigens of S. iniae in 
salinities similar to sea water (Delamare-Deboutteville, Wood and Barnes, 2006). 
In contrast, results presented by Bricknell, Bisset and Bowden (2002) suggested 
that optimal binding of Atlantic salmon antibodies was within the range of pH 7 
to 8 and at an osmolality similar to physiological, between 100 and 400 m0smr1• 
MBP is a useful ligand for isolating serum lgM from teleosts including tomato 
clown fish (Cobb, Levy and Noga, 1998) barramundi, (Crosbie and Nowak, 
2002) and rockfish, Sebastes schlegeli Higendorf, (Shin, Lee and Palaksha, 
2006). Bricknell et al., (2002) did not assess ifthe binding of Atlantic salmon 
IgM to MBP was mediated by the Fe or the Fab regions, therefore the level of 
antibody binding detected may not be representative ofFab binding. Therefore 
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the ability of Atlantic salmon antibodies to bind target epitope(s) in seawater can 
not be inferred from the work of Bricknell et al., (2002). 
Preliminary assessment of the fate ofa monoclonal antibody (3F4) that bound 
wild-type Neoparamoeba spp. suggested that antibodies do not remain attached 
to live wild-type Neoparamoeba spp. in sea water (Appendix 3). The antibodies 
may have been shed, pinocytosed and destroyed or rejected, or simply antibodies 
lost the ability to bind the cell-surface of wild-type Neoparamoeba spp. in sea 
water due to conformational change(s). The binding of salmon anti-
Neoparamoeba spp. antibodies was also assessed and while antibody binding 
was observed after wild-type Neoparamoeba spp. were suspended in sea water 
for 1 h, consistent results were not attained in repeated assays (data not shown). 
The effect of antibodies on wild-type Neoparamoeba spp. in vivo may be 
influenced by antibody titre and/or the specificity of the antigenic determinants 
therefore further research in this area is warranted. Such assays should assess the 
binding of Atlantic salmon anti-Neoparamoeba spp. antibodies to wild-type 
Neoparamoeba spp. over time, across a range of salinities. 
As previously discussed (Chapter 1), vaccination studies with crude wild-type 
Neoparamoeba spp. preparations are impractical, therefore other approaches are 
needed for the identification of candidate vaccine antigens for an anti-AGD 
vaccine. Taking the approach of screening host sera to identify candidate vaccine 
antigens for an anti-AGD vaccine was less effective than anticipated. Serum 
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antibodies from a single AGD-affected Atlantic salmon (fish 1) bound peptide 
antigenic determinants of wild-type Neoparamoeba spp .. It may be possible to 
identify these antigenic determinants by cDNA expression library screening and 
this is currently being pursued in our laboratory. If antibodies present in the 
serum offish 1 detect recombinant wild-type Neoparamoeba spp. peptide(s), 
further assessment of the recombinant protein(s) as candidate anti-AGD vaccine 
antigen(s) is warranted. Laboratory testing of DNA vaccines for AGD have 
shown modest protection of Atlantic salmon against wild-type Neoparamoeba 
spp. (Cook, Campbell, Patil, Elliott and Prideaux, 2007). However whether 
protection is mediated via the induction of an adaptive immune response is 
unknown. The role of adaptive immunity in resistance of Atlantic salmon to 
AGD is central for the development of an anti-A GD vaccine and measurement of 
adaptive immune parameters including serum and mucosal antibodies should be 
conducted in parallel with challenge studies. 
Colonisation of wild-type Neoparamoeba spp. on Atlantic salmon gill tissues 
may occur passively or be mediated via specific ligand interactions. To explore 
the presence of lectin-mediated colonisation of wild-type Neoparamoeba spp. to 
Atlantic salmon gill tissue, trophozoites were incubated in mucus or a range of 
saccharides before inoculating fish holding systems containing AGD-naive 
Atlantic salmon (Chapter 5). Interestingly a significant reduction in AGD 
pathology compared to the control was seen with all treatments. High 
concentrations of saccharides, as used in Chapter 5, may produce a non-specific 
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inhibitory effect. Therefore assessment of low concentrations of each saccharide 
is warranted to identify ifthe inhibition observed may be specific. 
Antibodies that bind the E. histolytica Gal/GalNAc inhibitable lectin bound the 
cell-surface of wild-type Neoparamoeba spp .. Given this, it was hypothesised 
that wild-type Neoparamoeba spp. may employ a cell-surface lectin to attach to 
gill tissue. However an orthologue of the E. histolytica Gal/GalNAc inhibitable 
lectin expressed by wild-type Neoparamoeba spp. was not identified by 
homology cloning (Appendix 2). A number of monoclonal antibodies that bind 
the Gal/GalNAc inhibitable lectin of E. histolytica have been described and 
include antibodies that bind linear or conformational epitopes. The monoclonal 
antibody assessed in Chapter 5 (3F4) binds a conformational region of the 
Gal/GalNAc inhibitable lectin (Mann, Chung, Dodson, Ashley, Braga and 
Snodgrass, 1993). Assessment of the ability ofMAbs that bind linear epitope(s) 
of the E. histolytica Gal/GalNAc inhibitable lectin to bind live wild-type 
Neoparamoeba spp. may identify orthologous cell-surface molecules useful for 
vaccine candidate antigens. Another approach towards detection of an orthologue 
of the Gal/GalNAc inhibitable lectin expressed by wild-type Neoparamoeba spp. 
may include screening of a wild-type Neoparamoeba spp. cDNA library with 
Gal/GalNAc lectin probes or polyclonal and/or monoclonal Gal/GalNAc 
antibodies. 
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It is possible that initial colonisation of wild-type Neoparamoeba spp. on the gill 
tissues of Atlantic salmon is passive (entrapment in mucus) and the subsequent 
development of pathology may be reliant on ligand-mediated interactions. If the 
development of AGD pathology is ligand-mediated, these ligand(s) would be 
common to all fish susceptible to AGD including marine-farmed turbot, Psetta 
maxima L., (Dykova, Figueras and Novoa, 1995; Dykova, Figueras, Novoa and 
Casal, 1998) European sea bass, Dicentrarchus labrax L., and Blue warehou, 
Seriolella brama Giinther, (Adams, Villavedra and Nowak, 2008). Molecules 
associated with colonisation of wild-type Neoparamoeba spp. in vivo may 
represent novel candidate vaccine antigens for an anti-AGD vaccine. However, 
induction of a vaccine-induced antibody response may not be protective unless 
high-titre antibodies are present at the host-parasite interface. 
The presence of serum anti-Neoparamoeba spp. antibodies is not associated with 
AGD-resistance of Atlantic salmon. The fact that a high-titre serum anti-
Neoparamoeba spp. antibodies were detected in just two fish suggests that either 
processing and presentation of wild-type Neoparamoeba spp. antigens was 
successful in these individual fish or that these antibodies are natural or cross-
reactive antibodies that bind to wild-type Neoparamoeba spp. antigen(s). As the 
antigen processing and presentation machinery is significantly down-regulated in 
the gills of AGD-affected Atlantic salmon, it is questionable whether a serum 
antibody response could develop. However, the down-regulation of antigen 
processing machinery may be localised and away from the gill tissues, antigen 
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processing cells (APCs) may regain normal function. Further elucidation of the 
development of a systemic antibody response could include tracking wild-type 
Neoparamoeba spp. antigen uptake to identify if antigen(s) reach the lymphoid 
tissues of the anterior kidney or spleen. 
References 
Adams, M. B. and Nowak, B. F., (2003) Amoebic gill disease: sequential 
pathology in cultured Atlantic salmon, Salmo salar L. Journal of Fish Diseases 
26, 601-614. 
Adams, M. B. and Nowak, B. F., (2004) Sequential pathology after initial 
freshwater bath treatment for amoebic gill disease in cultured Atlantic salmon, 
Salmo salar L. Journal of Fish Diseases 21, 163-173. 
Adams, M. B., Villavedra, M. and Nowak, B., (2008) An opportunistic detection 
of amoebic gill disease (AGD) in blue warehou (Seriolella brama) collected from 
an Atlantic salmon (Salmo salar) production cage in south eastern Tasmania. 
Journal of Fish Diseases (accepted). 
Booth, J. H., (1979) The effects of oxygen supply, epinephrine, and 
acethylcholine on the distribution of blood flow in trout gills. Journal of 
Experimental Biology 83, 31-40. 
Bricknell, I. R., Bisset, P. F. and Bowden, T. J., (2002) The function of Atlantic 
salmon (Salmo salar L.) antibodies under extremes of pH and osmolarity. Fish 
and Shellfish Immunology 13, 215-219. 
Bridle, A. R., Butler, R. and Nowak, B. F., (2003) Immunostimulatory CpG 
oligodeoxynucleotides increase resistance against amoebic gill disease in Atlantic 
salmon, Salmo salar L. Journal of Fish Diseases 26, 367-371. 
Bridle, A. R., Carter, C. G., Morrison, R. N. and Nowak, B. F., (2005) The effect 
of 13-glucan administration on macrophage respiratory burst activity and Atlantic 
salmon, Salmo salar L. challenged with amoebic gill disease - evidence of 
inherent resistance. Journal of Fish Diseases 28, 1-10. 
Brode, S. and Macary, P.A., (2004) Cross-presentation: dendritic cells and 
macrophages bite off more than they can chew! Immunology 112, 345-351. 
Cain, K. D., Jones, D.R. and Raison, R. L., (2000) Characterisation ofmucosal 
and systemic immune responses in rainbow trout (Oncorhynchus mykiss) using 
surface plasmon resonance. Fish and Shellfish Immunology 10, 651-666. 
172 
Chapter6 
General Discussion 
Cobb, B. A. and Kasper, D. L., (2005) Coming of age: carbohydrates and 
immunity. European Journal of Immunology 35, 352-356. 
Cobb, C. S., Levy, M. G. and Noga, E. J., (1998) Acquired immunity to 
amyloodiniosis is associated with an antibody response. Diseases of Aquatic 
Organisms 34, 125-133. 
Cook, M. T., Campbell, G. W., Patil, J. G., Elliott, N. G. and Prideaux, C. (2007) 
Amoebic Gill Disease (AGD) Vaccine - DNA Approach. (Eds). 4th Aquafin 
CRC Conference. Barossa Valley, Rowlands Flat, South Australia. 
Bryant, M. S., Lester, R. G. J. and Whittington, R. J., (1995) Immunogenicity of 
amoebic antigens in rainbow trout, Oncorhynchus mykiss (Walbaum). Journal of 
Fish Diseases 18, 9-19 
Crosbie, P. B. B. and Nowak, B. F., (2002) Production of polyclonal antisera 
against barramundi (Lates calcarifer Bloch) serum immunoglobulin derived from 
affinity columns containing mannan-binding protein or staphylococcal protein A. 
Aquaculture 211, 49-63. 
Dai, W. J., Hemphihll, A., Waldvogel, A., Ingold, K., Deplazes, P., Mossman, H. 
and Gottstein, B., (2001) Major carbohydrate antigen of Echinococcus 
multilocularis induces an immunoglobulin G response independent of a.[3+ CD4+ 
T cells. Infection and Immunity 69, 6074-6083. 
Delamare-Deboutteville, J., Wood, D. and Barnes, A. C., (2006) Response and 
function of cutaneous mucosa! and serum antibodies in barramundi (Lates 
calcarifer) acclimated in seawater and freshwater. Fish and Shellfish 
Immunology 92-101. 
dos Santos, N. M. S., Taverne-Thiele, J. J., Barnes, A. C., van Muiswinkel, W. 
B., Ellis, A. E. and Rombout, J., (2001) The gill is a major organ for antibody 
secreting cell production following direct immersion of sea bass (Dicentrarchus 
labrax, L.) in a Photobacterium damselae ssp piscicida bacterin: an ontogenetic 
study. Fish and Shellfish Immunology 11, 65-74. 
Dykova, I., Figueras, A. and Novoa, B., (1995) Amoebic gill infection of turbot, 
Scophthalmus maximus. Folia Parasitologica 42, 91-96. 
Dykova, I., Figueras, A., Novoa, B. and Casal, J. F., (1998) Paramoeba sp., an 
agent of amoebic gill disease of turbot Scophthalmus maximus. Diseases of 
Aquatic Organisms 33, 137-141. 
Esteve-Gassent, M. D., Nielsen, M. E. and Amaro, C., (2003) The kinetics of 
antibody production in mucus and serum of European eel (Anguilla anguilla L.) 
173 
Chapter6 
General Discussion 
after vaccination against Vibrio vulnificus: development of a new method for 
antibody quantification in skin mucus. Fish and Shellfish Immunology 15, 51-61. 
Farrell, A. P., Daxboeck, C. and Randall, D. J., (1979) The effect of input 
pressure and flow on the pattern and resistance to flow in the isolated perfused 
gill of a teleost fish. Journal of Comparative Physiology 133, 233-240. 
Findlay, V. L., Helders, M., Munday, B. L. and Gurney, R., (1995) 
Demonstration of resistance to reinfection with Paramoeba sp. by Atlantic 
salmon, Salmo salar L. Journal of Fish Diseases 18, 639-642. 
Findlay, V. L. and Munday, B. L., (1998) Further studies on acquired resistance 
to amoebic gill disease (AGD) in Atlantic salmon, Salmo salar L. Journal of Fish 
Diseases 21, 121-125. 
Gache, C., Niman, H. L. and Vacquier, V. D., (1983) Monoclonal antibodies to 
the sea urchin egg vitelline layer inhibit fertilisation by blocking sperm adhesion. 
Experimental Cell Research 147, 75-84. 
Goldsby, R. A., Kindt, T. J., Osborne, B. A. and Kuby, J., (2003). Immunology. 
Fifth Edition. pp. 551. W.H. Freeman and Company, New York. 
Grayson, T. H., Jenkins, P. G., Wrathmell, A. B. and Harris, J.E., (1991) Serum 
responses to the salmon louse, Lepeophtheirus salmonis (Kroyer, 1838), in 
naturally infected salmonids and immunised rainbow trout, Oncorhynchus mykiss 
(Walbaum), and rabbits. Fish and Shellfish Immunology 1, 141-155. 
Gross, K. A. (2006) Interactions between Neoparamoeba spp. and Atlantic 
salmon (Salmo salar L.) immune system components. PhD thesis, University of 
Tasmania, Launceston. 
Gross, K. A., Morrison, R. N., Butler, R. and Nowak, B. F., (2004) Atlantic 
salmon, Salmo salar L., previously infected with Neoparamoeba sp. are not 
resistant to re-infection and have suppressed phagocyte function. Journal of Fish 
Diseases 27, 47-56. 
Hamuro, K., Suetake, H., Saha, N. R., Kikuchi, K. and Suzuki, Y., (2007) A 
teleost polymeric lg receptor exhibiting two lg-like domains transports tetrameric 
IgM into the skin. The Journal of Immunology 178, 5682-5689. 
Kawai, K., Kusuda, R. and Itami, T., (1981) Mechanisms of protection in ayu 
orally vaccinated for vibriosis. Fish Pathology 15, 257-262. 
LaFrentz, B. R., LaPatra, S. E., Jones, G. R., Congleton, J. L., Sun, B. and Cain, 
K. D., (2002) Characterization of serum and mucosal antibody responses and 
relative percent survival in rainbow trout, Oncorhynchus mykiss (Walbaum), 
174 
Chapter6 
General Discussion 
following immunization and challenge with Flavobacterium psychrophilum. 
Journal of Fish Diseases 25, 703-713. 
Lobb, C. J., (1987) Secretary immunity induced in catfish, Ictalurus punctatus, 
following bath immunisation. Developmental and Comparative Immunology 11, 
737-738. 
Lumsden, J. S., Ostland, V. E., MacPhee, D. D. and Ferguson, H. W., (1995) 
Production of gill-associated and serum antibody by rainbow trout 
(Oncorhynchus mykiss) following immersion immunization with acetone-killed 
Flavobacterium branchiophilum and the relationship to protection from 
experimental challenge. Fish and Shellfish Immunology 5, 151-165. 
Luo, X.-C., Xie, M.-Q., Zhu, X.-Q. and Li, A.-X., (2007) Protective immunity in 
grouper (Epinephelus coioides) following exposure to or injection with 
Cryptocaryon irritans. Fish and Shellfish Immunology 22, 427-432. 
MacKinnon, B. M., (1993) Host response of Atlantic salmon (Salmo salar) to 
infection by sea lice (Caligus elongatus). Canadian Journal of Fisheries and 
Aquatic Sciences 50, 789-792. 
Mann, B. J., Chung, H.-K., Dodson, J. M., Ashley, L. S., Braga, L. L. and 
Snodgrass, T., (1993) Neutralizing monoclonal antibody epitopes of the 
Entamoeba histolytica galactose adhesion map to the cysteine-rich extracellular 
domain of the 170-kilodalton subunit. Infection and Immunity 61, 1772-1778. 
Merino-Contreras, M. L., Guzman-Murillo, M.A., Ruiz-Bustos, E., Romero, M. 
J., Cadena-Roa, M.A. and Ascencio, F., (2001) Mucosal immune response of 
spotted sand bass Paralabrax maculatofasciatus (Steindachner, 1868) orally 
immunised with an extracellular lectin of Aeromonas veronii. Fish and Shellfish 
Immunology 11, 115-126. 
Morrison, R. N., Koppang, E. 0., Hordvik, I. and Nowak, B. F., (2006) MHC 
class II+ cells in the gills of Atlantic salmon (Salmo salar L.) affected by amoebic 
gill disease. Veterinary Immunology and Immunopathology 109, 397-303. 
Morrison, R. N. and Nowak, B. F., (2005) Bath treatment of Atlantic salmon 
(Salmo salar) with amoebae antigens fails to affect survival to subsequent 
amoebic gill disease (AGD) challenge. Bulletin of the European Association of 
Fish Pathologists 25, 155-160. 
Nowak, B., Morrison, R., Crosbie, P., Adam, B., Butler, R., Bridle, A. R., Gross, 
K., Vincent, B., Embar-Gopinath, S., Carson, J., Raison, R., Villavedra, M., 
McCarthy, K., Broady, K. and Wallach, M., (2004). Aquafin CRC Final report: 
Host-pathogen interactions in amoebic gill disease. pp. 141. University of 
Tasmania, Launceston. 
175 
Chapter6 
General Discussion 
Powell, M. D., Fisk, D. and Nowak, B. F., (2000) Effects of graded hypoxia on 
Atlantic salmon infected with amoebic gill disease. Journal of Fish Biology 57, 
1047-1057. 
Rubio-Godoy, M., Sigh, J., Buchmann, K. and Tinsley, R. C., (2003a) Antibodies 
against Discocotyle sagittata (Monogenea) in farmed trout. Diseases of Aquatic 
Organisms 56, 181-184. 
Rubio-Godoy, M., Sigh, J., Buchmann, K. and Tinsley, R. C., (2003b) 
Immunization of rainbow trout Oncorhynchus mykiss against Discocotyle 
sagittata (Monogenea). Diseases of Aquatic Organisms 55, 23-30. 
Shin, G., Lee, H. and Palaksha, K. J., (2006) Production of monoclonal 
antibodies against serum immunoglobulins of black rockfish (Sebastes schlegeli 
Higendorf). Journal of Veterinary Science 7, 293-295. 
Villavedra, M., Lemke, S., To, J., Broady, K., Wallach, M. and Raison, R. L., 
(2007) Carbohydrate epitopes are immunodominant at the surface of infectious 
Neoparamoeba sp. Journal of Fish Diseases 30, 191-199. 
Vincent, B. N., Morrison, R. N. and Nowak, B. F., (2006) Amoebic gill disease 
(AGD)-affected Atlantic salmon, Salmo salar L., are resistant to subsequent 
AGD challenge. Journal of Fish Diseases 29, 549-559. 
Xu, D. H. and Klesius, P.H., (2003) Protective effect of cutaneous antibody 
produced by channel catfish, Ictalurus punctatus (Rafinesque ), immune to 
/chthyophthirius multifiliis Fouquet on cohabited non-immune catfish. Journal of 
Fish Diseases 26, 287-291. 
Xu, D.-H. and Klesius, P.H., (2002) Antibody mediated immune response 
against /chthyophthirius multifiJiis using excised skin from channel catfish, 
/ctalurus punctatus (Rafinesque), immune to Ichthyophthirius. Journal of Fish 
Diseases 25, 299-306. 
Yambot, A. V. and Song, Y.-L., (2006) Immunization of grouper, Epinephelus 
coioides, confers protection against a protozoan parasite, Cryptocaryon irritans. 
Aquaculture 260, 1-9. 
Young, N. D., Cooper, G. A., Nowak, B. F., Koop, B. F. and Morrison, R. N., 
(2008) Coordinated down-regulation of the antigen processing machinery in the 
gills of amoebic gill disease-affected Atlantic salmon (Salmo salar L.). 
Molecular Immunology 45, 2581-2597. 
Zilberg, D., Findlay, V. L., Girling, P. and Munday, B. L., (2000) Effects of 
treatment with levamisole and glucans on mortality rates in Atlantic salmon 
176 
Chapter6 
General Discussion 
(Salmo salar L.) suffering from amoebic gill disease. Bulletin of the European 
Association of Fish Pathologists 20, 15-19. 
177 
This article has been removed for 
copyright or proprietary reasons.
Vincent, B. N., Adams, M. B., Crosbie, P. B. 
B., Nowak, B. F. and Morrison, R. N.,
(2007) Atlantic salmon (Salmo salar L.) 
exposed to cultured gill-derived 
Neoparamoeba branchiphila fail to develop 
amoebic gill disease (AGD). Bulletin of the 
European Association of Fish Pathologists 
21, 163-166
Appendix2 
Gal/GalNAc inhibitable lectin orthologue 
Appendix2 
Assessment of the expression of a GaVGalNAc inhibitable 
lectin orthologue by wild-type Neoparamoeba spp. 
Lectin-mediated attachment may be employed by parasites for attachment to the 
host. For example, attachment of the human pathogenic amoebae Entamoeba 
histolytica to colonic mucins is mediated by the Gal/GalNAc inhibitable lectin 
(Ravdin and Guerrant, 1981; Ravdin, John, Johnston, Innes and Guerrant, 1985; 
Chadee, Petri, Innes and Ravdin, 1987). The Gal/GalNAc inhibitable lectin has 
shown potential as a vaccine antigen against amebiasis in animal models (Zhang, 
Cieslak and Stanley, 1994; Soong, Kain, Abd-Alla, Jackson and Ravdin, 1995; 
Dodson, Lenkowski, Eubanks, Jackson, Napodano, Lyerly, Lockhart, Mann and 
Petri, 1999). Similarly, Hartmannella vermiformis express an orthologue of the 
Gal/GalNAc inhibitable lectin (Venkataraman, Haack, Bondada and Kwaik, 
1997). H. vermiformis are ancestrally related to N pemaquidensis and N 
aestuarina (see Peglar, Amaral Zettler, Anderson, Nerad, Gillevet, Mullen, 
Frasca, Silberman, O'Kelly and Sogin, 2003). We therefore hypothesised that 
wild-type Neoparamoeba spp. may express an orthologue of the Gal/GalNAc 
inhibitable lectin. However, an orthologue of the Gal/GalNAc expressed by wild-
type Neoparamoeba spp. was not identified here by homology cloning. 
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Wild-type Neoparamoeba spp. were isolated from AGO-affected Atlantic salmon 
as previously described (Morrison, Crosbie and Nowak, 2004). Amoebae were 
placed in Trizol (Invitrogen) and RNA was extracted following the 
manufacturer's instructions. The RNA quality and concentration was assessed by 
agarose gel electrophoresis and spectrophotometeric analysis. Wild-type 
Neoparamoeba spp. cDNA was produced using 650 µg total RNA and 
Superscript III reverse transcriptase (Invitrogen) following the manufacturer's 
instructions. 
Actin was used as a positive control for the reverse transcription reaction. Wild-
type Neoparamoeba spp. actin was amplified using the sense (ActN2) and anti-
sense (1354R) primers described by Fahrni et al., (2003). The PCR conditions 
were as follows: 1 cycle of 94°C for 3 min, 35 cycles of 94°C for 30 s, gradient 
48-58°C for 30 s and 72°C for 50 s, followed by 5 min at 72°C. PCR products 
were gel-purified (Qiagen). PCR products were sequenced using either the 
corresponding forward or reverse primers, the Applied Biosystems BigDye 
Terminator Ready Reaction kit (version 3.1) and reactions were analysed in the 
Applied Biosystems 3730xl DNA analyser (Applied Biosystems, Scoresby, 
Victoria, Australia). 
To assess the expression of an orthologue of the Gal/GalNAc inhibitable lectin 
by wild-type Neoparamoeba spp., primer pairs were designed from a sequence 
alignment of the E. histolytica (GenBank L14815) and E. dispar Gal/GalNAc 
inhibitable lectin (GenBank U73710). Conserved regions of the carbohydrate 
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recognition domain (Pillai, Wan, Yau, Ravdin and Kain, 1999) were targeted for 
primer design. As an orthologue of the E. histolytica Gal/GalNAc inhibitable 
binding lectin was isolated from H. vermiformis using a monoclonal anti-
Gal/GalNAc inhibitable antibody, the region that this antibody (1 G7) binds 
(Mann, Chung, Dodson, Ashley, Braga and Snodgrass, 1993) was also targeted 
and a set of primers were designed within this region (Fig. A2.1., Table 
A2. l .). Gradient PCRs were performed for each primer pair with a range of 
annealing temperatures between 45-60°C. PCR products were assessed by 
agarose gel electrophoresis. Where the PCR produced an amplicon of the 
expected size, the products were gel-purified and either directly sequenced or 
ligated into pGEM-T easy plasmid vector (Promega, Annadale, Australia). After 
transformation into E. coli (DHIOp), positive clones were selected for ampicillin 
resistance. Clones were inoculated into LB broth and plasmids were purified 
(QIAprep Spin miniprep kit, Qiagen). M13 Forward or Ml3 reverse 
oligonucleotides were used for sequencing reactions of plasmid DNA. Sequences 
were analysed as described above. 
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Table A2.l. Primers designed for the PCR amplification of a Gal/GalNAc inhibitable orthologue of wild-type Neoparamoeba spp .. 
Target regions 1-7 (Figure A2.1) and their expected amplicon size (base pairs), sense and antisense primers were designed from 
conserved regions of a sequence alignment of the E. histolytica and E. dispar Gal/GalNAc inhibitable lectin sequence as shown in 
Figure A2.l. 
Target Expected Sense (5'-3') Antisense (5'-3') 
region amplicon 
size (bo) 
1 1198 ATACACAGCAGGAACAGGAC GAACAATCAACATTCTCCCAA 
2 830 ATGAAAGAGGCAGACAAAGAAG AGAACTGATGAACCGTCAAGAT 
3 795 GAATTTATGAAAGAGGCAGAC ACATCTTCCTTGATTTGGTG 
4 320 GTTCAACAAACACCAGCAT GCCTCTTTCATAAATTCTTCAC 
5 763 GTTCAACAAACACCAGCAT CTTTACATCCATAATCTACTTCT 
6 199 GAATTTATGAAAGAGGCAGAC GGTTGACAATCAAAGTTAGG 
7 557 GTTCAACAAACACCAGCAT TGTTTTTATTCCATCTTTTTCT 
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Using the primer pair ActN2/l 354R, a PCR product of around 800 bp was 
amplified. Sequence data were assessed for identity by BLASTn search and the 
sequence (830 bp) shared significant sequence identity with eukaryotic actin 
genes. The sequence has been submitted to GenBank (EU089662). Primer pairs 
for amplicons 3, 4, 6 and 7 produced PCR products similar to the expected 
amplicon size. BLASTn and pair-wise comparisons with the E. histolytica 
Gal/GalNAc inhibitable lectin sequence were performed. No significant 
orthology with the Gal/GalNAc inhibitable lectin of E. histolytica was identified. 
Under the conditions applied in the current study, expression of an orthologue of 
the Gal/GalNAc inhibitable lectin of E. histolytica by wild-type Neoparamoeba 
spp. was not identified. An orthologue of the E. histolytica Gal/GalNAc 
inhibitable lectin was described for H. vermiformis using the monoclonal 
antibody 1G7 that binds the Gal/GalNAc inhibitable lectin of E. histolytica in the 
region of 1841-2504 (bp) that is outside the carbohydrate recognition domain 
(CRD) (Pillai, et al., 1999). Primer pair 1 used in the current study was 
positioned within this region while primer pairs 2-7 were positioned within the 
CRD and the region that codes for the Gal/GalNAc inhibitable lectin epitope 1 of 
E. histolytica that monoclonal antibody 3F4 binds (Mann, et al., 1993). 
E. histolytica is ancestrally related to H. vermiformis (Fahrni, et al., 2003; Peglar, 
et al., 2003) and binding of 1G7 to an orthologous lectin of H. vermiformis 
suggests that the Gal/GalNAc inhibitable lectin is conserved between these 
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species. N. pemaquidensis and N. aestuarina are ancestrally related to 
H. vermiformis (see Peglar, et al., 2003). The failure to amplify an orthologue of 
the Gal/GalNAc inhibitable binding lectin of E. histolytica may be attributed to 
primer design. Alternatively, an orthologue of the Gal/GalNAc inhibitable lectin 
may not be expressed by Neoparamoeba spp., or in the process of evolution, 
expression may have been lost. 
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Appendix3 
Binding of anti-Neoparamoeba spp. antibodies to 
wild-type Neoparamoeba spp. in sea water 
Attachment of a range of parasites to host cells is mediated by the binding of 
parasite lectins to carbohydrate residues of host tissues. In many instances, these 
interactions can be inhibited by blocking the carbohydrate recognition domain 
(CRD) of the lectin antibodies that bind the CRD. Attachment of the human 
pathogenic amoebae Entamoeba histolytica to colonic mucins is mediated by the 
Gal/GalNAc inhibitable lectin (Rav din and Guerrant, 1981; Ravdin, John, 
Johnston, Innes and Guerrant, 1985; Chadee, Petri, Innes and Ravdin, 1987). 
Monoclonal antibodies that bind the E. histolytica Gal/GalNAc inhibitable lectin 
block lectin activity of E. histolytica in vitro (see Ravdin, Petri, Murphy and 
Smith, 1986; Venkataraman, Haack, Bondada and Kwaik, 1997; Kwaik, 
Venkataraman, Harb and Gao, 1998). Monoclonal anti-Gal/GalNAc inhibitable 
lectin antibodies (3F4) bind the cell surface of wild-type Neoparamoeba spp. 
(Chapter 5). The question raised here is could antibodies that bind the cell-
surface of wild-type Neoparamoeba spp. in vitro remain bound bind in seawater? 
Wild-type Neoparamoeba spp. were isolated from AGD-affected Atlantic salmon 
following the method outlined by Morrison et al., (2004) and for the following 
experiments, both live and fixed wild-type Neoparamoeba spp. were used. Live 
wild-type Neoparamoeba spp. were washed 1 x in PBS and incubated with 
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monoclonal anti-Gal/GalNAc inhibitable lectin antibody 3F4 or monoclonal IgG 
isotype control (Sigma) at 100 µg/mL for 20 min at 4°C. Antibodies were diluted 
in 0.1 % BSA-PBS Cells were then washed 1 x in PBS and either fixed in SWD 
(500 µL) or transferred to 0.2 µm-filtered sea water (5 mL) and maintained in 
suspension by gentle rocking for 1 h at 20°C. Cells that were fixed immediately 
after incubation with primary antibodies were washed 3 x in PBS. Cells that were 
transferred to sea water were concentrated by centrifugation for 5 min at 500x g 
and washed 1 x in PBS. Sea water-incubated cells were then fixed and washed 3 
x in PBS. Bound antibodies were detected with FITC-conjugated goat anti-
mouse IgG (Sigma) following the manufacturer's instructions. A sub-sample of 
cells from each treatment was photographed (Leica DC300F, Leica 
Microsystems, Wetzlar, Germany) using light and epi-fluorescence microscopy. 
The proportion of wild-type Neoparamoeba spp. expressing epitope(s) to which 
the anti-Gal/GalNAc inhibitable lectin antibodies bound was quantified using 
flow cytometry (Coulter Epics, Beckman Coulter, USA). Ten thousand cells 
were assessed per treatment and data were analysed using WinMDI 2.8 software 
(Joseph Trotter, Scripps Research Institute, La Jolla, CA, USA). 
Binding of the monoclonal anti-E. histolytica Gal/GaINAc antibody, 3F4, to the cell-
surface of wild-type Neoparamoeba spp. was observed immediately following 
incubation. However 3F4 was not detected on the cell-surface of wild-type 
Neoparamoeba spp. after cells were suspended in sea water for one hour (Fig. A3.l). 
The binding of3F4 to wild-typeNeoparamoeba spp. may be disrupted in sea water. 
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Alternatively, wild-type Neoparamoeba spp. may have internalised bound antibodies 
and subsequently the antibodies were degraded or released into the water over the 
one-hour period. While capping of surface bound antibodies by Neoparainoeba spp. 
was not observed in the current study, E. histolytica rapidly redistributes surface 
bound antibodies, forming caps (Calderon, de Lourdes Munoz and Acosta, 1980). 
Disruption of protein synthesis in E. histolytica for 2 h by cycloheximide completely 
abolished binding of mucins (Chadee, Johnson, Orozco, Petri and Ravdin, 1988) 
suggesting that the tum over of cell-surface receptors of E. histolytica is rapid. 
Neoparamoeba spp. may also rapidly replenish cell membrane constituents to which 
3F 4 antibodies bind. Despite the factors associated with the loss of antibody on the 
cell-surface of wild-type Neoparamoeba spp., this may have implications for the 
potential of antibody-mediated protection of Atlantic salmon against wild-type 
Neoparamoeba spp .. However these data represent a single observation and to 
elucidate the potential effect( s) of salmon antibodies on the ability of wild-type 
Neoparamoeba spp. to colonise Atlantic salmon gill tissues, further research is 
warranted. 
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Figure A3.1. The monoclonal anti-Gal/GalNAc inhibitable lectin antibody 3F4 was not 
detectable on the cell-surface of wild-type Neoparamoeba spp. after probed cells were 
incubated in sea water for I h. Live wild-type Neoparamoeba spp. were probed with murine 
IgG isotype control (A) or 3F4 (C and E).The light micrographs correspond to the adjacent 
epi-fluorescent images. A sub-sample from each treatment was photographed before 
quantitative analysis of the remaining sample by flow cytometry. Therefore the histogram 
labels correspond to the images above. Live cells were either fixed following incubation 
with primary antibody (C) or transferred to sea water for I h (E) before fixation and 
detection of bound antibodies. The fluorescence intensity of the murine IgG isotype control 
is shown in the shaded section (A), the intensity of cells incubated in sea water for l h was 
very similar (E).Binding of3F4 to live wild-type Neoparamoeba spp. produces a 
fluorescence intensity significantly higher than the isotype control (C). Bound antibodies 
were detected with FITC-conjugated goat anti-mouse IgG. Data are representative of cells 
within the gated region shown in the dot plot. The proportion of cells producing a 
fluorescence intensity significantly higher than the isotype control are presented on the 
histogram and represent data assessed within the marked region (m). Flow cytometric data 
were analysed and presented using WinMDI 2.8 software. 
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!2S aMl!!ldl:s d:scri!JEd Iler: may te nalura! anbbailles 
g29 
6 
208 
EN TITT2' ooly eampies cantaJnlng arrtH.l:!i;par.mt12ta EPJI- a:iUt<1aleo wllll 
m rneasur..:Jle, ac11 .. 1ty acccfalng !II tne rnelllcd ouUlne:I II~ Ar:loooh 8. l<aatml 
Bl 11950) l'•Ee lllnee or !lstl ane and asti 111•::0. Due ta !he l;;rg:r "olllm: er si;ra 
BJ attanEd rrom run Lvjll, fiEh w1::0 serum wae used ~ 1ne PJEUI~" conl:rol. Binding er 
!H an!-olie.:iparamae.?i~ :;pp. antlDO:llESc presSJt In 1ll3 s.oJllm arnsn 011e pro:iuo;in an 
!3l oi;~cal dE>islly sl111lar to Ille p:n;JU~i: conlrol eera [FI!! 2) At a serum ~uuuoo et 
!36 1·1oc•. tne mean t'iJUCal aenelly ~irre:t by Ille AC-.D-nalVe eerum 1...-0.0 
Bi a 19±0 00), a1 lh: salll" eerum 11uuuo.,, al1l!bac!Es p.-esen.1 In !lie serum or nsh 
m Oil@ ami mm 11\'0 ~Ill., poolU~e ctAliml gera) .11roouce!I o~·i£31 ·UengJUi;g ~r 
~39 a 79:0 03) a 69=:1 02) respeo-.t.ely. \'flllle.! me op:!Oal densey pracwcEd at Ene 
He• serum dl~JUoo or 1:rno was nl]llter uir !Ion oreoe, anU-1.l:!Gpsram!:l2lla S!JP~ me 
Hl anlD!:d)' a::.1,1tyar bJlh nsh oo: and risn two EE>-um '"""equal lll 7 7 l!ilHs iit' ar 
'41 serum tt le !ll1Eres1lng UUt antJDo:Hes preeent In !lie eera or r.•ie neh we..-e 
HJ de'f.!ClaDIE b"j' Weo'.ern b!olUng yet In Olli ELISA, alElllcdy acU~lty 'l.'36 am,· 
;44 rneas=1" l'1 Iha eera Of nsli an: and nsn ilia. lln! ELISA. 0011dn1:m.s ap;iuea 
Hl nera and bf Vlnce.,t er ;;L ·12DOE) w2re inE same anm lt1 boln rnstancee. 
HS an1D:ldleE wsra dE-lectaDI• Dy weetern bXJIUng, Dut nl:<! IV/ ELISA. In ai cases, 
!47 megaU'Ae ;ma ,postr;e co~lrnl sera \'>ere lncilldcel cm eacn plate and 11tra1Jc~ 
HE Cl'JM•E were cbser.'2d rar Ene pcEIUYe co.,tral sera In eai:n ELISA Proc~rq er 
!49 •&11D-l.)]B anagen may damage, er aJrnlniile n=acUye =pl:ap:(s~ HDWE•"er. each 
m• ELISA. assay \\'as @cnauO'ed wr.n an 1r,dcp:naent allqlllll or wlld~jle 
m l~ramc.eti! spp antlge., rrcrn 1he earr.e an.ll;JEl:I PJCI Furli1Em1Dr&. l!ish two 
l!l an'll>::dlas \\'ele measuraDJe by lne ELISA ana ap;F.ar to t!nd !he Eii<"TIE 
' 
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Erl carl:leilylllc.:e epttopc(s) as tne !tirEe sera-~<lSr.t.·e nsn rrcrn lhe e~pertment 
EH der.oerlDed Dy Bf!Dle Et ;1. (!i.1JC<5~ GIYE<1 lhls. lh: !allure I~ detect anllbcales bi 
!55 El.lSI\. suggests !lla1 dE£1al1Jrall°'i pr..Jr ta Wi*Em tlo1Un.g rn;ay enhalle'.!! accEG& 
! !6 t-ll lne releYa.it epllopes or llliil antibody IE•els are, srnpty wry 101°1 
U1 
!!S ln summar,-. 5 al 1 re ,61:'1D-al!Eaed A'Jamb saJmcn dEYE!oped a serum anllbcn)' 
'19 respo.,se lo"o1•ar~s •1111c:-~pe Meopi!!amD~3 spp. cam011yural1' e~pe(&} rl 
!60 1'>11D-f.)JB MEO/li!larrl0~3 sp;i cpp>-3r ID DE lmmunoD°''lllnarl In AUanll~ S3lmcro 
!6! a11d me ceYEID,)mem ar anl!-pepad: aml!lodles spEdlc 10 wne1-;,-pe, 
i61 N.ecparamcei;a spp. Is, at ltito paint. an l&DIEO nndlng ii'u!!ner cnaraclerts"'xm 
!63 or me lllg':l maei:ular wE!ght pepad;o epltape(&]o Is Wiill"llrrtEd and lheee epltc1Je(s) 
E6f are CUITB1Uy unaar lllYEE;~c.;lJ!i. 
!6l 
!66 Tn~ <rulhlrs !llOflk M. Ma.11 8. Dr;::> cmstlle PJJTAS) rar t11Elr JacoratCC'1 suppo.1 
;o.i alld Elr!Jo. ZilErg ror 1ne ra!Jl:ll: anil-<0almon 1£1 anUtoa~·. Tills ·mr~ ror.ncel part or 
i<SS a ~rcjECJ or ;.quann CFl.C. a'.1111 rEOO!l~elll IUl!ds oom me Auslr.llan GClo'elllm:w.'s 
!69 CRCs Program, 1112 i'lshi!rl=s R & o ·D:Jri:ordllcn am! otner C.'l.C Pal11c~a.,J.e_ 
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JC•J Flgu1a 1. Bloj lng or s:rum anll·t.'8'.lparamce.!J• epp. "'1Ut<>aJe.; rmrr. n.r. onE 
JN arrd 0•11 t1.1J to 'Mtc!-t'j'pE Necp;r;m"'c·a spp. (WTJ pfoo~oes oleUr.:c.~· dlrrer.ant 
JC·~ pram:e.. An11..,.~W.Cl3ramct?!JC> .spp. anut-0a1es In one &Ei'l.1111 Dlnd l\'iD baa'lc.s 
JC'5 ~ a.'l'IY"l . :;oo ~oa IA) or wll:l·:)'pE a.1U!?J1 1WT1 and lh:ee ep lto~EiE'1 are not 
301 ~nsltl'~e Lo p:rDcra LE D:rld31lon ~O). In contra51, blndtlg <Jr iin1l~Nei:;:p:;r:imte~a 
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